{"id": 45714138, "time": "2025-06-02 00:17:13", "headline": "Vinod Khosla Tells Google Forget About Search, Sun Microsystems Co-Founder Urges Tech Giant To Invest 'Tens Of Billions' In Self-Driving Before Others Catch Up", "summary": "Venture capitalist Vinod Khosla urges Google to invest in Waymo as it could surpass Google&#39;s search empire, with 250,000 paid rides/week and 10 million lifetime trips.", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/markets/equities/25/06/45714138/vinod-khosla-tells-google-forget-about-search-sun-microsystems-co-founder-urges-tech-giant-to-invest-tens-of-billions-in-self-driving-before-others-catch-up", "tags": []}
{"id": 45714198, "time": "2025-06-02 00:38:06", "headline": "Elon Musk's 'Kekius Maximus' Gameplay Sends These Namesake Coins Surging", "summary": "Meme coins named after \u201cKekius Maximus\u201d surged late Sunday night after tech mogul Elon Musk mentioned it in an X post.", "symbols": ["ETHUSD", "SOLUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/cannabis/25/06/45714198/elon-musks-kekius-maximus-gameplay-sends-these-namesake-coins-surging", "tags": []}
{"id": 45714305, "time": "2025-06-02 01:10:07", "headline": "Elon Musk Says DOGE Became A 'Whipping Boy' For Everything Real Or Imagined \u2014  Tesla CEO Doesn't Agree With Everything White House Does But Won't Speak Out: 'Creates A Bone Of Contention'", "summary": "Elon Musk defended his role at DOGE, saying it was unfairly blamed for federal cutbacks, while admitting he doesn&#39;t agree with all of Trump&#39;s policies but avoids public criticism to prevent conflict.", "symbols": ["TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/cannabis/25/06/45714305/elon-musk-says-doge-became-a-whipping-boy-for-everything-real-or-imagined-tesla-ceo-doesnt-agree-with-everything-white-house-does-but-wont-speak-out", "tags": ["management"]}
{"id": 45714401, "time": "2025-06-02 01:43:53", "headline": "Reported Earlier, Japan Capital Spending (YoY) For Q1 6.4% Vs. 3.8% Est.; -0.2% Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45714401/reported-earlier-japan-capital-spending-yoy-for-q1-6-4-vs-3-8-est-0-2-prior", "tags": []}
{"id": 45714413, "time": "2025-06-02 01:47:27", "headline": "Sanofi To Acquire Blueprint Medicines For $9.5B, Paying $129/Share To Expand Rare Immunology Portfolio With Ayvakit And KIT Pipeline", "summary": "", "symbols": ["BPMC", "SNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45714413/sanofi-to-acquire-blueprint-medicines-for-9-5b-paying-129share-to-expand-rare-immunology-portfolio-w", "tags": ["merger"]}
{"id": 45714415, "time": "2025-06-02 01:48:22", "headline": "Flex LNG Finalizes $175M Lease Financing For Flex Courageous, Unlocking $42M And Extending Debt To 2035", "summary": "", "symbols": ["FLNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714415/flex-lng-finalizes-175m-lease-financing-for-flex-courageous-unlocking-42m-and-extending-debt-to-2035", "tags": []}
{"id": 45714416, "time": "2025-06-02 01:48:40", "headline": "Former Treasury Secretary Larry Summers Warns The Dollar Is Starting To Trade Like A Latin American Currency \u2014 Greenback Going From Safe Haven To Risk Asset?", "summary": "Former U.S. Treasury Secretary Lawrence Summers warns that the U.S. Dollar may no longer be the sanctuary that investors from across the globe once counted on.", "symbols": [], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/markets/macro-economic-events/25/06/45714416/former-treasury-secretary-larry-summers-warns-the-dollar-is-starting-to-trade-like-a-latin-american-currency-greenback-going-from-safe-haven-to-risk-asset", "tags": []}
{"id": 45714428, "time": "2025-06-02 01:51:04", "headline": "Sandoz Brings First Interchangeable Denosumab Biosimilars To US Market With WYOST And Jubbonti, Enhancing Treatment Options For Osteoporosis And Cancer", "summary": "", "symbols": ["SDZNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714428/sandoz-brings-first-interchangeable-denosumab-biosimilars-to-us-market-with-wyost-and-jubbonti-enhan", "tags": []}
{"id": 45714473, "time": "2025-06-02 01:52:31", "headline": "Vodafone Qatar Partners With Nokia To Transform 5G Network With Cloud-Native Core, Slicing Automation, And AI-Driven Assurance", "summary": "", "symbols": ["NOK", "VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714473/vodafone-qatar-partners-with-nokia-to-transform-5g-network-with-cloud-native-core-slicing-automation", "tags": ["contract"]}
{"id": 45714519, "time": "2025-06-02 01:55:50", "headline": "Ross Ulbricht, The Silk Road Founder Pardoned By Trump Soon After His Inauguration, Receives A Whopping $31 Million Worth Of Bitcoin In Donation Wallet", "summary": "A wallet linked to Ross Ulbricht, the creator of illegal drug marketplace\u00a0Silk Road, received over $30 million in Bitcoin (CRYPTO: BTC) on Saturday, sparking intrigue among the cryptocurrency community.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/cannabis/25/06/45714519/ross-ulbricht-the-silk-road-founder-pardoned-by-trump-soon-after-his-inauguration-receives-a-whopping-31-million-worth-of-bitcoin-in-donation-wallet", "tags": []}
{"id": 45714549, "time": "2025-06-02 02:03:22", "headline": "U.K. Nationwide HPI (MoM) For May 0.5% Vs. 0.0% Est.; -0.6% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45714549/u-k-nationwide-hpi-mom-for-may-0-5-vs-0-0-est-0-6-prior", "tags": []}
{"id": 45714550, "time": "2025-06-02 02:03:52", "headline": "U.K. Nationwide HPI (YoY) For May 3.5% Vs. 2.9% Est.; 3.4% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45714550/u-k-nationwide-hpi-yoy-for-may-3-5-vs-2-9-est-3-4-prior", "tags": []}
{"id": 45714555, "time": "2025-06-02 02:05:54", "headline": "Indivior To Delist From LSE, Citing US Revenue Dominance And Higher Nasdaq Liquidity In Move To Streamline Operations", "summary": "", "symbols": ["INDV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714555/indivior-to-delist-from-lse-citing-us-revenue-dominance-and-higher-nasdaq-liquidity-in-move-to-strea", "tags": ["earnings"]}
{"id": 45714570, "time": "2025-06-02 02:10:06", "headline": "NIO Delivers 23,231 Vehicles In May, Marking 13.1% Year-Over-Year Growth", "summary": "", "symbols": ["NIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714570/nio-delivers-23-231-vehicles-in-may-marking-13-1-year-over-year-growth", "tags": []}
{"id": 45714572, "time": "2025-06-02 02:12:02", "headline": "Reported Saturday, XPENG's May 2025 Delivery Update: Delivered 33,525 Vehicles, Up 230% YoY", "summary": "", "symbols": ["XPEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714572/reported-saturday-xpengs-may-2025-delivery-update-delivered-33-525-vehicles-up-230-yoy", "tags": []}
{"id": 45714576, "time": "2025-06-02 02:14:11", "headline": "Reported Saturday, ZEEKR's Cumulative Deliveries Reached 46,538 In May (+15.2% YoY), With 18,908 From Zeekr And 27,630 From Lynk & Co.", "summary": "", "symbols": ["ZK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714576/reported-saturday-zeekrs-cumulative-deliveries-reached-46-538-in-may-15-2-yoy-with-18-908-from-zeekr", "tags": []}
{"id": 45714579, "time": "2025-06-02 02:16:47", "headline": "Reported Saturday, Li Auto May Deliveries Rise 16.7% Year-Over-Year To 40,856 Vehicles", "summary": "", "symbols": ["LI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714579/reported-saturday-li-auto-may-deliveries-rise-16-7-year-over-year-to-40-856-vehicles", "tags": []}
{"id": 45714580, "time": "2025-06-02 02:18:55", "headline": "Reported Sunday, Mitsubishi Electric Joins G7 Nature Positive Alliance, Expanding Efforts To Align Business Growth With Biodiversity And Environmental Goals", "summary": "", "symbols": ["MIELY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714580/reported-sunday-mitsubishi-electric-joins-g7-nature-positive-alliance-expanding-efforts-to-align-bus", "tags": []}
{"id": 45714594, "time": "2025-06-02 02:22:06", "headline": "Reported Sunday, HUTCHMED Highlights SACHI Phase III Data At ASCO 2025: Savolitinib Plus Osimertinib Shows Significant PFS Benefit In EGFR+ NSCLC With MET Amplification", "summary": "", "symbols": ["HCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/small-business/25/06/45714594/reported-sunday-hutchmed-highlights-sachi-phase-iii-data-at-asco-2025-savolitinib-plus-osimertinib", "tags": ["fda"]}
{"id": 45714783, "time": "2025-06-02 02:25:01", "headline": "Reported Sunday, FDA Grants Priority Review To Kura And Kyowa Kirin's Ziftomenib NDA, Targeting First Menin Inhibitor Approval In NPM1-Mutant AML By November 30", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714783/reported-sunday-fda-grants-priority-review-to-kura-and-kyowa-kirins-ziftomenib-nda-targeting-first-m", "tags": ["fda"]}
{"id": 45714786, "time": "2025-06-02 02:27:00", "headline": "Reported Sunday,Cenovus Energy Temporarily Halts Christina Lake Output Due To Wildfires, Affecting 238,000 BPD Of Production", "summary": "", "symbols": ["CVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714786/reported-sunday-cenovus-energy-temporarily-halts-christina-lake-output-due-to-wildfires-affecting-23", "tags": []}
{"id": 45714800, "time": "2025-06-02 02:37:01", "headline": "Fed's Christopher Waller Signals Caution On Rate Cut Amid Tariff-Driven Inflation Risks", "summary": "Federal Reserve Governor Christopher Waller warned that tariff-induced inflation could temporarily push prices higher.", "symbols": ["JPM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/macro-economic-events/25/06/45714800/feds-christopher-waller-signals-caution-on-rate-cut-amid-tariff-driven-inflation-risks", "tags": []}
{"id": 45714838, "time": "2025-06-02 02:51:18", "headline": "Delaying Artificial Intelligence The Real Existential Risk Says Joscha Bach, Scientist Says He's More Afraid That 'We Don't Build AI'", "summary": "Joscha Bach warns that humanity is more likely to face extinction from neglecting AI than from developing it too quickly.", "symbols": ["AAPL", "GOOG", "GOOGL", "META"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/markets/equities/25/06/45714838/delaying-artificial-intelligence-the-real-existential-risk-says-joscha-bach-scientist-says-hes-more-afraid-that-we-dont-build-ai", "tags": []}
{"id": 45714995, "time": "2025-06-02 02:52:57", "headline": "Reported Sunday, Arcus ARC-20 Data Show 46% Confirmed Response Rate With Casdatifan And Cabozantinib In Immunotherapy-Experienced Kidney Cancer", "summary": "", "symbols": ["RCUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45714995/reported-sunday-arcus-arc-20-data-show-46-confirmed-response-rate-with-casdatifan-and-cabozantinib-i", "tags": []}
{"id": 45715047, "time": "2025-06-02 02:57:24", "headline": "BYD's Aggressive Pricing Triggers EV 'Rat Race:' Stock Tumbles, Authorities Voice Concern", "summary": "BYD faces backlash for aggressive discounts in domestic EV market as Chinese officials warn of damage to supply chains and reputation.", "symbols": ["BYDDF", "BYDDY", "TSLA"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/news/topics/25/06/45715047/byds-aggressive-pricing-triggers-ev-rat-race-stock-tumbles-authorities-voice-concern", "tags": []}
{"id": 45715056, "time": "2025-06-02 02:57:54", "headline": "Reported Sunday, Allogene Reports 31% Confirmed Response Rate With ALLO-316 In CD70-High RCC Patients At ASCO, With Durable Remissions And Manageable Safety", "summary": "", "symbols": ["ALLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715056/reported-sunday-allogene-reports-31-confirmed-response-rate-with-allo-316-in-cd70-high-rcc-patients", "tags": []}
{"id": 45715071, "time": "2025-06-02 03:01:53", "headline": "Michael Saylor Asks Joe Rogan For A Chat: 'Let's Talk About Bitcoin'", "summary": "Strategy Inc. (NASDAQ:MSTR) executive chairman Michael Saylor expressed interest Saturday in discussing Bitcoin (CRYPTO: BTC) with popular podcaster Joe Rogan.", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/cannabis/25/06/45715071/michael-saylor-asks-joe-rogan-for-a-chat-lets-talk-about-bitcoin", "tags": []}
{"id": 45715095, "time": "2025-06-02 03:05:26", "headline": "Reported Sunday, Replimune Reports 32.9% ORR With RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At ASCO, With Deep Organ Injections Showing Higher Response Rates", "summary": "", "symbols": ["REPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715095/reported-sunday-replimune-reports-32-9-orr-with-rp1-plus-nivolumab-in-anti-pd1-failed-melanoma-at-as", "tags": []}
{"id": 45715134, "time": "2025-06-02 03:07:49", "headline": "MaxLinear And Comtrend Unveil EV Charging Station Modules Using G.hn For Real-Time, Reliable Data Over Existing Powerlines", "summary": "", "symbols": ["MXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715134/maxlinear-and-comtrend-unveil-ev-charging-station-modules-using-g-hn-for-real-time-reliable-data-ove", "tags": []}
{"id": 45715154, "time": "2025-06-02 03:10:41", "headline": "Colt, Honeywell, And Nokia Collaborate On Space-Based Quantum-Safe Cryptography Using Low Earth Orbit Satellites", "summary": "", "symbols": ["CZGZF", "HON", "NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715154/colt-honeywell-and-nokia-collaborate-on-space-based-quantum-safe-cryptography-using-low-earth-orbit", "tags": []}
{"id": 45715155, "time": "2025-06-02 03:10:50", "headline": "Elizabeth Warren Calls It 'Textbook Corruption,' Once Again Asks For Probe Into Elon Musk 'Cashing In' On Trump Tariffs", "summary": "Sen. Elizabeth Warren on Sunday reiterated her allegations that Elon Musk&#39;s Starlink benefited from Trump-era tariffs, calling it &#34;textbook corruption&#34; and urging a federal investigation into the timing of trade deals and foreign permits.", "symbols": ["TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/cannabis/25/06/45715155/elizabeth-warren-calls-it-textbook-corruption-once-again-asks-for-probe-into-elon-musk-cashing-in-on-trump-tariffs", "tags": ["legal"]}
{"id": 45715174, "time": "2025-06-02 03:18:12", "headline": "Clarivate And CAPES Sign Five-Year Agreement To Broaden Access To Trusted Academic And Life Sciences Tools Across Brazil", "summary": "", "symbols": ["CLVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715174/clarivate-and-capes-sign-five-year-agreement-to-broaden-access-to-trusted-academic-and-life-sciences", "tags": ["contract"]}
{"id": 45715176, "time": "2025-06-02 03:20:30", "headline": "Reported Saturday, Daiichi Sankyo And AstraZeneca's ENHERTU Demonstrates 14.7-Month Median OS And 30% Reduction In Risk Of Death In HER2+ Gastric Cancer", "summary": "", "symbols": ["AZN", "DSNKY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715176/reported-saturday-daiichi-sankyo-and-astrazenecas-enhertu-demonstrates-14-7-month-median-os-and-30-r", "tags": []}
{"id": 45715384, "time": "2025-06-02 03:23:22", "headline": "Top Wall Street Forecasters Revamp Campbell's Expectations Ahead Of Q3 Earnings", "summary": " ", "symbols": ["CPB"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45715384/top-wall-street-forecasters-revamp-campbells-expectations-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 45715393, "time": "2025-06-02 03:23:51", "headline": "Reported Sunday, AstraZeneca's Camizestrant Reduces Risk Of Progression Or Death By 56% In HR+ Advanced Breast Cancer With ESR1 Mutation In SERENA-6 Trial", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715393/reported-sunday-astrazenecas-camizestrant-reduces-risk-of-progression-or-death-by-56-in-hr-advanced", "tags": ["fda"]}
{"id": 45715397, "time": "2025-06-02 03:25:12", "headline": "Reported Sunday, AstraZeneca's IMFINZI Regimen Reduces Risk Of Progression, Recurrence, Or Death By 29% In Early Gastric Cancer In Phase 3 MATTERHORN Trial", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715397/reported-sunday-astrazenecas-imfinzi-regimen-reduces-risk-of-progression-recurrence-or-death-by-29-i", "tags": ["fda"]}
{"id": 45715400, "time": "2025-06-02 03:27:40", "headline": "Reported Sunday, AstraZeneca's DATROWAY Shows Over 55% Response Rate In First-Line Advanced NSCLC In TROPION-Lung02 Phase 1b Trial With Immunotherapy Combinations", "summary": "", "symbols": ["AZN", "DSNKY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715400/reported-sunday-astrazenecas-datroway-shows-over-55-response-rate-in-first-line-advanced-nsclc-in-tr", "tags": ["fda"]}
{"id": 45715402, "time": "2025-06-02 03:29:14", "headline": "Reported Saturday, Tempus Unveils Fuses Program To Transform Precision Medicine With AI-Powered Diagnostic Models And Multimodal Data At Scale", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715402/reported-saturday-tempus-unveils-fuses-program-to-transform-precision-medicine-with-ai-powered-diagn", "tags": []}
{"id": 45715412, "time": "2025-06-02 03:31:36", "headline": "Reported Sunday, Taiho And Cullinan's Zipalertinib Shows 40% ORR In Platinum-Treated EGFR ex20ins NSCLC, REZILIENT1 Results Published In JCO", "summary": "", "symbols": ["CGEM", "TAIHF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715412/reported-sunday-taiho-and-cullinans-zipalertinib-shows-40-orr-in-platinum-treated-egfr-ex20ins-nsclc", "tags": []}
{"id": 45715413, "time": "2025-06-02 03:33:37", "headline": "Joe Lonsdale Slams Healthcare 'Cartels:' Urges AI, Regulatory Reform To Slash Costs, Reclaim Biotech From China", "summary": "Joe Lonsdale delivered sharp criticism of America&#39;s healthcare system during the Reagan National Economic Forum.", "symbols": ["PLTR"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/health-care/25/06/45715413/joe-lonsdale-slams-healthcare-cartels-urges-ai-regulatory-reform-to-slash-costs-reclaim-biotech-from-china", "tags": []}
{"id": 45715436, "time": "2025-06-02 03:38:56", "headline": "US 'Never Going To Default,' Says Scott Bessent, Dismissing Jamie Dimon's Debt Crisis Warnings: 'For His Entire Career\u2026'", "summary": "Scott Bessent, the U.S. Treasury Secretary, assured that the country will not default on its debt, even as the deadline for raising the federal debt ceiling approaches.", "symbols": ["JPM"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/macro-economic-events/25/06/45715436/us-never-going-to-default-says-scott-bessent-dismissing-jamie-dimons-debt-crisis-warnings-for-his-entire-career", "tags": []}
{"id": 45715447, "time": "2025-06-02 03:41:14", "headline": "Xi Jinping's China Dismisses Trump's 'Groundless' Accusations On Geneva Trade Deal Breach, Vows Strong Retaliation", "summary": "China has refuted U.S. President Donald Trump&#39;s claims of breaching the Geneva trade agreement, labeling them as unfounded. ", "symbols": ["BABA", "BIDU"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/news/politics/25/06/45715447/xi-jinpings-china-dismisses-trumps-groundless-accusations-on-geneva-trade-deal-breach-vows-strong-retaliation", "tags": ["contract"]}
{"id": 45715466, "time": "2025-06-02 03:42:05", "headline": "Campbell's, SAIC And 3 Stocks To Watch Heading Into Monday", "summary": " ", "symbols": ["BPMC", "CPB", "CRDO", "PSTV", "SAIC", "SNY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/25/06/45715466/campbells-saic-and-3-stocks-to-watch-heading-into-monday", "tags": []}
{"id": 45715467, "time": "2025-06-02 03:42:12", "headline": "Reported Sunday, Protagonist And Takeda Present 32-Week VERIFY Data: Rusfertide Significantly Reduces Phlebotomy, Improves Symptoms In Polycythemia Vera", "summary": "", "symbols": ["PTGX", "TAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715467/reported-sunday-protagonist-and-takeda-present-32-week-verify-data-rusfertide-significantly-reduces", "tags": []}
{"id": 45715489, "time": "2025-06-02 03:50:29", "headline": "S&P 500 Records Gain For May: Investor Sentiment Declines, But Fear Index Remains In 'Greed' Zone", "summary": " ", "symbols": ["CPB", "CRDO", "DELL", "SAIC", "ULTA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/25/06/45715489/sp-500-records-gain-for-may-investor-sentiment-declines-but-fear-index-remains-in-greed-zone", "tags": []}
{"id": 45715585, "time": "2025-06-02 03:53:11", "headline": "Reported Saturday, Gilead's TROP-2 ADC Trodelvy, In Combination With Keytruda, Shows Clinically Meaningful Survival Gains And Fewer Adverse Event-Related Discontinuations In ASCENT-04", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715585/reported-saturday-gileads-trop-2-adc-trodelvy-in-combination-with-keytruda-shows-clinically-meaningf", "tags": []}
{"id": 45715622, "time": "2025-06-02 03:55:06", "headline": "Reported Sunday, Gilead's Kite Presents Real-World Data At ASCO 2025 Supporting Outpatient Use Of Yescarta For R/R Large B-Cell Lymphoma With Comparable Safety And Efficacy", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715622/reported-sunday-gileads-kite-presents-real-world-data-at-asco-2025-supporting-outpatient-use-of-yesc", "tags": []}
{"id": 45715629, "time": "2025-06-02 03:57:12", "headline": "Reported Sunday, China Liberal Education To Be Suspended From Nasdaq June 3 After Failing To Address 20-F Filing Delinquency", "summary": "", "symbols": ["CLEU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715629/reported-sunday-china-liberal-education-to-be-suspended-from-nasdaq-june-3-after-failing-to-address", "tags": []}
{"id": 45715650, "time": "2025-06-02 04:01:35", "headline": "France Manufacturing Purchasing Managers Index For May 49.8 Vs. 49.5 Est.; 48.7 Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45715650/france-manufacturing-purchasing-managers-index-for-may-49-8-vs-49-5-est-48-7-prio", "tags": []}
{"id": 45715660, "time": "2025-06-02 04:02:42", "headline": "Germany Manufacturing Purchasing Managers Index For May 48.3 Vs. 48.8 Est.; 48.4 Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45715660/germany-manufacturing-purchasing-managers-index-for-may-48-3-vs-48-8-est-48-4-pri", "tags": []}
{"id": 45715661, "time": "2025-06-02 04:04:21", "headline": "Eurozone Manufacturing Purchasing Managers Index For May 49.4 Vs. 48.4 Est.; 49.0\tPrior", "summary": "", "symbols": ["VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45715661/eurozone-manufacturing-purchasing-managers-index-for-may-49-4-vs-48-4-est-49-0-pr", "tags": []}
{"id": 45715667, "time": "2025-06-02 04:06:51", "headline": "Reported Saturday, Actuate's Elraglusib Meets Primary Endpoint In Phase 2 mPDAC Trial, Extending Median Overall Survival To 10.1 Months And Cutting Risk Of Death By 37%", "summary": "", "symbols": ["ACTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715667/reported-saturday-actuates-elraglusib-meets-primary-endpoint-in-phase-2-mpdac-trial-extending-median", "tags": ["fda"]}
{"id": 45715677, "time": "2025-06-02 04:08:45", "headline": "Tom Lee Bets On 'A New Bull Market,' As Trump's Tariff Retreat Fuels 'TACO' Trade Amid 'Run It Hot' Optimism", "summary": "Fundstrat&#39;s Tom Lee has been betting on a &#34;new bull market&#34; following the spike in the volatility gauge in April, while another analyst believes that it is the &#34;TACO&#34; trade that is fueling the &#34;run it hot&#34; optimism in the market.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45715677/tom-lee-bets-on-a-new-bull-market-as-trumps-tariff-retreat-fuels-taco-trade-amid-run-it-hot-optimism", "tags": []}
{"id": 45715685, "time": "2025-06-02 04:09:23", "headline": "Howard Lutnick Calls $1.2 Trillion Trade Deficit A 'National Emergency,' Says Trump's Tariffs Are 'Not Going Away'", "summary": "Commerce Secretary Howard Lutnick doubled down on the Trump administration&#39;s tariff strategy following recent federal court rulings that blocked key trade policies, declaring America&#39;s trade deficit a national emergency requiring immediate action.", "symbols": [], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/markets/economic-data/25/06/45715685/howard-lutnick-calls-1-2-trillion-trade-deficit-a-national-emergency-says-trumps-tariffs-are-not-going-away", "tags": ["legal"]}
{"id": 45715703, "time": "2025-06-02 04:10:30", "headline": "Reported Sunday, Zai Lab And Novocure Announce PANOVA-3 Results: TTFields Therapy Achieves Median OS Of 16.2 Months With Significant Gains In Quality Of Life And Pain Control", "summary": "", "symbols": ["NVCR", "ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715703/reported-sunday-zai-lab-and-novocure-announce-panova-3-results-ttfields-therapy-achieves-median-os-o", "tags": []}
{"id": 45715712, "time": "2025-06-02 04:15:04", "headline": "Obama's AI Job Loss Warnings Aren't Accidental, Says David Sacks: They're Fueling A Global Power Grab And 'The Most Orwellian Future Imaginable'", "summary": "David Sacks criticizes Obama&#39;s warnings about AI job displacement, calling them part of a power grab by government and globalist institutions.", "symbols": [], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/topics/25/06/45715712/obamas-ai-job-loss-warnings-arent-accidental-says-david-sacks-theyre-fueling-a-global-power-grab-and-the-most-orwellian-future-imaginable", "tags": []}
{"id": 45715724, "time": "2025-06-02 04:17:07", "headline": "Reported Saturday, Genentech's Itovebi-Based Regimen Cuts Risk Of Death By Over 30% In PIK3CA-Mutated HR-Positive, HER2-Negative Advanced Breast Cancer, Phase III INAVO120 Data Show", "summary": "", "symbols": ["RHHBF", "RHHBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715724/reported-saturday-genentechs-itovebi-based-regimen-cuts-risk-of-death-by-over-30-in-pik3ca-mutated-h", "tags": ["fda"]}
{"id": 45715734, "time": "2025-06-02 04:21:37", "headline": "Reported Saturday, Regeneron's Libtayo Demonstrates Practice-Changing Results In Adjuvant High-Risk Cutaneous Squamous Cell Carcinoma With 87% Two-Year Disease-Free Survival", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715734/reported-saturday-regenerons-libtayo-demonstrates-practice-changing-results-in-adjuvant-high-risk-cu", "tags": []}
{"id": 45715850, "time": "2025-06-02 04:28:04", "headline": "Trump Administration Silently Employs Palantir To Gather Personal Data Of Each American, Raising Privacy, Data Misuse Concerns: Report", "summary": "The Trump administration has reportedly been discreetly working with\u00a0Palantir Technologies Inc.\u00a0(NASDAQ: PLTR) to gather personal data of American citizens from various federal agencies, sparking concerns over privacy and potential misuse of personal data.", "symbols": ["PLTR", "SAP", "TSLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/equities/25/06/45715850/trump-administration-silently-employs-palantir-to-gather-personal-data-of-each-american-raising-privacy-data-misuse-concerns-report", "tags": []}
{"id": 45715859, "time": "2025-06-02 04:29:27", "headline": "Reported Saturday, Arvinas and Pfizer's Vepdegestrant Demonstrates Statistically Significant 2.9-Month PFS Benefit Over Fulvestrant In ESR1-Mutant Second-Line Advanced Breast Cancer", "summary": "", "symbols": ["ARVN", "PFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715859/reported-saturday-arvinas-and-pfizers-vepdegestrant-demonstrates-statistically-significant-2-9-month", "tags": []}
{"id": 45715861, "time": "2025-06-02 04:29:46", "headline": "Donald Trump Withdraws Jared Isaacman's Nomination For NASA Administrator, Says New Nominee Would 'Put America First in Space'", "summary": "Donald Trump withdrew Jared Isaacman&#39;s NASA administrator nomination due to prior political associations, new nominee will be announced soon.", "symbols": [], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/cannabis/25/06/45715861/donald-trump-withdraws-jared-isaacmans-nomination-for-nasa-administrator-says-new-nominee-would-put-america-first-in-space", "tags": []}
{"id": 45715879, "time": "2025-06-02 04:32:07", "headline": "Earnings Scheduled For June 2, 2025", "summary": " ", "symbols": ["CPB", "CRDO", "SAIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45715879/earnings-scheduled-for-june-2-2025", "tags": ["earnings"]}
{"id": 45715892, "time": "2025-06-02 04:33:26", "headline": "Hagerty's Broad Arrow Adds Belgium Auction Featuring 70 Classic Cars at Zoute Grand Prix", "summary": "", "symbols": ["HGTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715892/hagertys-broad-arrow-adds-belgium-auction-featuring-70-classic-cars-at-zoute-grand-prix", "tags": []}
{"id": 45715901, "time": "2025-06-02 04:35:47", "headline": "U.K. Manufacturing Purchasing Managers Index For May 46.4 Vs. 45.1 Est.; 45.4 Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45715901/u-k-manufacturing-purchasing-managers-index-for-may-46-4-vs-45-1-est-45-4-prior", "tags": []}
{"id": 45715925, "time": "2025-06-02 04:45:13", "headline": "Reported Saturday, BeOne's SEQUOIA Trial Shows BRUKINSA Plus Venetoclax Yields Deep, Durable Responses Across CLL Risk Groups Including del(17p) And TP53", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715925/reported-saturday-beones-sequoia-trial-shows-brukinsa-plus-venetoclax-yields-deep-durable-responses", "tags": ["fda"]}
{"id": 45715949, "time": "2025-06-02 04:52:23", "headline": "Reported Saturday, Immatics Presents Expanded IMA203 PRAME Cell Therapy Results At ASCO: Durable Objective Responses In 91% Of Patients And Favorable Safety Profile", "summary": "", "symbols": ["IMTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45715949/reported-saturday-immatics-presents-expanded-ima203-prame-cell-therapy-results-at-asco-durable-objec", "tags": []}
{"id": 45715939, "time": "2025-06-02 04:51:05", "headline": "51.2 Million Measles Cases, 159,200 Deaths: New Study Warns Of Surge In Preventable Diseases Amid Growing Vaccine Skepticism", "summary": "A new study warns that declining childhood vaccination rates in the United States could trigger a dramatic resurgence of diseases.", "symbols": [], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/news/health-care/25/06/45715939/51-2-million-measles-cases-159200-deaths-new-study-warns-of-surge-in-preventable-diseases-amid-vaccine-skepticism", "tags": []}
{"id": 45716055, "time": "2025-06-02 04:53:46", "headline": "Reported Saturday, Xilio's Tumor-Activated Anti-CTLA-4 Vilastobart Shows 26% Objective Response Rate With Durable Responses And Low Colitis In MSS CRC Without Liver Metastases", "summary": "", "symbols": ["XLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716055/reported-saturday-xilios-tumor-activated-anti-ctla-4-vilastobart-shows-26-objective-response-rate-wi", "tags": []}
{"id": 45716060, "time": "2025-06-02 04:56:21", "headline": "Reported Saturday, mNEXSPIKE Becomes FDA-Approved: Moderna's New COVID-19 Vaccine Shows Higher Efficacy vs. Spikevax In Phase 3 Trial", "summary": "", "symbols": ["MRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716060/reported-saturday-mnexspike-becomes-fda-approved-modernas-new-covid-19-vaccine-shows-higher-efficacy", "tags": ["fda"]}
{"id": 45716061, "time": "2025-06-02 04:58:27", "headline": "Reported Friday, Teva Showcases Real-World UZEDY Data Demonstrating Lower Relapse Rates, Better Adherence, And Reduced Healthcare Use Compared To Oral Antipsychotics", "summary": "", "symbols": ["TEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716061/reported-friday-teva-showcases-real-world-uzedy-data-demonstrating-lower-relapse-rates-better-adhere", "tags": []}
{"id": 45716143, "time": "2025-06-02 05:09:25", "headline": "Trump Administration Set To Ease Big Bank Rules In Major Rollback Since 2008 Crisis: Here Are The Stocks And ETFs Investors Could Consider", "summary": "As Donald Trump&#39;s administration nears completion of a proposal to ease big bank rules, they are largely expected to cheer the lower SLR.", "symbols": ["BAC", "BANF", "C", "FITB", "FTXO", "GGAL", "GS", "GSIB", "JPM", "KBE", "KBWB", "MS", "QQQ", "SPY", "WFC"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/etfs/sector-etfs/25/06/45716143/trump-administration-set-to-ease-big-bank-rules-in-major-rollback-since-2008-crisis-here-are-the-stocks-and-etfs-investors-could-consider", "tags": []}
{"id": 45716164, "time": "2025-06-02 05:12:52", "headline": "BMO Capital Initiates Coverage On Aspen Insurance Hldgs with Outperform Rating, Announces Price Target of $38", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716164/bmo-capital-initiates-coverage-on-aspen-insurance-hldgs-with-outperform-rating-announces-price-targe", "tags": ["analyst_init"]}
{"id": 45716167, "time": "2025-06-02 05:14:53", "headline": "BMO Capital Upgrades Nucor to Outperform, Raises Price Target to $145", "summary": "", "symbols": ["NUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716167/bmo-capital-upgrades-nucor-to-outperform-raises-price-target-to-145", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716170, "time": "2025-06-02 05:17:41", "headline": "Life360 Plans $250M Convertible Notes Offering, Eyes Future Growth and Strategic Deals", "summary": "", "symbols": ["LIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716170/life360-plans-250m-convertible-notes-offering-eyes-future-growth-and-strategic-deals", "tags": ["offering"]}
{"id": 45716179, "time": "2025-06-02 05:20:12", "headline": "Tesla's China Sales Slump While BYD And Li Auto Post Strong Gains: Report", "summary": "Tesla&#39;s Chinese sales declined compared to rivals NIO, Xpeng, Li Auto, and BYD in May as company also faces a drop in European sales", "symbols": ["BYDDF", "BYDDY", "LI", "NIO", "TSLA", "XPEV"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/news/topics/25/06/45716179/teslas-china-sales-slump-while-byd-and-li-auto-post-strong-gains-report", "tags": []}
{"id": 45716369, "time": "2025-06-02 05:24:57", "headline": "Goldman Sachs Initiates Coverage On Aspen Insurance Hldgs with Neutral Rating, Announces Price Target of $38", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716369/goldman-sachs-initiates-coverage-on-aspen-insurance-hldgs-with-neutral-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 45716370, "time": "2025-06-02 05:25:09", "headline": "Ethereum's L1 Will Be Scaled By 10x Over The Next Year, Says Vitalik Buterin", "summary": "Ethereum (CRYPTO: ETH) co-founder Vitalik Buterin said Friday that the blockchain&#39;s base layer will be scaled tenfold in about a year.\n\n\n\nWhat happened: Buterin was speaking about ecosystem developments at a fireside chat at ETHGlobal Prague 2025.", "symbols": ["ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/25/06/45716370/ethereums-l1-will-be-scaled-by-10x-over-the-next-year-says-vitalik-buterin", "tags": []}
{"id": 45716383, "time": "2025-06-02 05:27:14", "headline": "Trump Administration Shuts Down $66 Million Food Stamp Fraud And Bribery Scheme, Arrests USDA Employee And 5 Others", "summary": "The\u00a0U.S. Department of Agriculture (USDA)\u00a0has discovered a major\u00a0food stamp fraud\u00a0and bribery scheme, misappropriating millions of taxpayer dollars. This has led to the arrest of a USDA employee and five others.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/news/politics/25/06/45716383/trump-administration-shuts-down-66-million-food-stamp-fraud-and-bribery-scheme-arrests-usda-employee-and-5-others", "tags": []}
{"id": 45716392, "time": "2025-06-02 05:27:44", "headline": "Goldman Sachs Upgrades Old Dominion Freight Line to Buy, Raises Price Target to $200", "summary": "", "symbols": ["ODFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716392/goldman-sachs-upgrades-old-dominion-freight-line-to-buy-raises-price-target-to-200", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716400, "time": "2025-06-02 05:31:02", "headline": "'Pharma Bro' Martin Shkreli Sees $10 Trillion Potential In Palantir, But Cautions: 'One Bad Quarter And It's Down 50%'", "summary": "Former hedge fund manager Martin Shkreli expressed bullish views on Palantir Technologies Inc. while cautioning investors about the stock&#39;s inherent volatility during a conversation with tech and stock content creator Amit Kukreja.", "symbols": ["PLTR"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45716400/pharma-bro-martin-shkreli-sees-10-trillion-potential-in-palantir-but-cautions-one-bad-quarter-and-its-down-50", "tags": []}
{"id": 45716417, "time": "2025-06-02 05:33:47", "headline": "Pony.ai Teams Up With Xihu Group to Expand Driverless Ride Service Across Chinese Megacity Shenzhen", "summary": "", "symbols": ["PONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716417/pony-ai-teams-up-with-xihu-group-to-expand-driverless-ride-service-across-chinese-megacity-shenzhen", "tags": []}
{"id": 45716422, "time": "2025-06-02 05:34:55", "headline": "Goldman Sachs Upgrades Saia to Buy, Raises Price Target to $410", "summary": "", "symbols": ["SAIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716422/goldman-sachs-upgrades-saia-to-buy-raises-price-target-to-410", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716440, "time": "2025-06-02 05:38:03", "headline": "Goldman Sachs Upgrades ArcBest to Buy, Raises Price Target to $101", "summary": "", "symbols": ["ARCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716440/goldman-sachs-upgrades-arcbest-to-buy-raises-price-target-to-101", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716458, "time": "2025-06-02 05:43:16", "headline": "Ascendiant Capital Maintains Buy on 60 Degrees, Raises Price Target to $7", "summary": "", "symbols": ["SXTP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716458/ascendiant-capital-maintains-buy-on-60-degrees-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 45716460, "time": "2025-06-02 05:44:37", "headline": "Goldman Sachs Downgrades Union Pacific to Neutral, Maintains Price Target to $263", "summary": "", "symbols": ["UNP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716460/goldman-sachs-downgrades-union-pacific-to-neutral-maintains-price-target-to-263", "tags": ["analyst_down", "analyst_other"]}
{"id": 45716469, "time": "2025-06-02 05:47:51", "headline": "Goldman Sachs Downgrades Norfolk Southern to Neutral, Maintains Price Target to $278", "summary": "", "symbols": ["NSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716469/goldman-sachs-downgrades-norfolk-southern-to-neutral-maintains-price-target-to-278", "tags": ["analyst_down", "analyst_other"]}
{"id": 45716470, "time": "2025-06-02 05:48:28", "headline": "Nokia Was Worth 40 Times More Than Apple 25 Years Ago, When The Legendary Nokia 3310 Was Launched: 7 Years Later, Steve Jobs Ended The Era Of Dumb Phones. Is The Writing On The Wall For Cupertino As It Trails In The AI Race?", "summary": "Apple, once nearly 40 times smaller than Nokia, now risks repeating the Finnish giant&#39;s downfall as it trails rivals in the AI race.", "symbols": ["AAPL", "GOOG", "GOOGL", "MSFT", "NOK"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/news/topics/25/06/45716470/nokia-was-worth-40-times-more-than-apple-25-years-ago-when-the-legendary-nokia-3310-was-launched-7-years-later-steve-jobs-ended-the-era-of-dumb-phones-is-the-writing-on-the-wall-for-cupertino-as-i", "tags": []}
{"id": 45716621, "time": "2025-06-02 05:54:29", "headline": "Needham Maintains Buy on Shutterstock, Lowers Price Target to $25", "summary": "", "symbols": ["SSTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716621/needham-maintains-buy-on-shutterstock-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 45716628, "time": "2025-06-02 05:56:57", "headline": "Needham Reiterates Hold on First Advantageto Hold", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716628/needham-reiterates-hold-on-first-advantageto-hold", "tags": ["analyst_other"]}
{"id": 45716668, "time": "2025-06-02 06:00:41", "headline": "KKR Invests $600M in India's Manipal Group to Back Long-Term Growth and Expansion Plans", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716668/kkr-invests-600m-in-indias-manipal-group-to-back-long-term-growth-and-expansion-plans", "tags": []}
{"id": 45716734, "time": "2025-06-02 06:03:20", "headline": "US Stocks Likely To Open Lower After A Solid May: 'TACO' Trade And 'Run It Hot' Optimism 'Are Consensus At This Point,' Says Expert", "summary": "U.S. stock futures fell on Monday after a mixed close on Friday. Futures of major benchmark indices were trading lower in premarket.", "symbols": ["BNAI", "BPMC", "CPB", "CRDO", "DELL", "PSTV", "QQQ", "RVYL", "SAIC", "SNY", "SPY", "ULTA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/market-summary/25/06/45716734/us-stocks-likely-to-open-lower-after-a-solid-may-taco-trade-and-run-it-hot-optimism-are-consensus-at-this-point-says-expert", "tags": []}
{"id": 45716751, "time": "2025-06-02 06:05:38", "headline": "RBC Capital Upgrades Church & Dwight Co to Outperform, Raises Price Target to $114", "summary": "", "symbols": ["CHD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716751/rbc-capital-upgrades-church-dwight-co-to-outperform-raises-price-target-to-114", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716769, "time": "2025-06-02 06:05:59", "headline": "Shell, Occidental Petroleum And Exxon Mobil Rise In Monday Premarket: What's Going On?", "summary": "During the pre-market trading session on Monday, Shell PLC (NYSE: SHELL) and Occidental Petroleum Corp (NYSE: OXY) climbed 1.75% and 1.41%, respectively, whereas Exxon Mobil Corp (NYSE: XOM) and Chevron Corp (NYSE: CVX) climbed 0.88% and 0.85%, each oil prices witnessed more than 3% surge on Monday. This was because the OPEC+ group decided to maintain the output increase for July, mirroring the hikes of the previous two months.", "symbols": ["CVX", "OXY", "SHELL", "XOM"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/equities/25/06/45716769/shell-occidental-petroleum-and-exxon-mobil-rise-in-monday-premarket-whats-going-on", "tags": ["why_moving"]}
{"id": 45716782, "time": "2025-06-02 06:07:27", "headline": "Theravance Biopharma Secures $225M In Cash From GSK Deal, Bringing Total Trelegy Monetization Value To $1.525B", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716782/theravance-biopharma-secures-225m-in-cash-from-gsk-deal-bringing-total-trelegy-monetization-value-to", "tags": ["contract"]}
{"id": 45716784, "time": "2025-06-02 06:07:48", "headline": "Corpay Teams Up With Real Madrid to Help Manage Currency Risks in Global Operations", "summary": "", "symbols": ["CPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716784/corpay-teams-up-with-real-madrid-to-help-manage-currency-risks-in-global-operations", "tags": []}
{"id": 45716797, "time": "2025-06-02 06:08:13", "headline": "BeOne Medicines Announced New Clinical Data From Its Breast Cancer Pipeline At The American Society Of Clinical Oncology Annual Meeting, Poster Presentations Feature Preliminary Results Of The Dose Escalation Studies Of: BG-C9074 For Advanced Solid Tumors, Including Breast Cancer, And BG-68501 For In HR+/HER2- Breast Cancer Patients With Prior CDK4/6i Exposure", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45716797/beone-medicines-announced-new-clinical-data-from-its-breast-cancer-pipeline-at-the-american-socie", "tags": ["fda"]}
{"id": 45716798, "time": "2025-06-02 06:08:27", "headline": "SoftBank And Intel Set To Launch $70 Million AI Memory Project In Japan To Slash Power Use", "summary": "SoftBank Group Corp. and Intel Corp. are developing next-generation AI memory chips designed to consume half the power.", "symbols": ["INTC", "MU", "SFTBY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/06/45716798/softbank-and-intel-set-to-launch-70-million-ai-memory-project-in-japan-to-slash-power-use", "tags": []}
{"id": 45716808, "time": "2025-06-02 06:09:27", "headline": "EchoStar Taps Maxar for High-Power Satellite to Serve All 50 States and Puerto Rico", "summary": "", "symbols": ["SATS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716808/echostar-taps-maxar-for-high-power-satellite-to-serve-all-50-states-and-puerto-rico", "tags": []}
{"id": 45716809, "time": "2025-06-02 06:09:29", "headline": "US GoldMining To Join Russell 3000 Index Following Strong Progress At Whistler Gold-Copper Project", "summary": "", "symbols": ["USGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716809/us-goldmining-to-join-russell-3000-index-following-strong-progress-at-whistler-gold-copper-project", "tags": []}
{"id": 45716813, "time": "2025-06-02 06:10:41", "headline": "Global Net Lease Appoints Robert Kauffman as New Chair After Sue Perrotty Steps Down From Role", "summary": "", "symbols": ["GNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716813/global-net-lease-appoints-robert-kauffman-as-new-chair-after-sue-perrotty-steps-down-from-role", "tags": ["management"]}
{"id": 45716816, "time": "2025-06-02 06:11:18", "headline": "Dole Expands Public-Private Partnerships To Broaden Access To Social Services For Costa Rican Farm Workers", "summary": "", "symbols": ["DOLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716816/dole-expands-public-private-partnerships-to-broaden-access-to-social-services-for-costa-rican-farm-w", "tags": []}
{"id": 45716817, "time": "2025-06-02 06:11:33", "headline": "Goldman Sachs Downgrades CSX to Neutral, Maintains Price Target to $35", "summary": "", "symbols": ["CSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716817/goldman-sachs-downgrades-csx-to-neutral-maintains-price-target-to-35", "tags": ["analyst_down", "analyst_other"]}
{"id": 45716922, "time": "2025-06-02 06:13:26", "headline": "Taiwan Semiconductor Eyes UAE Gigafab, Seeks Crucial US Green Light", "summary": "Taiwan Semiconductor is considering building a gigafab in UAE, seeking diversification and access to AI chip market. Talks with Trump admin failed.", "symbols": ["AMD", "AMZN", "GOOG", "GOOGL", "MSFT", "NVDA", "PLTR", "TSLA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/large-cap/25/06/45716922/taiwan-semiconductor-eyes-uae-gigafab-seeks-crucial-us-green-light", "tags": []}
{"id": 45716923, "time": "2025-06-02 06:13:36", "headline": "Xilio Therapeutics Commenced An Underwritten Public Offering Of Pre-funded Warrants To Purchase Shares, Terms Not Disclosed", "summary": "", "symbols": ["XLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45716923/xilio-therapeutics-commenced-an-underwritten-public-offering-of-pre-funded-warrants-to-purchase-s", "tags": ["offering"]}
{"id": 45716937, "time": "2025-06-02 06:15:26", "headline": "Goldman Sachs Downgrades Canadian Pacific Kansas to Neutral, Maintains Price Target to $91", "summary": "", "symbols": ["CP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716937/goldman-sachs-downgrades-canadian-pacific-kansas-to-neutral-maintains-price-target-to-91", "tags": ["analyst_down", "analyst_other"]}
{"id": 45716946, "time": "2025-06-02 06:15:58", "headline": "atai And Beckley Merger Advances Strategic Vision For Psychedelic Drug Development With Deep CNS Expertise", "summary": "", "symbols": ["ATAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716946/atai-and-beckley-merger-advances-strategic-vision-for-psychedelic-drug-development-with-deep-cns-exp", "tags": ["merger"]}
{"id": 45716947, "time": "2025-06-02 06:17:19", "headline": "Goldman Sachs Downgrades JB Hunt Transport Servs to Neutral, Maintains Price Target to $164", "summary": "", "symbols": ["JBHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716947/goldman-sachs-downgrades-jb-hunt-transport-servs-to-neutral-maintains-price-target-to-164", "tags": ["analyst_down", "analyst_other"]}
{"id": 45716948, "time": "2025-06-02 06:17:34", "headline": "Sol\u00e9sence Entered Into Amendments To Its Existing Loan Agreements, Providing Increased Borrowing Capacity To Support The Execution Of Strategic Objectives", "summary": "", "symbols": ["SLSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716948/sol-sence-entered-into-amendments-to-its-existing-loan-agreements-providing-increased-borrowing-capa", "tags": []}
{"id": 45716949, "time": "2025-06-02 06:18:25", "headline": "BranchOut Food Gets $1M Boost From Kaufman Kapital to Pay Down Debt and Fuel Growth", "summary": "", "symbols": ["BOF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716949/branchout-food-gets-1m-boost-from-kaufman-kapital-to-pay-down-debt-and-fuel-growth", "tags": []}
{"id": 45716950, "time": "2025-06-02 06:18:31", "headline": "Cango Enters Definitive Agreement With Founders And EWCL For $70M Class B Share Sale", "summary": "", "symbols": ["CANG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45716950/cango-enters-definitive-agreement-with-founders-and-ewcl-for-70m-class-b-share-sale", "tags": ["contract"]}
{"id": 45716951, "time": "2025-06-02 06:19:35", "headline": "Goldman Sachs Upgrades Werner Enterprises to Buy, Raises Price Target to $39", "summary": "", "symbols": ["WERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716951/goldman-sachs-upgrades-werner-enterprises-to-buy-raises-price-target-to-39", "tags": ["analyst_up", "price_target_up"]}
{"id": 45716952, "time": "2025-06-02 06:19:38", "headline": "Needham Maintains Buy on Liquidia, Raises Price Target to $32", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716952/needham-maintains-buy-on-liquidia-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 45716957, "time": "2025-06-02 06:19:54", "headline": "Asia And Europe Markets Slide, Oil Gains 3% - Global Markets Today While US Slept", "summary": "US markets closed mixed on Friday, with S&amp;P 500 flat but posting strong monthly gain. Asian markets down as oil prices rise and USD weakens.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/market-summary/25/06/45716957/asia-and-europe-markets-slide-oil-gains-3-global-markets-today-while-us-slept", "tags": []}
{"id": 45716982, "time": "2025-06-02 06:21:11", "headline": "Kenvue Earns Spot On Fortune 500, Citing Strong Global Sales And Iconic Brand Portfolio", "summary": "", "symbols": ["KVUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716982/kenvue-earns-spot-on-fortune-500-citing-strong-global-sales-and-iconic-brand-portfolio", "tags": []}
{"id": 45716998, "time": "2025-06-02 06:22:08", "headline": "Goldman Sachs Upgrades Schneider National to Buy, Raises Price Target to $32", "summary": "", "symbols": ["SNDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716998/goldman-sachs-upgrades-schneider-national-to-buy-raises-price-target-to-32", "tags": ["analyst_up", "price_target_up"]}
{"id": 45717233, "time": "2025-06-02 06:24:01", "headline": "Goldman Sachs Upgrades Knight-Swift to Buy, Raises Price Target to $65", "summary": "", "symbols": ["KNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717233/goldman-sachs-upgrades-knight-swift-to-buy-raises-price-target-to-65", "tags": ["analyst_up", "price_target_up"]}
{"id": 45717287, "time": "2025-06-02 06:29:18", "headline": "HC Wainwright & Co. Assumes PolyPid at Buy, Announces Price Target of $11", "summary": "", "symbols": ["PYPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717287/hc-wainwright-co-assumes-polypid-at-buy-announces-price-target-of-11", "tags": []}
{"id": 45717345, "time": "2025-06-02 06:32:25", "headline": "HC Wainwright & Co. Initiates Coverage On Cardiol Therapeutics with Buy Rating, Announces Price Target of $9", "summary": "", "symbols": ["CRDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717345/hc-wainwright-co-initiates-coverage-on-cardiol-therapeutics-with-buy-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 45717346, "time": "2025-06-02 06:32:25", "headline": "HC Wainwright & Co. Initiates Coverage On Cardiol Therapeutics with Buy Rating, Announces Price Target of $9", "summary": "", "symbols": ["CRDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717346/hc-wainwright-co-initiates-coverage-on-cardiol-therapeutics-with-buy-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 45717360, "time": "2025-06-02 06:32:42", "headline": "Hyperscale Data Announced The Sale Of Its Minority Equity Interest In A Privately Held Pharmaceutical Company For Gross Proceeds Of $4.65M In Cash", "summary": "", "symbols": ["GPUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717360/hyperscale-data-announced-the-sale-of-its-minority-equity-interest-in-a-privately-held-pharmaceutica", "tags": []}
{"id": 45717380, "time": "2025-06-02 06:33:21", "headline": "Vera Therapeutics Says Atacicept ORIGIN Phase 3 Trial Meets Primary Endpoint Of Reduction In UPCR For IgAN Treatment; Vera Currently Plans To Submit BLA For Accelerated Approval To FDA In 4Q 2025", "summary": "", "symbols": ["VERA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717380/vera-therapeutics-says-atacicept-origin-phase-3-trial-meets-primary-endpoint-of-reduction-in-upcr-fo", "tags": ["fda"]}
{"id": 45717381, "time": "2025-06-02 06:33:21", "headline": "Southwest Airlines And China Airlines Group, A Taiwan-based Carrier, Are In Discussions To Create An Interline Partnership In Early 2026, With Published Connections Expected To Go On Sale Later This Year", "summary": "", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717381/southwest-airlines-and-china-airlines-group-a-taiwan-based-carrier-are-in-discussions-to-create-an-i", "tags": ["contract"]}
{"id": 45717382, "time": "2025-06-02 06:33:53", "headline": "B of A Securities Upgrades Boeing to Buy, Raises Price Target to $260", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717382/b-of-a-securities-upgrades-boeing-to-buy-raises-price-target-to-260", "tags": ["analyst_up", "price_target_up"]}
{"id": 45717383, "time": "2025-06-02 06:34:09", "headline": "Liquidia Begins Shipping Newly Approved Yutrepia for Rare Lung Diseases Just Days After FDA OK", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717383/liquidia-begins-shipping-newly-approved-yutrepia-for-rare-lung-diseases-just-days-after-fda-ok", "tags": ["fda"]}
{"id": 45717384, "time": "2025-06-02 06:34:12", "headline": "Inertial Labs, A VIAVI Solutions Announced The Launch Of A Visual-aided Inertial Navigation System (VINS) That Enables Aircraft To Maintain Accurate Flightpaths When No Reliable GPS/GNSS Signal Is Available", "summary": "", "symbols": ["VIAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717384/inertial-labs-a-viavi-solutions-announced-the-launch-of-a-visual-aided-inertial-navigation-system-vi", "tags": []}
{"id": 45717390, "time": "2025-06-02 06:35:05", "headline": "Piedmont Office Realty Trust Announced That It Has Completed Over 500,000 Square Feet Of Leasing Thus Far In The Second Quarter, With 350,000 Square Feet Related To New Tenants", "summary": "", "symbols": ["PDM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717390/piedmont-office-realty-trust-announced-that-it-has-completed-over-500-000-square-feet-of-leasing-thu", "tags": []}
{"id": 45717392, "time": "2025-06-02 06:35:30", "headline": "B of A Securities Maintains Buy on Amazon.com, Raises Price Target to $248", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717392/b-of-a-securities-maintains-buy-on-amazon-com-raises-price-target-to-248", "tags": ["analyst_other", "price_target_up"]}
{"id": 45717393, "time": "2025-06-02 06:35:45", "headline": "CareTrust REIT Closes Amendment, Enhancing Credit Facility With $500M Term Loan", "summary": "", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717393/caretrust-reit-closes-amendment-enhancing-credit-facility-with-500m-term-loan", "tags": []}
{"id": 45717395, "time": "2025-06-02 06:36:07", "headline": "KORE Group Names Mitel Exec Anthony Bellomo as New CFO, Replacing Paul Holtz", "summary": "", "symbols": ["KORE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717395/kore-group-names-mitel-exec-anthony-bellomo-as-new-cfo-replacing-paul-holtz", "tags": ["management"]}
{"id": 45717396, "time": "2025-06-02 06:36:35", "headline": "Broadstone Net Lease Disclosed That Quarter-to-date, It Has Invested $83.3M, Including $54.7M In New Property Acquisitions And $28.6M In Build-to-suit Developments", "summary": "", "symbols": ["BNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717396/broadstone-net-lease-disclosed-that-quarter-to-date-it-has-invested-83-3m-including-54-7m-in-new-pro", "tags": []}
{"id": 45717397, "time": "2025-06-02 06:37:07", "headline": "HC Wainwright & Co. Assumes Senseonics Holdings at Buy, Announces Price Target of $1.1", "summary": "", "symbols": ["SENS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717397/hc-wainwright-co-assumes-senseonics-holdings-at-buy-announces-price-target-of-1-1", "tags": []}
{"id": 45717413, "time": "2025-06-02 06:40:09", "headline": "Caretrust REIT Acquires Portfolio Of Skilled Nursing Facilities In Pacific Northwest For About $146M, Inclusive Of Transaction Costs", "summary": "", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717413/caretrust-reit-acquires-portfolio-of-skilled-nursing-facilities-in-pacific-northwest-for-about-146m", "tags": ["merger"]}
{"id": 45717415, "time": "2025-06-02 06:41:46", "headline": "Reuters Reported Iran Poised To Dismiss US Nuclear Proposal, Citing Iranian Diplomat", "summary": "", "symbols": ["EIS", "SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717415/reuters-reported-iran-poised-to-dismiss-us-nuclear-proposal-citing-iranian-diplomat", "tags": []}
{"id": 45717435, "time": "2025-06-02 06:43:19", "headline": "HC Wainwright & Co. Assumes Avalo Therapeutics at Buy, Announces Price Target of $15", "summary": "", "symbols": ["AVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717435/hc-wainwright-co-assumes-avalo-therapeutics-at-buy-announces-price-target-of-15", "tags": []}
{"id": 45717446, "time": "2025-06-02 06:45:15", "headline": "HC Wainwright & Co. Initiates Coverage On Boundless Bio with Buy Rating, Announces Price Target of $5", "summary": "", "symbols": ["BOLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717446/hc-wainwright-co-initiates-coverage-on-boundless-bio-with-buy-rating-announces-price-target-of-5", "tags": ["analyst_init"]}
{"id": 45717449, "time": "2025-06-02 06:46:28", "headline": "Mizuho Upgrades Red Rock Resorts to Outperform, Maintains Price Target to $50", "summary": "", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717449/mizuho-upgrades-red-rock-resorts-to-outperform-maintains-price-target-to-50", "tags": ["analyst_up", "analyst_other"]}
{"id": 45716936, "time": "2025-06-02 06:14:56", "headline": "Medicaid Cuts Are 'Heroic,' Speaker Mike Johnson Says: 4.8 Million Won't Lose Healthcare 'Unless They Choose To Do So'", "summary": "Johnson defends Trump&#39;s bill, saying those who lose Medicaid will do so by choice, recommends volunteer work to stay eligible.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/politics/25/06/45716936/speaker-mike-johnson-says-4-8-million-wont-lose-medicaid-unless-they-choose-to-do-so-calls-gop-cuts-an-important-and-frankly-heroic-thing", "tags": []}
{"id": 45717461, "time": "2025-06-02 06:47:23", "headline": "BioNTech And Bristol Myers Squibb Partner To Advance Bispecific Antibody BNT327 For Solid Tumors", "summary": "", "symbols": ["BMY", "BNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717461/biontech-and-bristol-myers-squibb-partner-to-advance-bispecific-antibody-bnt327-for-solid-tumors", "tags": []}
{"id": 45717463, "time": "2025-06-02 06:48:36", "headline": "Piper Sandler Initiates Coverage On Aspen Insurance Hldgs with Overweight Rating, Announces Price Target of $40", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717463/piper-sandler-initiates-coverage-on-aspen-insurance-hldgs-with-overweight-rating-announces-price-tar", "tags": ["analyst_init"]}
{"id": 45717475, "time": "2025-06-02 06:50:19", "headline": "Piper Sandler Initiates Coverage On American Integrity with Overweight Rating, Announces Price Target of $20", "summary": "", "symbols": ["AII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717475/piper-sandler-initiates-coverage-on-american-integrity-with-overweight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 45717476, "time": "2025-06-02 06:50:46", "headline": "Elon Musk Launches XChat With Claimed Bitcoin-Style Encryption, But Expert Says It's Like Running A 'Rocket On Water'", "summary": "Elon Musk announced the launch of the XChat messaging app with claimed Bitcoin (CRYPTO: BTC) -style encryption, but cybersecurity experts are challenging the technical accuracy of the platform\u2019s security assertions.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/news/social-media/25/06/45717476/elon-musk-launches-xchat-with-claimed-bitcoin-style-encryption-but-expert-says-its-like-running-a-rocket-on-water", "tags": []}
{"id": 45717488, "time": "2025-06-02 06:51:33", "headline": "Pharvaris Presents Key Findings On Bradykinin B2 Antagonists At Angioedema Workshop", "summary": "", "symbols": ["PHVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717488/pharvaris-presents-key-findings-on-bradykinin-b2-antagonists-at-angioedema-workshop", "tags": []}
{"id": 45717492, "time": "2025-06-02 06:52:37", "headline": "Medicaid Cut Concerns Are 'Totally Ridiculous,' Says Trump's Budget Chief Russell Vought, Quips 'I Love Elon' While Countering Musk's Criticism", "summary": "OMB Director Vought defends Trump&#39;s big, beautiful bill against Medicaid cuts, dismissing concerns as ridiculous.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/politics/25/06/45717492/medicaid-cut-concerns-are-totally-ridiculous-says-trumps-budget-chief-russell-vought-quips-i-love-elon-while-countering-musks-criticism", "tags": []}
{"id": 45717703, "time": "2025-06-02 06:55:04", "headline": "Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45717703/trading-halt-halted-at-6-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45717712, "time": "2025-06-02 06:58:16", "headline": "Raymond James Downgrades Rackspace Technology to Market Perform", "summary": "", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717712/raymond-james-downgrades-rackspace-technology-to-market-perform", "tags": ["analyst_down"]}
{"id": 45717715, "time": "2025-06-02 06:59:46", "headline": "Science Applications Intl Q1 Adj. EPS $1.92 Misses $2.22 Estimate, Sales $1.88B Beat $1.87B Estimate", "summary": "", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45717715/science-applications-intl-q1-adj-eps-1-92-misses-2-22-estimate-sales-1-88b-beat-1-87b-estimate", "tags": ["earnings"]}
{"id": 45717797, "time": "2025-06-02 07:01:26", "headline": "Science Applications Intl Affirms FY2026 Adj EPS Guidance of $9.10-$9.30 vs $10.24 Est; Affirms FY2026 Sales Guidance of $7.60B-$7.75B vs $7.93B Est", "summary": "", "symbols": ["SAIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717797/science-applications-intl-affirms-fy2026-adj-eps-guidance-of-9-10-9-30-vs-10-24-est-affirms-fy2026-s", "tags": ["earnings", "guidance"]}
{"id": 45717821, "time": "2025-06-02 07:02:40", "headline": "Aclaris Therapeutics Has Initiated A Randomized, Double-blind, Placebo-Controlled Phase 2 Trial Of Bosakitug (ATI-045) For Moderate-to-severe Atopic Dermatitis, Top Line Results Expected In The Second Half Of 2026", "summary": "", "symbols": ["ACRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45717821/aclaris-therapeutics-has-initiated-a-randomized-double-blind-placebo-controlled-phase-2-trial-of-", "tags": ["fda"]}
{"id": 45717822, "time": "2025-06-02 07:02:58", "headline": "June Social Security Checks Could Drop Sharply Due To Student Loan Garnishments \u2014 Experts Share Ways To Get Relief", "summary": "Retirees who have defaulted on their student loans may see a reduction in their Social Security checks from June. This is a result of\u00a0the U.S. Department of Education&#39;s decision to recommence involuntary collections on defaulted student loans, including garnishing wages, intercepting tax refunds, and seizing a portion of Social Security benefits.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/personal-finance/management/25/06/45717822/june-social-security-checks-could-drop-sharply-due-to-student-loan-garnishments-experts-share-ways-to-get-relief", "tags": []}
{"id": 45717824, "time": "2025-06-02 07:03:05", "headline": "'If Your Product Is Great, It Doesn't Need To Be Good:' When Gmail Creator Paul Buchheit Took Aim At Tech's Obsession With Features", "summary": "Paul Buchheit, Gmail&#39;s creator, argued that successful products don&#39;t need a lot of features.", "symbols": ["AAPL", "MSFT"], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/topics/25/06/45717824/if-your-product-is-great-it-doesnt-need-to-be-good-when-gmail-creator-paul-buchheit-took-aim-at-techs-obsession-with-features", "tags": []}
{"id": 45717831, "time": "2025-06-02 07:03:24", "headline": "Relay Therapeutics Says Updated Interim Clinical Data For RLY-2608 Remain Consistent, Showing 10.3-Month Median PFS Overall And 11.0-Month Median PFS In 2L Patients With PI3K\u03b1-Mutated, HR+/HER2- Metastatic Breast Cancer", "summary": "", "symbols": ["RLAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717831/relay-therapeutics-says-updated-interim-clinical-data-for-rly-2608-remain-consistent-showing-10-3-mo", "tags": ["fda"]}
{"id": 45717851, "time": "2025-06-02 07:04:51", "headline": "Anixa Biosciences Completes Enrollment In Phase 1 Clinical Trial Of Breast Cancer Vaccine", "summary": "", "symbols": ["ANIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717851/anixa-biosciences-completes-enrollment-in-phase-1-clinical-trial-of-breast-cancer-vaccine", "tags": ["fda"]}
{"id": 45717852, "time": "2025-06-02 07:05:00", "headline": "Keybanc Initiates Coverage On Shake Shack with Sector Weight Rating", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717852/keybanc-initiates-coverage-on-shake-shack-with-sector-weight-rating", "tags": ["analyst_init"]}
{"id": 45717857, "time": "2025-06-02 07:05:33", "headline": "Lyra Therapeutics' ENLIGHTEN 2 Phase 3 Trial Of LYR-210 For Chronic Rhinosinusitis Met Its Primary Endpoint, With LYR-210 Demonstrating Statistically Significant Improvement Compared To Sham Control In A Composite Of The Three Cardinal Symptoms", "summary": "", "symbols": ["LYRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45717857/lyra-therapeutics-enlighten-2-phase-3-trial-of-lyr-210-for-chronic-rhinosinusitis-met-its-primary", "tags": ["fda"]}
{"id": 45717874, "time": "2025-06-02 07:07:03", "headline": "Alkermes Highlights LYBALVI And ARISTADA Data At Key Scientific Conferences", "summary": "", "symbols": ["ALKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717874/alkermes-highlights-lybalvi-and-aristada-data-at-key-scientific-conferences", "tags": []}
{"id": 45717880, "time": "2025-06-02 07:07:56", "headline": "HC Wainwright & Co. Maintains Buy on Verona Pharma, Raises Price Target to $90", "summary": "", "symbols": ["VRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717880/hc-wainwright-co-maintains-buy-on-verona-pharma-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 45717911, "time": "2025-06-02 07:08:26", "headline": "Regeneron Pharmaceutical Announced A Strategic In-licensing Agreement With Hansoh Pharmaceuticals Group Company Limited To Acquire Exclusive Clinical Development And Commercial Rights Outside Of The Chinese Mainland, Hong Kong And Macau For A Dual Glp-1/GIP Receptor Agonist Currently In Phase 3 Testing", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717911/regeneron-pharmaceutical-announced-a-strategic-in-licensing-agreement-with-hansoh-pharmaceuticals-gr", "tags": ["fda", "merger", "contract"]}
{"id": 45717912, "time": "2025-06-02 07:08:29", "headline": "Reviva's Brilaroxazine Shows Broad, Durable Efficacy And Low Discontinuation In 1-Year RECOVER Phase 3 Extension Study", "summary": "", "symbols": ["RVPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717912/revivas-brilaroxazine-shows-broad-durable-efficacy-and-low-discontinuation-in-1-year-recover-phase-3", "tags": ["fda"]}
{"id": 45717913, "time": "2025-06-02 07:08:39", "headline": "Cyngn Launches Dealer Portal to Speed Up Sales of Its Autonomous Vehicle Tech", "summary": "", "symbols": ["CYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717913/cyngn-launches-dealer-portal-to-speed-up-sales-of-its-autonomous-vehicle-tech", "tags": []}
{"id": 45717917, "time": "2025-06-02 07:09:23", "headline": "Sanofi Has Exercised Its Option To Exclusively License Nurix Therapeutics' STAT6 Program, Including The Drug Development Candidate NX-3911, Nurix To Receive A $15M License Extension Fee From Sanofi Under Its 2019 Collaboration Agreement", "summary": "", "symbols": ["NRIX", "SNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45717917/sanofi-has-exercised-its-option-to-exclusively-license-nurix-therapeutics-stat6-program-including", "tags": ["contract"]}
{"id": 45717918, "time": "2025-06-02 07:09:27", "headline": "KalVista Announces New Sebetralstat Data On HAE Attack Progression at Key Conferences", "summary": "", "symbols": ["KALV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717918/kalvista-announces-new-sebetralstat-data-on-hae-attack-progression-at-key-conferences", "tags": []}
{"id": 45717919, "time": "2025-06-02 07:09:45", "headline": "Outlook Therapeutics Launches First-Ever Eye Drug Bevacizumab for Wet AMD in Germany and UK", "summary": "", "symbols": ["OTLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717919/outlook-therapeutics-launches-first-ever-eye-drug-bevacizumab-for-wet-amd-in-germany-and-uk", "tags": ["guidance"]}
{"id": 45717921, "time": "2025-06-02 07:09:45", "headline": "Guardant Health Announced That The Results Of The Phase III SERENA-6 Trial - Sponsored By Astrazeneca - Demonstrate The Clinical Value Of The Guardant360 Cdx Test In A Circulating Tumor DNA-guided Approach To Detect And Treat Emerging Resistance In 1St-line Therapy Ahead Of Radiological Disease Progression In Breast Cancer", "summary": "", "symbols": ["GH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717921/guardant-health-announced-that-the-results-of-the-phase-iii-serena-6-trial-sponsored-by-astrazeneca", "tags": ["fda"]}
{"id": 45717930, "time": "2025-06-02 07:10:57", "headline": "Bruker Unveils New timsUltra AIP System With Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics And Metaproteomics", "summary": "", "symbols": ["BRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717930/bruker-unveils-new-timsultra-aip-system-with-enhanced-extreme-sensitivity-for-single-cell-proteomics", "tags": []}
{"id": 45717937, "time": "2025-06-02 07:11:14", "headline": "Zai Lab Limited Announced That Updated Data From An Ongoing, Global Phase 1A/1B Clinical Trial (NCT06179069) Evaluating Zocilurtatug Pelitecan, Or Zl-1310, The Company's Potential First-in-class, Delta-like Ligand (DLL3) Antibody-drug Conjugate (ADC) For Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC)", "summary": "", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717937/zai-lab-limited-announced-that-updated-data-from-an-ongoing-global-phase-1a1b-clinical-trial-nct0617", "tags": ["fda"]}
{"id": 45717938, "time": "2025-06-02 07:11:23", "headline": "SCIEX And Evosep Sign Reseller Agreement To Expand Access To Standardized High-Throughput Proteomics For Pharma And Biotech", "summary": "", "symbols": ["DHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717938/sciex-and-evosep-sign-reseller-agreement-to-expand-access-to-standardized-high-throughput-proteomics", "tags": ["contract"]}
{"id": 45717939, "time": "2025-06-02 07:12:02", "headline": "Trevi's Cough Drug Haduvio Shows Results in IPF Patients, Cutting Coughs by Over 60%", "summary": "", "symbols": ["TRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717939/trevis-cough-drug-haduvio-shows-results-in-ipf-patients-cutting-coughs-by-over-60", "tags": []}
{"id": 45717942, "time": "2025-06-02 07:12:11", "headline": "Bruker Launches proteoElute nanoLC System, Advancing Ultra-Sensitive Proteomics", "summary": "", "symbols": ["BRKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717942/bruker-launches-proteoelute-nanolc-system-advancing-ultra-sensitive-proteomics", "tags": []}
{"id": 45717943, "time": "2025-06-02 07:12:22", "headline": "Jade Biosciences Announced New Preclinical Data On JADE101, Its Anti-april Monoclonal Antibody Being Developed For The Treatment Of IgA Nephropathy (IgAN)", "summary": "", "symbols": ["JBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717943/jade-biosciences-announced-new-preclinical-data-on-jade101-its-anti-april-monoclonal-antibody-being", "tags": []}
{"id": 45717944, "time": "2025-06-02 07:12:32", "headline": "Nebius Invests In ClickHouse Series C To Unlock Value And Fuel AI Infrastructure Expansion", "summary": "", "symbols": ["NBIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717944/nebius-invests-in-clickhouse-series-c-to-unlock-value-and-fuel-ai-infrastructure-expansion", "tags": []}
{"id": 45717945, "time": "2025-06-02 07:13:22", "headline": "AngloGold Sells Brazil Mine to Aura Minerals for $76M, Plus Future Royalties", "summary": "", "symbols": ["AU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717945/anglogold-sells-brazil-mine-to-aura-minerals-for-76m-plus-future-royalties", "tags": []}
{"id": 45717953, "time": "2025-06-02 07:13:30", "headline": "BioCryst To Present New ORLADEYO Data At 2025 EAACI Meeting, Highlighting HAE Prophylaxis In Adults and Children", "summary": "", "symbols": ["BCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717953/biocryst-to-present-new-orladeyo-data-at-2025-eaaci-meeting-highlighting-hae-prophylaxis-in-adults-a", "tags": []}
{"id": 45717954, "time": "2025-06-02 07:13:48", "headline": "Kymera Therapeutics Announced Clinical Results From The Phase 1 Healthy Volunteer Study Of KT-621", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45717954/kymera-therapeutics-announced-clinical-results-from-the-phase-1-healthy-volunteer-study-of-kt-621", "tags": ["fda"]}
{"id": 45717955, "time": "2025-06-02 07:13:53", "headline": "China's NIO Clocks 13% Deliveries Growth In May, Tesla Lags", "summary": "NIO Inc. delivered 23,231 vehicles in May 2025, with a 13.1% increase from last year. Its newer brands, ONVO and FIREFLY, contributed to its growth.", "symbols": ["LI", "NIO", "TSLA", "XPEV"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45717955/chinas-nio-clocks-13-deliveries-growth-in-may-tesla-lags", "tags": []}
{"id": 45717956, "time": "2025-06-02 07:14:02", "headline": "Dow Announced That It Has Signed A Sale And Purchase Agreement To Sell Its 50% Interest In Dowaksa Advanced Composites Holdings Bv (Dowaksa) To Aksa Akrilik Kimya Sanayii A.\u015e For Proceeds Of $125M", "summary": "", "symbols": ["DOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717956/dow-announced-that-it-has-signed-a-sale-and-purchase-agreement-to-sell-its-50-interest-in-dowaksa-ad", "tags": ["contract"]}
{"id": 45717967, "time": "2025-06-02 07:14:32", "headline": "uniQure Secures FDA Alignment On AMT-130, Targeting 2026 BLA Submission", "summary": "", "symbols": ["QURE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717967/uniqure-secures-fda-alignment-on-amt-130-targeting-2026-bla-submission", "tags": ["fda"]}
{"id": 45717975, "time": "2025-06-02 07:14:54", "headline": "Nokia Teams Up With Andorix To Expand Indoor 5G and Edge Solutions Across U.S. And Canadian Properties", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717975/nokia-teams-up-with-andorix-to-expand-indoor-5g-and-edge-solutions-across-u-s-and-canadian-propertie", "tags": []}
{"id": 45717983, "time": "2025-06-02 07:15:43", "headline": "Eli Lilly Rises 1.5% After Key Trading Signal", "summary": "A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose up to 1.5%.", "symbols": [], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/markets/equities/25/06/45717983/eli-lilly-rises-1-5-after-key-trading-signal", "tags": []}
{"id": 45717984, "time": "2025-06-02 07:16:00", "headline": "Truist Securities Initiates Coverage On Block with Sell Rating, Announces Price Target of $60", "summary": "", "symbols": ["XYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717984/truist-securities-initiates-coverage-on-block-with-sell-rating-announces-price-target-of-60", "tags": ["analyst_init"]}
{"id": 45717994, "time": "2025-06-02 07:16:13", "headline": "Campbell Soup Q3 Adj. EPS $0.73 Beats $0.66 Estimate, Sales $2.48B Beat $2.43B Estimate", "summary": "", "symbols": ["CPB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45717994/campbell-soup-q3-adj-eps-0-73-beats-0-66-estimate-sales-2-48b-beat-2-43b-estimate", "tags": ["earnings"]}
{"id": 45717998, "time": "2025-06-02 07:16:49", "headline": "Rivian Automotive Intends To Offer $1.25B Senior Secured Green Notes Offering To Refinance Outstanding Senior Secured Notes due 2026", "summary": "", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45717998/rivian-automotive-intends-to-offer-1-25b-senior-secured-green-notes-offering-to-refinance-outstandin", "tags": ["offering"]}
{"id": 45718002, "time": "2025-06-02 07:18:12", "headline": "The Campbell's Affirms FY2025 Adj EPS Guidance of $2.95-$3.05 vs $2.98 Est", "summary": "", "symbols": ["CPB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718002/the-campbells-affirms-fy2025-adj-eps-guidance-of-2-95-3-05-vs-2-98-est", "tags": ["earnings", "guidance"]}
{"id": 45718016, "time": "2025-06-02 07:21:15", "headline": "Truist Securities Initiates Coverage On Global E Online with Sell Rating, Announces Price Target of $31", "summary": "", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718016/truist-securities-initiates-coverage-on-global-e-online-with-sell-rating-announces-price-target-of-3", "tags": ["analyst_init"]}
{"id": 45718017, "time": "2025-06-02 07:21:17", "headline": "'Nothing Stops This Train': US Fiscal Deficits Drive Bitcoin's Case As A Hedge, Says Lyn Alden", "summary": "Economist Lyn Alden warns that U.S.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45718017/nothing-stops-this-train-us-fiscal-deficits-drive-bitcoins-case-as-a-hedge-says-lyn-alden", "tags": []}
{"id": 45718039, "time": "2025-06-02 07:23:15", "headline": "Truist Securities Initiates Coverage On PayPal Holdings with Sell Rating, Announces Price Target of $68", "summary": "", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718039/truist-securities-initiates-coverage-on-paypal-holdings-with-sell-rating-announces-price-target-of-6", "tags": ["analyst_init"]}
{"id": 45718243, "time": "2025-06-02 07:25:09", "headline": "Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45718243/trading-halt-halt-status-updated-at-7-25-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45718252, "time": "2025-06-02 07:25:31", "headline": "Truist Securities Initiates Coverage On Affirm Holdings with Buy Rating, Announces Price Target of $58", "summary": "", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718252/truist-securities-initiates-coverage-on-affirm-holdings-with-buy-rating-announces-price-target-of-58", "tags": ["analyst_init"]}
{"id": 45718255, "time": "2025-06-02 07:27:06", "headline": "Elizabeth Warren Agrees With Trump On Scrapping Debt Limit\u2014But Blasts $4 Trillion Hike For Billionaire Tax Breaks", "summary": "Sen. Elizabeth Warren (D-Mass.) expressed rare agreement with President Donald Trump on eliminating the federal debt ceiling while sharply criticizing proposed tax breaks for wealthy Americans amid escalating fiscal concerns.", "symbols": [], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/news/politics/25/06/45718255/elizabeth-warren-agrees-with-trump-on-scrapping-debt-limit-but-blasts-4-trillion-hike-for-billionaire-tax-breaks", "tags": ["contract"]}
{"id": 45718276, "time": "2025-06-02 07:29:14", "headline": "Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["ASTL", "BMGL", "BNAI", "BNTX", "BPMC", "BSII", "CLEU", "CLF", "FAAS", "INM", "LOGC", "LUCD", "LYRA", "RSLS", "SBET", "SLE", "SLXN", "SNY", "TIRX", "VERA", "XLO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/25/06/45718276/why-blueprint-medicines-shares-are-trading-higher-by-27-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 45718339, "time": "2025-06-02 07:31:56", "headline": "Arrowhead Pharma Doses First Subjects In Phase 1/2a Clinical Trial Of ARO-ALK7, Investigational RNAi Therapeutic Being Developed As Potential Treatment For Obesity", "summary": "", "symbols": ["ARWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718339/arrowhead-pharma-doses-first-subjects-in-phase-12a-clinical-trial-of-aro-alk7-investigational-rnai-t", "tags": ["fda"]}
{"id": 45718342, "time": "2025-06-02 07:32:27", "headline": "IN8Bio Announced New Long-term Clinical Data From Its Fully Enrolled Phase 1 Trial Of INB-200 In Patients With Newly Diagnosed Glioblastoma Multiforme, Demonstrating Prolonged Progression-Free Survival", "summary": "", "symbols": ["INAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45718342/in8bio-announced-new-long-term-clinical-data-from-its-fully-enrolled-phase-1-trial-of-inb-200-in-", "tags": ["fda"]}
{"id": 45718343, "time": "2025-06-02 07:32:28", "headline": "Truist Securities Initiates Coverage On Lightspeed Commerce with Hold Rating, Announces Price Target of $11", "summary": "", "symbols": ["LSPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718343/truist-securities-initiates-coverage-on-lightspeed-commerce-with-hold-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 45718356, "time": "2025-06-02 07:33:41", "headline": "Truist Securities Initiates Coverage On Shift4 Payments with Hold Rating, Announces Price Target of $97", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718356/truist-securities-initiates-coverage-on-shift4-payments-with-hold-rating-announces-price-target-of-9", "tags": ["analyst_init"]}
{"id": 45718357, "time": "2025-06-02 07:33:53", "headline": "Context Therapeutics Is Presenting A Trial In Progress Poster For The Phase 1 Trial Of CTIM-76 In Ovarian, Endometrial, And Testicular Cancers At The 2025 American Society Of Clinical Oncology Annual Meeting, Expect To Share Initial Data In The First Half Of 2026", "summary": "", "symbols": ["CNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45718357/context-therapeutics-is-presenting-a-trial-in-progress-poster-for-the-phase-1-trial-of-ctim-76-in", "tags": ["fda"]}
{"id": 45718358, "time": "2025-06-02 07:34:01", "headline": "BriaCell Highlights Breast Cancer Trial Data at 2025 ASCO Annual Meeting", "summary": "", "symbols": ["BCTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718358/briacell-highlights-breast-cancer-trial-data-at-2025-asco-annual-meeting", "tags": ["fda"]}
{"id": 45718359, "time": "2025-06-02 07:34:22", "headline": "American Resources Secures $150M Investment To Expand Rare Earth Refining", "summary": "", "symbols": ["AREC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718359/american-resources-secures-150m-investment-to-expand-rare-earth-refining", "tags": []}
{"id": 45718367, "time": "2025-06-02 07:35:09", "headline": "Intellinetics Lands $40M Deal, Largest in Company History, for Document Scanning Services", "summary": "", "symbols": ["INLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718367/intellinetics-lands-40m-deal-largest-in-company-history-for-document-scanning-services", "tags": ["contract"]}
{"id": 45718265, "time": "2025-06-02 07:28:19", "headline": "Medicaid Cuts Backlash Grows As Sen. Joni Ernst Tells Voters 'Well, We All Are Going To Die,' Mocks Critics From A Cemetery", "summary": "Senator Joni Ernst faces backlash for dismissing voter&#39;s healthcare concerns with reminder of mortality.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/politics/25/06/45718265/medicaid-cuts-backlash-grows-as-sen-joni-ernst-tells-voters-well-we-all-are-going-to-die-mocks-critics-from-a-cemetery", "tags": []}
{"id": 45718394, "time": "2025-06-02 07:39:20", "headline": "Truist Securities Initiates Coverage On Fiserv with Buy Rating, Announces Price Target of $181", "summary": "", "symbols": ["FI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718394/truist-securities-initiates-coverage-on-fiserv-with-buy-rating-announces-price-target-of-181", "tags": ["analyst_init"]}
{"id": 45718400, "time": "2025-06-02 07:40:23", "headline": "Femasys Prices 3.6M Share Public Offering At $0.85/Shr; Announces Private Placement Of 1.69M Shares At Up To $1.02/Shr", "summary": "", "symbols": ["FEMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718400/femasys-prices-3-6m-share-public-offering-at-0-85shr-announces-private-placement-of-1-69m-shares-at", "tags": ["offering"]}
{"id": 45718402, "time": "2025-06-02 07:40:52", "headline": "Pony.ai, Xihu Group To Deploy Over 1,000 Robotaxis In Shenzhen", "summary": "Pony AI Inc. (NASDAQ: PONY) partners with Shenzhen Xihu Corporation Limited to deploy 1,000 Robotaxis in Shenzhen. Plans for global expansion and IPO.", "symbols": ["CARZ", "PONY"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45718402/pony-ai-xihu-group-to-deploy-over-1000-robotaxis-in-shenzhen", "tags": ["contract"]}
{"id": 45718413, "time": "2025-06-02 07:41:19", "headline": "Truist Securities Initiates Coverage On SoFi Technologies with Hold Rating, Announces Price Target of $14", "summary": "", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718413/truist-securities-initiates-coverage-on-sofi-technologies-with-hold-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 45718416, "time": "2025-06-02 07:41:51", "headline": "Kymera Therapeutics Shares Resume Trading, Up 55% After Reporting Data In The Phase 1 Healthy Volunteer Study Of KT-621", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718416/kymera-therapeutics-shares-resume-trading-up-55-after-reporting-data-in-the-phase-1-healthy-voluntee", "tags": ["fda"]}
{"id": 45718434, "time": "2025-06-02 07:43:37", "headline": "Truist Securities Initiates Coverage On Flywire with Buy Rating, Announces Price Target of $12", "summary": "", "symbols": ["FLYW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718434/truist-securities-initiates-coverage-on-flywire-with-buy-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 45718435, "time": "2025-06-02 07:43:48", "headline": "Humana Reaffirms FY25 Guidance Of $14.68 EPS And $16.25 Adj EPS", "summary": "", "symbols": ["HUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718435/humana-reaffirms-fy25-guidance-of-14-68-eps-and-16-25-adj-eps", "tags": ["earnings", "guidance"]}
{"id": 45718436, "time": "2025-06-02 07:43:51", "headline": "Market-Moving News for June 2nd", "summary": "", "symbols": ["CLF", "LYRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45718436/market-moving-news-for-june-2nd", "tags": []}
{"id": 45718438, "time": "2025-06-02 07:44:07", "headline": "Bond Market Will Dictate BOJ's Next Move", "summary": " ", "symbols": [], "source": "benzinga", "author": "Singapore Forex Club", "url": "https://www.benzinga.com/markets/forex/25/06/45718438/bond-market-will-dictate-bojs-next-move", "tags": []}
{"id": 45718452, "time": "2025-06-02 07:44:54", "headline": "Nebius Group Raises $1B Through Convertible Notes to Fuel AI Infrastructure Growth", "summary": "", "symbols": ["NBIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718452/nebius-group-raises-1b-through-convertible-notes-to-fuel-ai-infrastructure-growth", "tags": []}
{"id": 45718458, "time": "2025-06-02 07:46:40", "headline": "CAE Taps Matthew Bromberg as New CEO, Replacing Longtime Leader Marc Parent", "summary": "", "symbols": ["CAE", "TSX:CAE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718458/cae-taps-matthew-bromberg-as-new-ceo-replacing-longtime-leader-marc-parent", "tags": ["management"]}
{"id": 45718471, "time": "2025-06-02 07:50:11", "headline": "Michael Saylor's Strategy Outperforms Apple, Tesla, Amazon And Other Mag 7 Stocks And It's Not Even Close: Has The 'Bitcoin Treasury' Bet Paid Off?", "summary": "Michael Saylor&#39;s &#39;Bitcoin Treasury&#39; gambit has been a monumental success, outpacing stocks, commodities, and even Bitcoin itself.", "symbols": ["AAPL", "AMZN", "BITS", "GLD", "GME", "GOOG", "IBIT", "MAGS", "MARA", "META", "MSFT", "MSTR", "NVDA", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/crypto/25/06/45718471/michael-saylors-strategy-outperforms-apple-tesla-amazon-and-other-mag-7-stocks-and-its-not-even-close-has-the-bitcoin-treasury-bet-paid-off", "tags": []}
{"id": 45718710, "time": "2025-06-02 07:54:17", "headline": "Truist Securities Initiates Coverage On BILL Holdings with Hold Rating, Announces Price Target of $47", "summary": "", "symbols": ["BILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718710/truist-securities-initiates-coverage-on-bill-holdings-with-hold-rating-announces-price-target-of-47", "tags": ["analyst_init"]}
{"id": 45718711, "time": "2025-06-02 07:54:26", "headline": "D. Boral Capital Maintains Buy on Trevi Therapeutics, Maintains $21 Price Target", "summary": "", "symbols": ["TRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718711/d-boral-capital-maintains-buy-on-trevi-therapeutics-maintains-21-price-target", "tags": ["analyst_other"]}
{"id": 45718718, "time": "2025-06-02 07:55:05", "headline": "Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45718718/trading-halt-halted-at-7-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45718728, "time": "2025-06-02 07:56:23", "headline": "Truist Securities Initiates Coverage On Mastercard with Buy Rating, Announces Price Target of $640", "summary": "", "symbols": ["MA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718728/truist-securities-initiates-coverage-on-mastercard-with-buy-rating-announces-price-target-of-640", "tags": ["analyst_init"]}
{"id": 45718730, "time": "2025-06-02 07:57:55", "headline": "Truist Securities Initiates Coverage On Visa with Buy Rating, Announces Price Target of $400", "summary": "", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718730/truist-securities-initiates-coverage-on-visa-with-buy-rating-announces-price-target-of-400", "tags": ["analyst_init"]}
{"id": 45718731, "time": "2025-06-02 07:58:03", "headline": "Rosenblatt Maintains Buy on CrowdStrike Holdings, Raises Price Target to $515", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718731/rosenblatt-maintains-buy-on-crowdstrike-holdings-raises-price-target-to-515", "tags": ["analyst_other", "price_target_up"]}
{"id": 45718734, "time": "2025-06-02 07:59:15", "headline": "Truist Securities Initiates Coverage On DLocal with Hold Rating, Announces Price Target of $12", "summary": "", "symbols": ["DLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718734/truist-securities-initiates-coverage-on-dlocal-with-hold-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 45718736, "time": "2025-06-02 07:59:57", "headline": "Rosenblatt Maintains Buy on Couchbase, Maintains $20 Price Target", "summary": "", "symbols": ["BASE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718736/rosenblatt-maintains-buy-on-couchbase-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 45718888, "time": "2025-06-02 08:00:37", "headline": "Expert Outlook: SoFi Technologies Through The Eyes Of 5 Analysts", "summary": " ", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718888/expert-outlook-sofi-technologies-through-the-eyes-of-5-analysts", "tags": ["guidance"]}
{"id": 45718895, "time": "2025-06-02 08:00:53", "headline": "Truist Securities Initiates Coverage On Toast with Buy Rating, Announces Price Target of $48", "summary": "", "symbols": ["TOST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718895/truist-securities-initiates-coverage-on-toast-with-buy-rating-announces-price-target-of-48", "tags": ["analyst_init"]}
{"id": 45718898, "time": "2025-06-02 08:00:57", "headline": "Assessing Shift4 Payments: Insights From 15 Financial Analysts", "summary": " ", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718898/assessing-shift4-payments-insights-from-15-financial-analysts", "tags": []}
{"id": 45718903, "time": "2025-06-02 08:01:07", "headline": "What 18 Analyst Ratings Have To Say About PayPal Holdings", "summary": " ", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718903/what-18-analyst-ratings-have-to-say-about-paypal-holdings", "tags": []}
{"id": 45718913, "time": "2025-06-02 08:01:18", "headline": "Expert Outlook: Flywire Through The Eyes Of 8 Analysts", "summary": " ", "symbols": ["FLYW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718913/expert-outlook-flywire-through-the-eyes-of-8-analysts", "tags": ["guidance"]}
{"id": 45718925, "time": "2025-06-02 08:01:34", "headline": "Beyond The Numbers: 9 Analysts Discuss Red Rock Resorts Stock", "summary": " ", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718925/beyond-the-numbers-9-analysts-discuss-red-rock-resorts-stock", "tags": []}
{"id": 45718928, "time": "2025-06-02 08:01:55", "headline": "Breaking Down BILL Holdings: 19 Analysts Share Their Views", "summary": " ", "symbols": ["BILL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45718928/breaking-down-bill-holdings-19-analysts-share-their-views", "tags": []}
{"id": 45718946, "time": "2025-06-02 08:02:22", "headline": "Ethereum Books Record Institutional Inflows, XRP Sees Outflows: What Is Going On?", "summary": "Ethereum (CRYPTO: ETH) has emerged as the top-performing digital asset among institutional investment products, notching $321 million in inflows last week, its strongest 6-week streak since December 2024, according to a report.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45718946/ethereum-books-record-institutional-inflows-xrp-sees-outflows-what-is-going-on", "tags": []}
{"id": 45718949, "time": "2025-06-02 08:02:38", "headline": "Allarity Therapeutics Says First Patient Enrolled In New Phase 2 Clinical Trial Protocol Of Stenoparib For Treatment Of Advanced, Platinum-Resistant Or Platinum-Ineligible Ovarian Cancer", "summary": "", "symbols": ["ALLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718949/allarity-therapeutics-says-first-patient-enrolled-in-new-phase-2-clinical-trial-protocol-of-stenopar", "tags": ["fda"]}
{"id": 45718958, "time": "2025-06-02 08:03:06", "headline": "Truist Securities Initiates Coverage On Fidelity National Info with Hold Rating, Announces Price Target of $84", "summary": "", "symbols": ["FIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718958/truist-securities-initiates-coverage-on-fidelity-national-info-with-hold-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 45718979, "time": "2025-06-02 08:04:19", "headline": "Celularity Highlights Unique Potential Of Proprietary Advanced Biomaterial Technology As Novel Cellular Delivery System For Ocular Surface Reconstruction", "summary": "", "symbols": ["CELU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718979/celularity-highlights-unique-potential-of-proprietary-advanced-biomaterial-technology-as-novel-cellu", "tags": []}
{"id": 45718994, "time": "2025-06-02 08:04:50", "headline": "Truist Securities Initiates Coverage On Global Payments with Hold Rating, Announces Price Target of $79", "summary": "", "symbols": ["GPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45718994/truist-securities-initiates-coverage-on-global-payments-with-hold-rating-announces-price-target-of-7", "tags": ["analyst_init"]}
{"id": 45719002, "time": "2025-06-02 08:05:02", "headline": "'I'm Trying To Save Medicaid,' Says Trump-Appointed CMS Chief Dr. Oz As CBO Estimates 7.6 Million Could Lose Coverage Under GOP's 'Big, Beautiful Bill'", "summary": "Trump&#39;s pick for CMS defends Medicaid cuts, saying it&#39;s about long-term survival and increasing spending. Critics worry millions may lose coverage.", "symbols": [], "source": "benzinga", "author": "Proiti Seal Acharya", "url": "https://www.benzinga.com/news/health-care/25/06/45719002/im-trying-to-save-medicaid-says-trump-appointed-cms-chief-dr-oz-as-cbo-estimates-7-6-million-could-lose-coverage-under-gops-big-beautiful-bill", "tags": []}
{"id": 45719029, "time": "2025-06-02 08:06:01", "headline": "LMP Capital and Income Fund Board Approves 1-For-3 Rights Offering", "summary": "", "symbols": ["SCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719029/lmp-capital-and-income-fund-board-approves-1-for-3-rights-offering", "tags": ["offering"]}
{"id": 45719050, "time": "2025-06-02 08:06:58", "headline": "Nutriband Quarterly Reports Revenue For Q1 2025, Up 63% YOY And Announces Strategic Progress Toward NDA Filing For Abuse-Deterrent Patch Development Of AVERSA Fentanyl", "summary": "", "symbols": ["NTRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719050/nutriband-quarterly-reports-revenue-for-q1-2025-up-63-yoy-and-announces-strategic-progress-toward", "tags": ["earnings"]}
{"id": 45719056, "time": "2025-06-02 08:07:16", "headline": "Lineage Announces Planned Retirement Of CFO, Rob Crisci", "summary": "", "symbols": ["LINE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719056/lineage-announces-planned-retirement-of-cfo-rob-crisci", "tags": ["management"]}
{"id": 45719064, "time": "2025-06-02 08:07:37", "headline": "Top 2 Real Estate Stocks That Could Surge This Quarter", "summary": " ", "symbols": ["OPI", "WHLR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45719064/top-2-real-estate-stocks-that-could-surge-this-quarter", "tags": []}
{"id": 45719065, "time": "2025-06-02 08:07:38", "headline": "12 Industrials Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["ARAI", "BTOC", "BURU", "CAPT", "GWH", "HKPD", "HOVR", "NVVE", "QH", "SAIC", "SPWR", "WETO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45719065/12-industrials-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 45719068, "time": "2025-06-02 08:07:43", "headline": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["BMGL", "KYMR", "LUCD", "LYRA", "PSTV", "RGC", "RSLS", "SLXN", "TELO", "TIL", "VERA", "XLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45719068/12-health-care-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 45719070, "time": "2025-06-02 08:07:49", "headline": "12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["BQ", "CLEU", "ECDA", "EDUC", "ELA", "GNS", "LOGC", "MMA", "ROLR", "SBET", "UHG", "VSA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45719070/12-consumer-discretionary-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 45719071, "time": "2025-06-02 08:07:55", "headline": "11 Materials Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["BSLK", "CENX", "CLF", "CMC", "IPX", "ITP", "MGIH", "NUE", "ORGN", "STLD", "TANH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45719071/11-materials-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 45719079, "time": "2025-06-02 08:08:04", "headline": "Indaptus Therapeutics Doses First Patient In Phase 1b/2 Trial Expansion Of Decoy20 Combo For Advanced Solid Tumors", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719079/indaptus-therapeutics-doses-first-patient-in-phase-1b2-trial-expansion-of-decoy20-combo-for-advan", "tags": ["fda"]}
{"id": 45719080, "time": "2025-06-02 08:08:11", "headline": "Newsmax Expects To List On U.S. Small-Cap Russell 2000 Index, Effective June 30, 2025, As Part Of 2025 Russell Indexes Reconstitution", "summary": "", "symbols": ["NMAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719080/newsmax-expects-to-list-on-u-s-small-cap-russell-2000-index-effective-june-30-2025-as-part-of-2025-r", "tags": []}
{"id": 45719129, "time": "2025-06-02 08:08:58", "headline": "Sutro Biopharma Appoints Greg Chow As CFO, Effective June 2, 2025", "summary": "", "symbols": ["STRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719129/sutro-biopharma-appoints-greg-chow-as-cfo-effective-june-2-2025", "tags": ["management"]}
{"id": 45719142, "time": "2025-06-02 08:09:54", "headline": "Opus Genetics; LYNX-2 Phase 3 Trial Met Primary Endpoint For Phentolamine Ophthalmic Solution 0.75% In Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719142/opus-genetics-lynx-2-phase-3-trial-met-primary-endpoint-for-phentolamine-ophthalmic-solution-0-75", "tags": ["fda"]}
{"id": 45719144, "time": "2025-06-02 08:09:58", "headline": "PDS Biotech Reports Durable 30-Month Median Overall Survival In 1L Recurrent/Metastatic HNSCC, Highlights Urgent Need In Rapidly Rising HPV16-Positive Cases", "summary": "", "symbols": ["PDSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719144/pds-biotech-reports-durable-30-month-median-overall-survival-in-1l-recurrentmetastatic-hnscc-high", "tags": []}
{"id": 45719151, "time": "2025-06-02 08:10:26", "headline": "Radiopharm Theranostics Says Preclinical Data From Studies With Lu177-B7H3-Monoclonal Antibody RV01 Demonstrates Favourable Biodistribution And Shows That RV01 Maintained High Tumour Uptake", "summary": "", "symbols": ["RADX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719151/radiopharm-theranostics-says-preclinical-data-from-studies-with-lu177-b7h3-monoclonal-antibody-rv01", "tags": []}
{"id": 45719162, "time": "2025-06-02 08:11:00", "headline": "General Mills And Lactalis Receive Regulatory Clearance For Sale OF U.S. Yogurt Transaction", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719162/general-mills-and-lactalis-receive-regulatory-clearance-for-sale-of-u-s-yogurt-transaction", "tags": []}
{"id": 45719165, "time": "2025-06-02 08:11:28", "headline": "Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges", "summary": "Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.", "symbols": ["ABT", "BBNX", "DXCM", "PODD", "TNDM"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/45719165/goldman-sachs-bullish-on-dexcom-and-insulet-as-diabetes-tech-surges", "tags": []}
{"id": 45719166, "time": "2025-06-02 08:11:30", "headline": "Jefferies Upgrades Rollins to Buy, Raises Price Target to $65", "summary": "", "symbols": ["ROL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719166/jefferies-upgrades-rollins-to-buy-raises-price-target-to-65", "tags": ["analyst_up", "price_target_up"]}
{"id": 45719168, "time": "2025-06-02 08:11:40", "headline": "Coya Therapeutics Announces Issuance Of U.S. Patent Relevant To Investigational RTU Liquid Formulation Of IL-2", "summary": "", "symbols": ["COYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719168/coya-therapeutics-announces-issuance-of-u-s-patent-relevant-to-investigational-rtu-liquid-formulatio", "tags": []}
{"id": 45719175, "time": "2025-06-02 08:12:04", "headline": "Aqua Metals Secures Key U.S. Patent For Breakthrough Lithium Battery Recycling Technology, Further Strengthens The Co's AquaRefining Intellectual Property Portfolio", "summary": "", "symbols": ["AQMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719175/aqua-metals-secures-key-u-s-patent-for-breakthrough-lithium-battery-recycling-technology-further-str", "tags": []}
{"id": 45719179, "time": "2025-06-02 08:12:27", "headline": "Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout", "summary": "Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.", "symbols": ["BPMC", "NRIX", "SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45719179/sanofi-expands-rare-immunology-portfolio-with-blueprint-buyout", "tags": ["merger"]}
{"id": 45719189, "time": "2025-06-02 08:12:52", "headline": "Ascendis Pharma Announced FDA Acceptance For Priority Review Of New Drug Application For TransCon CNP For Children With Achondroplasia And Set Prescription Drug User Fee Act Goal Date Of Nov. 30, 2025 To Complete Review.", "summary": "", "symbols": ["ASND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719189/ascendis-pharma-announced-fda-acceptance-for-priority-review-of-new-drug-application-for-transcon", "tags": ["fda"]}
{"id": 45719197, "time": "2025-06-02 08:13:04", "headline": "Esperion Reaches Settlement With Hetero USA To Delay Generic NEXLETOL Launch Until 2040, While Patent Litigation Against Additional Generic Challengers Remains Ongoing", "summary": "", "symbols": ["ESPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719197/esperion-reaches-settlement-with-hetero-usa-to-delay-generic-nexletol-launch-until-2040-while-patent", "tags": ["legal"]}
{"id": 45719201, "time": "2025-06-02 08:13:16", "headline": "JPMorgan CEO Dimon, Speaking On Fox Business Said JPM Will Be At The Forefront Of Crypto", "summary": "", "symbols": ["BTC", "ETH", "JPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/06/45719201/jpmorgan-ceo-dimon-speaking-on-fox-business-said-jpm-will-be-at-the-forefront-of-crypto", "tags": ["management"]}
{"id": 45719208, "time": "2025-06-02 08:14:10", "headline": "Cramer: Should've Told Investors To 'Pull The Trigger' On Trade Desk, Can't Believe 'How Low' Gentex Has Fallen", "summary": " ", "symbols": ["ET", "GNTX", "OKE", "QXO", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/large-cap/25/06/45719208/cramer-shouldve-told-investors-to-pull-the-trigger-on-trade-desk-cant-believe-how-low-gentex-has-fallen", "tags": []}
{"id": 45719209, "time": "2025-06-02 08:14:21", "headline": "Jefferies Initiates Coverage On Aspen Insurance Hldgs with Buy Rating, Announces Price Target of $42", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719209/jefferies-initiates-coverage-on-aspen-insurance-hldgs-with-buy-rating-announces-price-target-of-42", "tags": ["analyst_init"]}
{"id": 45719218, "time": "2025-06-02 08:14:33", "headline": "TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster At 2025 ASCO Annual Meeting", "summary": "", "symbols": ["HURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719218/tuhura-biosciences-presents-ifx-hu2-0-trial-in-progress-poster-at-2025-asco-annual-meeting", "tags": ["fda"]}
{"id": 45719220, "time": "2025-06-02 08:14:37", "headline": "AstraZeneca And Daiichi Sankyo's ENHERTU Plus Pertuzumab Shows Median Progression-Free Survival Greater Than Three Years", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719220/astrazeneca-and-daiichi-sankyos-enhertu-plus-pertuzumab-shows-median-progression-free-survival-great", "tags": []}
{"id": 45719222, "time": "2025-06-02 08:14:42", "headline": "Pasithea Announces Its PAS-004 Shows Early Activity And Durable Disease Stability In Heavily Pretreated Solid Tumors, Including BRAF-Mutated Melanoma, With Favorable Safety And Pharmacokinetics In Ongoing Phase 1 Dose Escalation Trial", "summary": "", "symbols": ["KTTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719222/pasithea-announces-its-pas-004-shows-early-activity-and-durable-disease-stability-in-heavily-pret", "tags": ["fda"]}
{"id": 45719227, "time": "2025-06-02 08:14:55", "headline": "Applied Digital Enters 15-Year Lease Agreements With CoreWeave, Expects $7B Revenue Over Term", "summary": "", "symbols": ["APLD", "CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719227/applied-digital-enters-15-year-lease-agreements-with-coreweave-expects-7b-revenue-over-term", "tags": ["earnings"]}
{"id": 45719239, "time": "2025-06-02 08:15:36", "headline": "Webus Signs Up To $300M XRP Treasury Management Agreement With Samara Alpha", "summary": "", "symbols": ["WETO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719239/webus-signs-up-to-300m-xrp-treasury-management-agreement-with-samara-alpha", "tags": ["contract"]}
{"id": 45719260, "time": "2025-06-02 08:16:10", "headline": "Panama Approves Cobre Panama Copper Export Plan, But Mine Remains Shut", "summary": " ", "symbols": ["FQVLF"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/markets/commodities/25/06/45719260/panama-approves-cobre-panama-copper-export-plan-but-mine-remains-shut", "tags": []}
{"id": 45719261, "time": "2025-06-02 08:16:13", "headline": "Mersana Therapeutics Announces Additional Interim Phase 1 Clinical Data For Emiltatug Ledadotin, B7-H4-Directed Dolasynthen ADC", "summary": "", "symbols": ["MRSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719261/mersana-therapeutics-announces-additional-interim-phase-1-clinical-data-for-emiltatug-ledadotin-b7-h", "tags": ["fda"]}
{"id": 45719276, "time": "2025-06-02 08:18:11", "headline": "Hyperfine Secures FDA Clearance For Next-Gen AI-Powered Portable MRI Scanner", "summary": "", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719276/hyperfine-secures-fda-clearance-for-next-gen-ai-powered-portable-mri-scanner", "tags": ["fda"]}
{"id": 45719291, "time": "2025-06-02 08:19:22", "headline": "Live On Fox Business; JPMorgan Chase CEO Jamie Dimon Says U.S. Bond Market Will Have \"Tough Time\" Due To Deficit And Bond Market Spreads \"Will Gap Out\"", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45719291/live-on-fox-business-jpmorgan-chase-ceo-jamie-dimon-says-u-s-bond-market-will-hav", "tags": ["management"]}
{"id": 45719298, "time": "2025-06-02 08:19:42", "headline": "Nutriband Q1 EPS $(0.12) Beats $(0.20) Estimate, Sales $667.43K Miss $705.00K Estimate", "summary": "", "symbols": ["NTRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45719298/nutriband-q1-eps-0-12-beats-0-20-estimate-sales-667-43k-miss-705-00k-estimate", "tags": ["earnings"]}
{"id": 45719301, "time": "2025-06-02 08:19:46", "headline": "Trump Rails Against Court Rulings Blocking His Tariffs, Says US Could Be 'Held Hostage' By Foreign Nations", "summary": "President Donald Trump claimed losing legal challenges to his sweeping tariffs would lead to the &#34;economic ruination&#34; of America after federal courts blocked his emergency trade powers while an appeals court provided temporary relief.", "symbols": [], "source": "benzinga", "author": "Tanya Rawat", "url": "https://www.benzinga.com/news/legal/25/06/45719301/trump-rails-against-court-rulings-blocking-his-tariffs-says-us-could-be-held-hostage-by-foreign-nations", "tags": ["legal"]}
{"id": 45719330, "time": "2025-06-02 08:20:55", "headline": "Southwest Airlines Makes First Trans-Pacific Move With China Airlines Partnership", "summary": "Southwest Airlines to launch first trans-Pacific partnership with China Airlines, expanding global connectivity and customer access by 2026", "symbols": ["IYT", "JETS", "LUV"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/travel/25/06/45719330/southwest-airlines-makes-first-trans-pacific-move-with-china-airlines-partnership", "tags": ["contract"]}
{"id": 45719333, "time": "2025-06-02 08:21:06", "headline": "Alpha Modus CEO's Family Trusts Voluntarily Exchange 3.2M Series C Preferred Shares For Over 26M Class A Common Shares With Lock-Up Through June 2026", "summary": "", "symbols": ["AMOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719333/alpha-modus-ceos-family-trusts-voluntarily-exchange-3-2m-series-c-preferred-shares-for-over-26m-clas", "tags": ["management"]}
{"id": 45719355, "time": "2025-06-02 08:21:23", "headline": "Top 3 Utilities Stocks That May Crash In June", "summary": " ", "symbols": ["CEG", "KEP", "NRG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45719355/top-3-utilities-stocks-that-may-crash-in-june", "tags": []}
{"id": 45719365, "time": "2025-06-02 08:21:59", "headline": "Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'", "summary": " ", "symbols": ["ABBV", "GAP", "JPM", "META"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/large-cap/25/06/45719365/meta-jpmorgan-gap-and-a-health-care-stock-on-cnbcs-final-trades", "tags": []}
{"id": 45719481, "time": "2025-06-02 08:23:47", "headline": "Stifel Maintains Buy on Limbach Holdings, Raises Price Target to $141", "summary": "", "symbols": ["LMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719481/stifel-maintains-buy-on-limbach-holdings-raises-price-target-to-141", "tags": ["analyst_other", "price_target_up"]}
{"id": 45719574, "time": "2025-06-02 08:24:03", "headline": "Leerink Partners Downgrades Arvinas to Market Perform, Lowers Price Target to $9", "summary": "", "symbols": ["ARVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719574/leerink-partners-downgrades-arvinas-to-market-perform-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 45719598, "time": "2025-06-02 08:25:06", "headline": "Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45719598/trading-halt-halt-status-updated-at-8-25-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45719635, "time": "2025-06-02 08:27:34", "headline": "Barclays Downgrades Centene to Equal-Weight, Lowers Price Target to $65", "summary": "", "symbols": ["CNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719635/barclays-downgrades-centene-to-equal-weight-lowers-price-target-to-65", "tags": ["analyst_down", "price_target_down"]}
{"id": 45719637, "time": "2025-06-02 08:27:48", "headline": "BlueLinx Holdings And LP Building Solutions Announce Expansion Of Distribution Partnership To Springfield, Missouri", "summary": "", "symbols": ["BXC", "LPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719637/bluelinx-holdings-and-lp-building-solutions-announce-expansion-of-distribution-partnership-to-spring", "tags": ["contract"]}
{"id": 45719649, "time": "2025-06-02 08:29:22", "headline": "Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?", "summary": "Lyra&#39;s LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a favorable safety profile.", "symbols": ["GSK", "LYRA"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45719649/why-is-lyra-therapeutics-stock-surging-over-400-on-monday", "tags": ["why_moving", "fda"]}
{"id": 45719665, "time": "2025-06-02 08:29:57", "headline": "Erasca Secures FDA Clearance For First-In-Class Pan-KRAS Inhibitor ERAS-4001", "summary": "", "symbols": ["ERAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719665/erasca-secures-fda-clearance-for-first-in-class-pan-kras-inhibitor-eras-4001", "tags": ["fda"]}
{"id": 45719740, "time": "2025-06-02 08:30:52", "headline": "Litchfield Hills Initiates Coverage On Inspira Technologies Oxy with Buy Rating, Announces Price Target of $2", "summary": "", "symbols": ["IINN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719740/litchfield-hills-initiates-coverage-on-inspira-technologies-oxy-with-buy-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 45719774, "time": "2025-06-02 08:31:36", "headline": "Galloway Capital Partners And Affiliate, Diveroli Investment Group, Announces 4.31% Stake in Babcock & Wilcox Enterprises", "summary": "", "symbols": ["BW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719774/galloway-capital-partners-and-affiliate-diveroli-investment-group-announces-4-31-stake-in-babcock-wi", "tags": []}
{"id": 45719775, "time": "2025-06-02 08:31:39", "headline": "TruGolf Secures Nasdaq Compliance Extension, Subject To Panel Conditions", "summary": "", "symbols": ["TRUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719775/trugolf-secures-nasdaq-compliance-extension-subject-to-panel-conditions", "tags": []}
{"id": 45719780, "time": "2025-06-02 08:32:24", "headline": "How To Earn $500 A Month From Dollar General Stock Ahead Of Q1 Earnings", "summary": " ", "symbols": ["DG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/06/45719780/how-to-earn-500-a-month-from-dollar-general-stock-ahead-of-q1-earnings", "tags": ["earnings"]}
{"id": 45719783, "time": "2025-06-02 08:32:40", "headline": "TELA Bio Appoints Jeffrey Blizard As President Effective Immediately", "summary": "", "symbols": ["TELA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719783/tela-bio-appoints-jeffrey-blizard-as-president-effective-immediately", "tags": ["management"]}
{"id": 45719805, "time": "2025-06-02 08:33:22", "headline": "Classover Holdings Enters Into Securities Purchase Agreement With Solana Growth Ventures For Issuance Of Up To $500M In Senior Secured Convertible Notes, Advancing Strategic Initiative To Build Solana-Based Treasury Reserve", "summary": "", "symbols": ["KIDZ", "KIDZW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719805/classover-holdings-enters-into-securities-purchase-agreement-with-solana-growth-ventures-for-issuanc", "tags": ["contract"]}
{"id": 45719806, "time": "2025-06-02 08:33:35", "headline": "Ladenburg Thalmann Downgrades NorthWestern Energy Group to Neutral, Lowers Price Target to $56", "summary": "", "symbols": ["NWE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719806/ladenburg-thalmann-downgrades-northwestern-energy-group-to-neutral-lowers-price-target-to-56", "tags": ["analyst_down", "price_target_down"]}
{"id": 45719262, "time": "2025-06-02 08:16:13", "headline": "UPDATE: Applied Digital Subsidiaries Sign $7B, 15-Year Datacenter Lease Agreements With CoreWeave For Full Capacity Of Two Under-Construction HPC Facilities At 400MW North Dakota Campus, Committing To Deliver 250MW Of Infrastructure Starting In 2025\u20132026", "summary": "", "symbols": ["APLD", "CRWV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719262/applied-digital-subsidiaries-sign-7b-15-year-datacenter-lease-agreements-with-coreweave-for-full-cap", "tags": []}
{"id": 45719811, "time": "2025-06-02 08:34:09", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Hamilton Lane, Lowers Price Target to $155", "summary": "", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719811/keefe-bruyette-woods-maintains-market-perform-on-hamilton-lane-lowers-price-target-to-155", "tags": ["analyst_other", "price_target_down"]}
{"id": 45719820, "time": "2025-06-02 08:34:24", "headline": "Vistagen Therapeutics Provides Update For U.S. Registration-Directed PALISADE-3 Phase 3 Trial Evaluating Fasedienol For Acute Treatment Of Social Anxiety Disorder", "summary": "", "symbols": ["VTGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45719820/vistagen-therapeutics-provides-update-for-u-s-registration-directed-palisade-3-phase-3-trial-eval", "tags": ["fda"]}
{"id": 45719828, "time": "2025-06-02 08:34:56", "headline": "Neurocrine Biosciences Announces New Data From Phase 4 KINECT-PROTM Open-Label Study Showing Robust, Sustained Improvements In Physical, Social And Emotional Functioning In Patients With Tardive Dyskinesia Taking Once-Daily INGREZZA Capsules", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719828/neurocrine-biosciences-announces-new-data-from-phase-4-kinect-protm-open-label-study-showing-robust", "tags": []}
{"id": 45719838, "time": "2025-06-02 08:35:44", "headline": "Taoping Wins $2.8M Contract To Supply Hunan Xiuxiang Agricultural Technology With Designated Agricultural Products", "summary": "", "symbols": ["TAOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719838/taoping-wins-2-8m-contract-to-supply-hunan-xiuxiang-agricultural-technology-with-designated-agricult", "tags": ["contract"]}
{"id": 45719839, "time": "2025-06-02 08:35:44", "headline": "Citigroup Initiates Coverage On RPM Intl with Buy Rating, Announces Price Target of $135", "summary": "", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719839/citigroup-initiates-coverage-on-rpm-intl-with-buy-rating-announces-price-target-of-135", "tags": ["analyst_init"]}
{"id": 45719840, "time": "2025-06-02 08:35:53", "headline": "Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals", "summary": "Moderna&#39;s mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved efficacy and safety profile.", "symbols": ["MRNA", "NVAX", "SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/fda/25/06/45719840/modernas-new-covid-vaccine-secures-fda-clearance-for-seniors-at-risk-individuals", "tags": ["fda"]}
{"id": 45719841, "time": "2025-06-02 08:35:56", "headline": "The Campbell's Sees FY25 Adjusted EPS To Be At The Low End Of The Guidance Range Due To The Slower Than Anticipated Recovery In The Snacks Business, Excluding The Impact Of Tariffs", "summary": "", "symbols": ["CPB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719841/the-campbells-sees-fy25-adjusted-eps-to-be-at-the-low-end-of-the-guidance-range-due-to-the-slower-th", "tags": ["earnings", "guidance"]}
{"id": 45719843, "time": "2025-06-02 08:35:58", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Seacoast Banking, Raises Price Target to $32", "summary": "", "symbols": ["SBCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719843/keefe-bruyette-woods-maintains-outperform-on-seacoast-banking-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 45719864, "time": "2025-06-02 08:36:33", "headline": "Safe & Green To Acquire 100% Of Issued And Outstanding Shares Of Giant Containers; Terms Not Disclosed", "summary": "", "symbols": ["SGBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719864/safe-green-to-acquire-100-of-issued-and-outstanding-shares-of-giant-containers-terms-not-disclosed", "tags": ["merger"]}
{"id": 45719866, "time": "2025-06-02 08:37:00", "headline": "NewGen To Invest  $30M In Solana Digital Asset Staking", "summary": "", "symbols": ["NIVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/06/45719866/newgen-to-invest-30m-in-solana-digital-asset-staking", "tags": []}
{"id": 45719884, "time": "2025-06-02 08:38:02", "headline": "Sabre Agrees With Salamair, Utilizing Sabre's Marketplace To Enhance Salamair's Global Visibility, Expand Market Reach, And Drive Revenue Growth", "summary": "", "symbols": ["SABR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719884/sabre-agrees-with-salamair-utilizing-sabres-marketplace-to-enhance-salamairs-global-visibility-expan", "tags": ["earnings"]}
{"id": 45719896, "time": "2025-06-02 08:38:15", "headline": "BTCS Acquires 1,000 ETH For ~$2.63M", "summary": "", "symbols": ["BTCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/06/45719896/btcs-acquires-1-000-eth-for-2-63m", "tags": ["merger"]}
{"id": 45719919, "time": "2025-06-02 08:39:23", "headline": "NewGenIvf Group Plans To Invest $30M In Staking Digital Asset Solana, Marking Substantial Expansion Of Digital Asset Investment Strategy", "summary": "", "symbols": ["NIVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719919/newgenivf-group-plans-to-invest-30m-in-staking-digital-asset-solana-marking-substantial-expansion-of", "tags": []}
{"id": 45719928, "time": "2025-06-02 08:39:27", "headline": "Dyadic International Announces COO Joe Hazelton Appointed As President, Effective Immediately", "summary": "", "symbols": ["DYAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719928/dyadic-international-announces-coo-joe-hazelton-appointed-as-president-effective-immediately", "tags": []}
{"id": 45719953, "time": "2025-06-02 08:41:05", "headline": "Morgan Stanley Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $755", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719953/morgan-stanley-maintains-overweight-on-regeneron-pharmaceuticals-lowers-price-target-to-755", "tags": ["analyst_other", "price_target_down"]}
{"id": 45719956, "time": "2025-06-02 08:41:49", "headline": "Federal Reserve's Preferred Inflation Gauge Falls To 2025 Low, But Jerome Powell Maintains 'Wait-And-See' Stance Amid Tariff Uncertainty", "summary": "April&#39;s PCE shows that disinflation has set in, making it complicated for the Federal Reserve to hold rates amid tariff turmoil.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/news/macro-notification/25/06/45719956/federal-reserves-preferred-inflation-gauge-falls-to-2025-low-but-jerome-powell-maintains-wait-and-see-stance-amid-tariff-uncertainty", "tags": ["analyst_other"]}
{"id": 45719957, "time": "2025-06-02 08:41:50", "headline": "Citigroup Initiates Coverage On Aspen Insurance Hldgs with Buy Rating, Announces Price Target of $43", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719957/citigroup-initiates-coverage-on-aspen-insurance-hldgs-with-buy-rating-announces-price-target-of-43", "tags": ["analyst_init"]}
{"id": 45719976, "time": "2025-06-02 08:42:29", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["NXST", "OMC", "T"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45719976/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-and-telecom-stocks-delivering-high-dividend-yields-4", "tags": ["dividend"]}
{"id": 45719977, "time": "2025-06-02 08:42:57", "headline": "SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session", "summary": " ", "symbols": ["ARVN", "ASTL", "BYDDF", "BYDDY", "DH", "IPX", "LI", "LOGC", "LUCD", "LVWR", "NIO", "QD", "SAIC", "SBET", "TSLA", "XPEV"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45719977/saic-tesla-and-other-big-stocks-moving-lower-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 45719990, "time": "2025-06-02 08:43:19", "headline": "Citigroup Initiates Coverage On Prairie Operating with Buy Rating, Announces Price Target of $8", "summary": "", "symbols": ["PROP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45719990/citigroup-initiates-coverage-on-prairie-operating-with-buy-rating-announces-price-target-of-8", "tags": ["analyst_init"]}
{"id": 45719995, "time": "2025-06-02 08:43:21", "headline": "Credo Technology Group Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["CRDO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45719995/credo-technology-group-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 45720002, "time": "2025-06-02 08:43:27", "headline": "Campbell's Brews Up Strong Q3: Beats Estimates As Home Cooking Sector Simmers", "summary": "&#34;Consumers are cooking at home at the highest levels since early 2020,&#34; Campbell&#39;s CEO Mick Beekhuizen says.", "symbols": ["CPB"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/large-cap/25/06/45720002/campbells-brews-up-strong-q3-beats-estimates-as-home-cooking-sector-simmers", "tags": ["management"]}
{"id": 45720003, "time": "2025-06-02 08:43:27", "headline": "Hyperscale Data Fuels AI Ambitions With $4.65 Million Pharma Divestment", "summary": "Hyperscale Data sells minority stake for $4.65M, aligning with strategy to divest non-core investments. Focus now on 617K sq ft data center for AI.", "symbols": ["GPUS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45720003/hyperscale-data-fuels-ai-ambitions-with-4-65-million-pharma-divestment", "tags": []}
{"id": 45720036, "time": "2025-06-02 08:44:06", "headline": "Cactus To Acquire 65% Interest In Baker Hughes Surface Pressure Control Business For $344.5M", "summary": "", "symbols": ["BKR", "WHD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720036/cactus-to-acquire-65-interest-in-baker-hughes-surface-pressure-control-business-for-344-5m", "tags": ["merger"]}
{"id": 45720075, "time": "2025-06-02 08:45:08", "headline": "Morgan Stanley Initiates Coverage On Chagee Holdings with Overweight Rating, Announces Price Target of $37.5", "summary": "", "symbols": ["CHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720075/morgan-stanley-initiates-coverage-on-chagee-holdings-with-overweight-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 45720080, "time": "2025-06-02 08:45:52", "headline": "Microsoft Announces $400 Million Investment To Expand AI And Cloud Infrastructure In Switzerland", "summary": "Microsoft Corporation\u00a0(NASDAQ: MSFT) has announced a $400 million investment in Switzerland to bolster\u00a0its cloud computing and artificial\u00a0intelligence (AI) infrastructure.", "symbols": ["AMZN", "MSFT", "NVDA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/equities/25/06/45720080/microsoft-announces-400-million-investment-to-expand-ai-and-cloud-infrastructure-in-switzerland", "tags": []}
{"id": 45720095, "time": "2025-06-02 08:46:22", "headline": "Click Holdings Receives Nasdaq Notification On Minimum Bid Price Deficiency", "summary": "", "symbols": ["CLIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720095/click-holdings-receives-nasdaq-notification-on-minimum-bid-price-deficiency", "tags": []}
{"id": 45720101, "time": "2025-06-02 08:46:36", "headline": "Worksport Reports $1.22M In April Sales", "summary": "", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45720101/worksport-reports-1-22m-in-april-sales", "tags": []}
{"id": 45720108, "time": "2025-06-02 08:47:03", "headline": "Morgan Stanley Maintains Equal-Weight on EOG Resources, Raises Price Target to $135", "summary": "", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720108/morgan-stanley-maintains-equal-weight-on-eog-resources-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720125, "time": "2025-06-02 08:48:25", "headline": "Scotiabank Upgrades BCE to Sector Outperform, Announces C$39 Price Target", "summary": "", "symbols": ["TSX:BCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720125/scotiabank-upgrades-bce-to-sector-outperform-announces-c-39-price-target", "tags": ["analyst_up"]}
{"id": 45720126, "time": "2025-06-02 08:48:42", "headline": "U.S. Gold Corp Joins Russell 3000 And Russell 2000 Indexes Following Annual Reconstitution", "summary": "", "symbols": ["USAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720126/u-s-gold-corp-joins-russell-3000-and-russell-2000-indexes-following-annual-reconstitution", "tags": []}
{"id": 45720127, "time": "2025-06-02 08:48:57", "headline": "Xilio Therapeutics Prices $50M Public Offering Of Pre-Funded Warrants And Series A, B, C Warrants To Purchase 66.7M Shares Each At $0.7499 Per Unit; Co May Receive Additional Gross Proceeds From The Offering Of Up To ~$100M Before Deducting Underwriting Discounts And Commissions And Offering Expenses", "summary": "", "symbols": ["XLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720127/xilio-therapeutics-prices-50m-public-offering-of-pre-funded-warrants-and-series-a-b-c-warrants-to-pu", "tags": ["offering"]}
{"id": 45720129, "time": "2025-06-02 08:49:13", "headline": "PDS Biotechnology shares are trading lower. The company provided updates and survival data for its VERSATILE-002 trial.", "summary": "", "symbols": ["PDSB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45720129/pds-biotechnology-shares-are-trading-lower-the-company-provided-updates-and-survival-data-for-its-ve", "tags": ["why_moving", "fda"]}
{"id": 45720157, "time": "2025-06-02 08:50:29", "headline": "UBS Upgrades SPX Technologies to Buy, Raises Price Target to $182", "summary": "", "symbols": ["SPXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720157/ubs-upgrades-spx-technologies-to-buy-raises-price-target-to-182", "tags": ["analyst_up", "price_target_up"]}
{"id": 45720159, "time": "2025-06-02 08:50:58", "headline": "Fly-E Group Prices $6.94M Public Offering Of 28.6M Shares And 57.2M 5-Year Warrants At $0.2428 Per Unit", "summary": "", "symbols": ["FLYE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720159/fly-e-group-prices-6-94m-public-offering-of-28-6m-shares-and-57-2m-5-year-warrants-at-0-2428-per-uni", "tags": ["offering"]}
{"id": 45720160, "time": "2025-06-02 08:51:00", "headline": "Mizuho Maintains Outperform on Veeva Systems, Raises Price Target to $295", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720160/mizuho-maintains-outperform-on-veeva-systems-raises-price-target-to-295", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720174, "time": "2025-06-02 08:52:33", "headline": "Wells Fargo Initiates Coverage On Aspen Insurance Hldgs with Equal-Weight Rating, Announces Price Target of $37", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720174/wells-fargo-initiates-coverage-on-aspen-insurance-hldgs-with-equal-weight-rating-announces-price-tar", "tags": ["analyst_init"]}
{"id": 45720176, "time": "2025-06-02 08:52:50", "headline": "Mizuho Maintains Outperform on Westlake, Lowers Price Target to $82", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720176/mizuho-maintains-outperform-on-westlake-lowers-price-target-to-82", "tags": ["analyst_other", "price_target_down"]}
{"id": 45720177, "time": "2025-06-02 08:53:08", "headline": "HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Raises Price Target to $85", "summary": "", "symbols": ["VERA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720177/hc-wainwright-co-maintains-buy-on-vera-therapeutics-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720410, "time": "2025-06-02 08:55:05", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45720410/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45720411, "time": "2025-06-02 08:55:05", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["APDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45720411/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 45720415, "time": "2025-06-02 08:55:10", "headline": "Mizuho Maintains Outperform on Canadian Solar, Lowers Price Target to $15", "summary": "", "symbols": ["CSIQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720415/mizuho-maintains-outperform-on-canadian-solar-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 45720416, "time": "2025-06-02 08:55:13", "headline": "6 In 10 Americans Fear Social Security Will Vanish Before They Retire, As 2033 Insolvency Clock Ticks Louder", "summary": "Many Americans fear Social Security will disappear by the time they retire, creating an urgent need for personal saving.", "symbols": ["BLK"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/personal-finance/management/25/06/45720416/6-in-10-americans-fear-social-security-will-vanish-before-they-retire-as-2033-insolvency-clock-ticks-louder", "tags": []}
{"id": 45720441, "time": "2025-06-02 08:55:46", "headline": "Needham Downgrades Blueprint Medicines to Hold, Maintains Price Target to $130", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720441/needham-downgrades-blueprint-medicines-to-hold-maintains-price-target-to-130", "tags": ["analyst_down", "analyst_other"]}
{"id": 45720446, "time": "2025-06-02 08:56:10", "headline": "This Nucor Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday", "summary": " ", "symbols": ["BA", "CHD", "NUE", "ROL", "SAIA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/25/06/45720446/this-nucor-analyst-turns-bullish-here-are-top-5-upgrades-for-monday", "tags": ["analyst_up"]}
{"id": 45720456, "time": "2025-06-02 08:57:02", "headline": "Mizuho Maintains Outperform on Enphase Energy, Lowers Price Target to $53", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720456/mizuho-maintains-outperform-on-enphase-energy-lowers-price-target-to-53", "tags": ["analyst_other", "price_target_down"]}
{"id": 45718360, "time": "2025-06-02 07:34:42", "headline": "Jony Ive Once Said Steve Jobs Demanded Everyone At Apple Often Answer This Question: 'It Still Shocks Me How Few People Actually Practice This'", "summary": "Jony Ive learned from Steve Jobs that the hardest part of creativity is having the nerve to drop most ideas. This lesson has been adopted by other CEOs, including Salesforce&#39;s Marc Benioff.", "symbols": ["AAPL", "CRM", "DIS", "SNOW"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/cannabis/25/06/45718360/jony-ive-once-said-steve-jobs-demanded-everyone-at-apple-often-answer-this-question-it-still-shocks-me-how-few-people-actually-practice-this", "tags": []}
{"id": 45720461, "time": "2025-06-02 08:58:52", "headline": "Mizuho Maintains Outperform on First Solar, Raises Price Target to $275", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720461/mizuho-maintains-outperform-on-first-solar-raises-price-target-to-275", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720665, "time": "2025-06-02 09:00:18", "headline": "Demystifying Global E Online: Insights From 16 Analyst Reviews", "summary": " ", "symbols": ["GLBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720665/demystifying-global-e-online-insights-from-16-analyst-reviews", "tags": []}
{"id": 45720742, "time": "2025-06-02 09:00:27", "headline": "10 Analysts Assess Toast: What You Need To Know", "summary": " ", "symbols": ["TOST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720742/10-analysts-assess-toast-what-you-need-to-know", "tags": []}
{"id": 45720746, "time": "2025-06-02 09:00:34", "headline": "What Analysts Are Saying About Fidelity National Info Stock", "summary": " ", "symbols": ["FIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720746/what-analysts-are-saying-about-fidelity-national-info-stock", "tags": []}
{"id": 45720750, "time": "2025-06-02 09:00:44", "headline": "Canadian Solar Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["CSIQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720750/canadian-solar-stock-a-deep-dive-into-analyst-perspectives-6-ratings", "tags": []}
{"id": 45720753, "time": "2025-06-02 09:00:55", "headline": "Analyst Expectations For Blueprint Medicines's Future", "summary": " ", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720753/analyst-expectations-for-blueprint-mediciness-future", "tags": []}
{"id": 45720757, "time": "2025-06-02 09:00:59", "headline": "Mizuho Maintains Outperform on Fluence Energy, Lowers Price Target to $6", "summary": "", "symbols": ["FLNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720757/mizuho-maintains-outperform-on-fluence-energy-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 45720764, "time": "2025-06-02 09:01:05", "headline": "Breaking Down Centene: 5 Analysts Share Their Views", "summary": " ", "symbols": ["CNC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45720764/breaking-down-centene-5-analysts-share-their-views", "tags": []}
{"id": 45720765, "time": "2025-06-02 09:01:05", "headline": "How Is The Market Feeling About Guidewire Software?", "summary": " ", "symbols": ["GWRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45720765/how-is-the-market-feeling-about-guidewire-software", "tags": []}
{"id": 45720771, "time": "2025-06-02 09:01:10", "headline": "How Is The Market Feeling About Interparfums?", "summary": " ", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45720771/how-is-the-market-feeling-about-interparfums", "tags": []}
{"id": 45720775, "time": "2025-06-02 09:01:15", "headline": "How Do Investors Really Feel About Oscar Health?", "summary": " ", "symbols": ["OSCR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45720775/how-do-investors-really-feel-about-oscar-health", "tags": []}
{"id": 45720783, "time": "2025-06-02 09:01:22", "headline": "Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data", "summary": "Vera Therapeutics&#39; share price surged over 65% during the pre-market trading session after the company released ORIGIN Phase 3 trial data.", "symbols": ["VERA"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45720783/kidney-health-focused-vera-therapeutics-stock-price-spikes-on-heels-of-successful-trial-data", "tags": ["fda"]}
{"id": 45720808, "time": "2025-06-02 09:01:46", "headline": "Aeries Technology Announces Strategic Partnership With Fortra To Expand Existing India-Based Workforce And Add Nearshore Hub", "summary": "", "symbols": ["AERT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720808/aeries-technology-announces-strategic-partnership-with-fortra-to-expand-existing-india-based-workfor", "tags": ["contract"]}
{"id": 45720831, "time": "2025-06-02 09:02:21", "headline": "Mizuho Maintains Outperform on Nextracker, Raises Price Target to $67", "summary": "", "symbols": ["NXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720831/mizuho-maintains-outperform-on-nextracker-raises-price-target-to-67", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720837, "time": "2025-06-02 09:02:54", "headline": "TD SYNNEX Appoints Kenneth Lamneck As Chair Of Nominating And Corporate Governance Committee", "summary": "", "symbols": ["SNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720837/td-synnex-appoints-kenneth-lamneck-as-chair-of-nominating-and-corporate-governance-committee", "tags": ["management"]}
{"id": 45720842, "time": "2025-06-02 09:03:04", "headline": "Palladyne AI Corp. To Join Russell 3000 And Russell 2000 Index, Effective After The U.S. Market Opens On June 30, 2025", "summary": "", "symbols": ["PDYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720842/palladyne-ai-corp-to-join-russell-3000-and-russell-2000-index-effective-after-the-u-s-market-opens-o", "tags": []}
{"id": 45720851, "time": "2025-06-02 09:03:29", "headline": "C3 AI Wins $13M Order To Expand Predictive Maintenance Program Across U.S. Air Force Fleet", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720851/c3-ai-wins-13m-order-to-expand-predictive-maintenance-program-across-u-s-air-force-fleet", "tags": []}
{"id": 45720856, "time": "2025-06-02 09:03:44", "headline": "Mizuho Maintains Outperform on Shoals Technologies Gr, Raises Price Target to $7", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720856/mizuho-maintains-outperform-on-shoals-technologies-gr-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720862, "time": "2025-06-02 09:04:03", "headline": "Actuate Therapeutics Highlights Insights On Phase 2 Trial Results Showing Clinically Meaningful Survival Benefit And Favorable Safety Of Elraglusib Combined With Gemcitabine/Nab-Paclitaxel In Untreated Metastatic Pancreatic Cancer At KOL Event", "summary": "", "symbols": ["ACTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45720862/actuate-therapeutics-highlights-insights-on-phase-2-trial-results-showing-clinically-meaningful-s", "tags": ["fda"]}
{"id": 45720868, "time": "2025-06-02 09:04:10", "headline": "ClearOne Authorizes 1-fFr-15 Reverse Stock Split", "summary": "", "symbols": ["CLRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720868/clearone-authorizes-1-ffr-15-reverse-stock-split", "tags": []}
{"id": 45720888, "time": "2025-06-02 09:04:48", "headline": "Nature's Sunshine Products Announces CEO Terrence Moorehead To Step Down Upon Successor Appointment, Board Launches Executive Search Process While Reaffirming Full Year 2025 Outlook", "summary": "", "symbols": ["NATR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720888/natures-sunshine-products-announces-ceo-terrence-moorehead-to-step-down-upon-successor-appointment-b", "tags": ["guidance", "management"]}
{"id": 45720907, "time": "2025-06-02 09:04:54", "headline": "ImmunityBio Receives FDA Expanded Access Authorization For Treatment Of Lymphopenia With ANKTIVA In Patients With Solid Tumors", "summary": "", "symbols": ["IBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45720907/immunitybio-receives-fda-expanded-access-authorization-for-treatment-of-lymphopenia-with-anktiva-", "tags": ["fda"]}
{"id": 45720921, "time": "2025-06-02 09:05:07", "headline": "Myriad Genetics Announces MONSTAR-SCREEN 3 Data, Advancing Pan-Cancer MRD Testing", "summary": "", "symbols": ["MYGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720921/myriad-genetics-announces-monstar-screen-3-data-advancing-pan-cancer-mrd-testing", "tags": []}
{"id": 45720937, "time": "2025-06-02 09:05:38", "headline": "Mizuho Maintains Neutral on SolarEdge Technologies, Raises Price Target to $18", "summary": "", "symbols": ["SEDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720937/mizuho-maintains-neutral-on-solaredge-technologies-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 45720940, "time": "2025-06-02 09:05:50", "headline": "Artelo Biosciences Welcomes Publication Of Peer-Reviewed Review Highlighting Therapeutic Potential Of Fatty Acid Binding Protein Inhibitors In Treating Anxiety And Mood Disorders, Underscoring Key Roles Of FABP5, FABP3, And FABP7 In Neuroinflammation And Endocannabinoid Regulation", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45720940/artelo-biosciences-welcomes-publication-of-peer-reviewed-review-highlighting-therapeutic-potentia", "tags": []}
{"id": 45720942, "time": "2025-06-02 09:06:02", "headline": "Cemtrex's Vicon Receives $0.8M Contracts From U.K. Correctional Facilities", "summary": "", "symbols": ["CETX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720942/cemtrexs-vicon-receives-0-8m-contracts-from-u-k-correctional-facilities", "tags": []}
{"id": 45720948, "time": "2025-06-02 09:06:23", "headline": "'How Alibaba Helped China Take the Lead From the U.S. in Open-Source AI' - The Information", "summary": "", "symbols": ["BABA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720948/how-alibaba-helped-china-take-the-lead-from-the-u-s-in-open-source-ai-the-information", "tags": []}
{"id": 45720972, "time": "2025-06-02 09:07:52", "headline": "Mizuho Maintains Outperform on Sunrun, Lowers Price Target to $13", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720972/mizuho-maintains-outperform-on-sunrun-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 45720980, "time": "2025-06-02 09:08:31", "headline": "CERo Therapeutics Secures Key U.S. And European Patents For Next-Gen T Cell Therapies", "summary": "", "symbols": ["CERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45720980/cero-therapeutics-secures-key-u-s-and-european-patents-for-next-gen-t-cell-therapies", "tags": []}
{"id": 45721021, "time": "2025-06-02 09:10:07", "headline": "Leading And Lagging Sectors For June 2, 2025", "summary": " ", "symbols": ["XLB", "XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/25/06/45721021/leading-and-lagging-sectors-for-june-2-2025", "tags": []}
{"id": 45721046, "time": "2025-06-02 09:10:53", "headline": "Diana Shipping Inc. Secures Time Charter Contract For Newcastlemax Vessel m/v Newport News At $25,000 Per Day With Bohai Ocean Shipping Through June To October 2026, Projecting ~$10.95M Gross Revenue For Minimum Charter Period", "summary": "", "symbols": ["DSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721046/diana-shipping-inc-secures-time-charter-contract-for-newcastlemax-vessel-mv-newport-news-at-25-000-p", "tags": ["earnings", "contract"]}
{"id": 45721051, "time": "2025-06-02 09:11:43", "headline": "Wedbush Downgrades Blueprint Medicines to Neutral, Raises Price Target to $129", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721051/wedbush-downgrades-blueprint-medicines-to-neutral-raises-price-target-to-129", "tags": ["analyst_down", "price_target_up"]}
{"id": 45721053, "time": "2025-06-02 09:11:48", "headline": "Get Ready To Pay The Price Of Tariffs: GE Is Already Passing Costs To Customers", "summary": "GE Aerospace Inc. to raise prices due to $500 million cost burden from trade tariffs, impacting airlines and passengers. CEO Larry Culp shares plans.", "symbols": ["BA", "GE"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/equities/25/06/45721053/get-ready-to-pay-the-price-of-tariffs-ge-is-already-passing-costs-to-customers", "tags": ["management"]}
{"id": 45721069, "time": "2025-06-02 09:12:47", "headline": "This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday", "summary": " ", "symbols": ["AHL", "CRDL", "RPM", "SHAK", "V"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/45721069/this-visa-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday", "tags": ["analyst_init"]}
{"id": 45721083, "time": "2025-06-02 09:13:27", "headline": "Brookfield Residential Forms Strategic JV With Trez Capital To Develop New Master-Planned Community In Central Florida Named Osprey Creek", "summary": "", "symbols": ["BN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721083/brookfield-residential-forms-strategic-jv-with-trez-capital-to-develop-new-master-planned-community", "tags": []}
{"id": 45721123, "time": "2025-06-02 09:15:36", "headline": "Raymond James Maintains Outperform on Block, Raises Price Target to $79", "summary": "", "symbols": ["XYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721123/raymond-james-maintains-outperform-on-block-raises-price-target-to-79", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721129, "time": "2025-06-02 09:15:50", "headline": "Top 10 Trending Stocks On WallStreetBets As Of June 2, 2025 (Via Swaggy Stocks)", "summary": "", "symbols": ["BULL", "CLF", "GLD", "GOOG", "GOOGL", "NVDA", "PLTR", "RDDT", "TSLA", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45721129/top-10-trending-stocks-on-wallstreetbets-as-of-june-2-2025-via-swaggy-stocks", "tags": []}
{"id": 45721135, "time": "2025-06-02 09:16:02", "headline": "ASP Isotopes Prices $50M Underwritten Registered Direct Offering Of 7.5M Shares At $6.65 Each To Institutional Investor", "summary": "", "symbols": ["ASPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721135/asp-isotopes-prices-50m-underwritten-registered-direct-offering-of-7-5m-shares-at-6-65-each-to-insti", "tags": ["offering"]}
{"id": 45721138, "time": "2025-06-02 09:16:37", "headline": "Dow Exits DowAksa JV, Stays Course On 'Best-Owner' Strategy", "summary": "Dow&#39;s decision to exit the joint venture aligns with its &#34;best-owner mindset&#34; strategy, which emphasizes concentrating on core.", "symbols": ["DOW", "NDIV", "SPHD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/asset-sales/25/06/45721138/dow-exits-dowaksa-jv-stays-course-on-best-owner-strategy", "tags": []}
{"id": 45721141, "time": "2025-06-02 09:16:52", "headline": "FormFactor Purchases Manufacturing Site In Farmers Branch, Texas For $55M", "summary": "", "symbols": ["FORM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721141/formfactor-purchases-manufacturing-site-in-farmers-branch-texas-for-55m", "tags": []}
{"id": 45721150, "time": "2025-06-02 09:17:39", "headline": "Raymond James Maintains Strong Buy on EOG Resources, Raises Price Target to $158", "summary": "", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721150/raymond-james-maintains-strong-buy-on-eog-resources-raises-price-target-to-158", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721154, "time": "2025-06-02 09:19:01", "headline": "Raymond James Maintains Strong Buy on e.l.f. Beauty, Raises Price Target to $130", "summary": "", "symbols": ["ELF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721154/raymond-james-maintains-strong-buy-on-e-l-f-beauty-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721195, "time": "2025-06-02 09:20:13", "headline": "Signet Jewelers Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["SIG"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45721195/signet-jewelers-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 45721200, "time": "2025-06-02 09:20:29", "headline": "Keybanc Maintains Overweight on UnitedHealth Group, Lowers Price Target to $400", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721200/keybanc-maintains-overweight-on-unitedhealth-group-lowers-price-target-to-400", "tags": ["analyst_other", "price_target_down"]}
{"id": 45721221, "time": "2025-06-02 09:21:00", "headline": "BWS Financial Maintains Buy on Movado Group, Maintains $31.5 Price Target", "summary": "", "symbols": ["MOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721221/bws-financial-maintains-buy-on-movado-group-maintains-31-5-price-target", "tags": ["analyst_other"]}
{"id": 45721229, "time": "2025-06-02 09:21:40", "headline": "Truist Securities Maintains Buy on Dollar Tree, Raises Price Target to $100", "summary": "", "symbols": ["DLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721229/truist-securities-maintains-buy-on-dollar-tree-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721231, "time": "2025-06-02 09:23:00", "headline": "JMP Securities Initiates Coverage On Aspen Insurance Hldgs with Market Outperform Rating, Announces Price Target of $45", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721231/jmp-securities-initiates-coverage-on-aspen-insurance-hldgs-with-market-outperform-rating-announces-p", "tags": ["analyst_init"]}
{"id": 45721232, "time": "2025-06-02 09:23:07", "headline": "NUBURU Announces $100M Equity Facility To Enhance Financial Flexibility Through 2028", "summary": "", "symbols": ["BURU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721232/nuburu-announces-100m-equity-facility-to-enhance-financial-flexibility-through-2028", "tags": []}
{"id": 45721233, "time": "2025-06-02 09:23:23", "headline": "This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday", "summary": " ", "symbols": ["BPMC", "CNC", "NWE", "RXT", "UNP"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-stock-ratings/downgrades/25/06/45721233/this-union-pacific-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday", "tags": ["analyst_down"]}
{"id": 45721429, "time": "2025-06-02 09:24:17", "headline": "Truist Securities Maintains Hold on Five Below, Raises Price Target to $112", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721429/truist-securities-maintains-hold-on-five-below-raises-price-target-to-112", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721461, "time": "2025-06-02 09:26:07", "headline": "Truist Securities Maintains Hold on JPMorgan Chase, Raises Price Target to $280", "summary": "", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721461/truist-securities-maintains-hold-on-jpmorgan-chase-raises-price-target-to-280", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721477, "time": "2025-06-02 09:27:17", "headline": "Technical Analysis For Trading SPY, Top Tech Stocks Today", "summary": " ", "symbols": [], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/markets/equities/25/06/45721477/technical-analysis-for-trading-spy-top-tech-stocks-today", "tags": []}
{"id": 45721480, "time": "2025-06-02 09:27:55", "headline": "JMP Securities Initiates Coverage On American Integrity with Outperform Rating, Announces Price Target of $23", "summary": "", "symbols": ["AII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721480/jmp-securities-initiates-coverage-on-american-integrity-with-outperform-rating-announces-price-targe", "tags": ["analyst_init"]}
{"id": 45721492, "time": "2025-06-02 09:28:32", "headline": "Stifel Maintains Hold on Parker Hannifin, Raises Price Target to $670", "summary": "", "symbols": ["PH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721492/stifel-maintains-hold-on-parker-hannifin-raises-price-target-to-670", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721500, "time": "2025-06-02 09:29:44", "headline": "Reitar Logtech Holdings Announces Up To $1.5B BTC Acquisition To Bolster Treasury Reserves And Accelerate Global Logistics Technology Expansion", "summary": "", "symbols": ["RITR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721500/reitar-logtech-holdings-announces-up-to-1-5b-btc-acquisition-to-bolster-treasury-reserves-and-accele", "tags": []}
{"id": 45721501, "time": "2025-06-02 09:29:44", "headline": "Applied Digital Stock Surges On AI Data Center Deal With CoreWeave: What You Need To Know", "summary": "Applied Digital Corp (NASDAQ:APLD) shares are trading higher Monday after the company announced long-term lease agreements with CoreWeave Inc (NASDAQ:CRWV).", "symbols": ["APLD", "CRWV"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45721501/applied-digital-stock-surges-on-ai-data-center-deal-with-coreweave-what-you-need-to-know", "tags": ["why_moving", "contract"]}
{"id": 45721528, "time": "2025-06-02 09:30:25", "headline": "JMP Securities Reiterates Market Outperform on Roku, Maintains $95 Price Target", "summary": "", "symbols": ["ROKU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721528/jmp-securities-reiterates-market-outperform-on-roku-maintains-95-price-target", "tags": ["analyst_other"]}
{"id": 45721531, "time": "2025-06-02 09:30:40", "headline": "Iovance Biotherapeutics Publishes Final Analysis Of Phase 2 C-144-01 Clinical Trial Evaluating Individualized T Cell Therapy Amtagvi In Patients With Advanced Melanoma In Journal of Clinical Oncology.", "summary": "", "symbols": ["IOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45721531/iovance-biotherapeutics-publishes-final-analysis-of-phase-2-c-144-01-clinical-trial-evaluating-in", "tags": ["fda"]}
{"id": 45721549, "time": "2025-06-02 09:31:58", "headline": "MiNK Therapeutics Awarded Grant From NIAID To Support Development Of MiNK's Allo- iNKT Cell Therapy Platform For Prevention And Treatment Of GvHD", "summary": "", "symbols": ["INKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721549/mink-therapeutics-awarded-grant-from-niaid-to-support-development-of-minks-allo-inkt-cell-therapy-pl", "tags": ["contract"]}
{"id": 45721557, "time": "2025-06-02 09:33:23", "headline": "HC Wainwright & Co. Assumes Sensei Biotherapeutics at Buy, Announces Price Target of $5", "summary": "", "symbols": ["SNSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721557/hc-wainwright-co-assumes-sensei-biotherapeutics-at-buy-announces-price-target-of-5", "tags": []}
{"id": 45721566, "time": "2025-06-02 09:33:47", "headline": "Innovex International Completes Acquisition Of Citadel Casing Solutions; Transaction Valued At 3.8x LTM Adjusted EBITDA And Projected To Be 8% Accretive To EPS, With $2M In Cost Synergies Expected Within 3-Months", "summary": "", "symbols": ["INVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45721566/innovex-international-completes-acquisition-of-citadel-casing-solutions-transaction-valued-at-3-8x-l", "tags": ["earnings"]}
{"id": 45721567, "time": "2025-06-02 09:33:49", "headline": "OceanPal Signs MOA To Sell 2004-Built Dry Bulk Vessel \"Protefs\" To Third Party For $7M Before Commissions With Delivery To Buyer No Later Than June 17, 2025", "summary": "", "symbols": ["OP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721567/oceanpal-signs-moa-to-sell-2004-built-dry-bulk-vessel-protefs-to-third-party-for-7m-before-commissio", "tags": []}
{"id": 45721585, "time": "2025-06-02 09:35:24", "headline": "BMO Capital Maintains Outperform on Samsara, Raises Price Target to $54", "summary": "", "symbols": ["IOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721585/bmo-capital-maintains-outperform-on-samsara-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721625, "time": "2025-06-02 09:36:24", "headline": "Guggenheim Maintains Neutral on New York Times, Raises Price Target to $55", "summary": "", "symbols": ["NYT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721625/guggenheim-maintains-neutral-on-new-york-times-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721631, "time": "2025-06-02 09:36:32", "headline": "First Interstate BancSystem Appoints David Della Camera As EVP And CFO, Succeeding Marcy Mutch, Effective June 1, 2025", "summary": "", "symbols": ["FIBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721631/first-interstate-bancsystem-appoints-david-della-camera-as-evp-and-cfo-succeeding-marcy-mutch-effect", "tags": ["management"]}
{"id": 45721646, "time": "2025-06-02 09:37:19", "headline": "Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday", "summary": " ", "symbols": ["BA", "BPMC", "DLTR", "EOG", "KNX", "ROL", "SEDG", "SPXC", "UNH", "XYZ"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/25/06/45721646/boeing-to-rally-more-than-25-here-are-10-top-analyst-forecasts-for-monday", "tags": []}
{"id": 45721715, "time": "2025-06-02 09:37:56", "headline": "BMO Capital Maintains Outperform on Regeneron Pharmaceuticals, Lowers Price Target to $600", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721715/bmo-capital-maintains-outperform-on-regeneron-pharmaceuticals-lowers-price-target-to-600", "tags": ["analyst_other", "price_target_down"]}
{"id": 45721757, "time": "2025-06-02 09:38:52", "headline": "FT Global Capital To Auction Nearly 2M Shares Of Future FinTech Common Stock In U.S. District Court Following Court Order, Seeking To Enforce $10.8M Judgment Amid Ongoing Domestic And International Legal Actions Against Future FinTech", "summary": "", "symbols": ["FTFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721757/ft-global-capital-to-auction-nearly-2m-shares-of-future-fintech-common-stock-in-u-s-district-court-f", "tags": ["legal"]}
{"id": 45721846, "time": "2025-06-02 09:41:01", "headline": "Nordic American Tankers' Founder, Chairman & CEO, Herbjorn Hansson Buys 100.000 Shares In NAT At $2.70/Shr", "summary": "", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721846/nordic-american-tankers-founder-chairman-ceo-herbjorn-hansson-buys-100-000-shares-in-nat-at-2-70shr", "tags": ["insider", "management"]}
{"id": 45721884, "time": "2025-06-02 09:42:16", "headline": "Canaccord Genuity Maintains Buy on UiPath, Raises Price Target to $16", "summary": "", "symbols": ["PATH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721884/canaccord-genuity-maintains-buy-on-uipath-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 45721899, "time": "2025-06-02 09:42:49", "headline": "Verastem Oncology Announces Updated Data From Dose Escalation Phase Of The Phase 1/2 Trial Of GFH375; Study Shows ORR Of 52% In Patients With Pancreatic Ductal Adenocarcinoma And ORR Of 42% With Non-Small Cell Lung Cancer", "summary": "", "symbols": ["VSTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721899/verastem-oncology-announces-updated-data-from-dose-escalation-phase-of-the-phase-12-trial-of-gfh375", "tags": ["fda"]}
{"id": 45721914, "time": "2025-06-02 09:43:17", "headline": "Canaccord Genuity Maintains Buy on PagerDuty, Lowers Price Target to $21", "summary": "", "symbols": ["PD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45721914/canaccord-genuity-maintains-buy-on-pagerduty-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 45722015, "time": "2025-06-02 09:45:29", "headline": "Canaccord Genuity Maintains Buy on Zscaler, Raises Price Target to $305", "summary": "", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722015/canaccord-genuity-maintains-buy-on-zscaler-raises-price-target-to-305", "tags": ["analyst_other", "price_target_up"]}
{"id": 45722016, "time": "2025-06-02 09:45:33", "headline": "B of A Securities Maintains Underperform on Albany International, Lowers Price Target to $65", "summary": "", "symbols": ["AIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722016/b-of-a-securities-maintains-underperform-on-albany-international-lowers-price-target-to-65", "tags": ["analyst_other", "price_target_down"]}
{"id": 45722033, "time": "2025-06-02 09:46:05", "headline": "S&P Global Manufacturing PMI For May 52.0 Vs 52.3 Est.; 50.2 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45722033/s-p-global-manufacturing-pmi-for-may-52-0-vs-52-3-est-50-2-prior", "tags": []}
{"id": 45722096, "time": "2025-06-02 09:47:29", "headline": "Deutsche Bank Initiates Coverage On Aspen Insurance Hldgs with Buy Rating, Announces Price Target of $42", "summary": "", "symbols": ["AHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722096/deutsche-bank-initiates-coverage-on-aspen-insurance-hldgs-with-buy-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 45722106, "time": "2025-06-02 09:47:57", "headline": "Strategy And Metaplanet Deepen Bitcoin Exposure With Over $190 Million In Fresh Buys Amid $105K Market Level", "summary": "Two corporate giants, Strategy Inc. and Metaplanet, acquire more Bitcoin in early June, reinforcing the trend of institutional BTC embrace. #Bitcoin #CorporateInvestment", "symbols": ["MSTR"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45722106/strategy-and-metaplanet-deepen-bitcoin-exposure-with-over-190-million-in-fresh-buys-amid-105k-market-level", "tags": ["merger"]}
{"id": 45722137, "time": "2025-06-02 09:48:58", "headline": "Knightscope Announces Over $1M In New Contracts, Including Major Client Renewals, Expanded Service Deployments, And New Wins Across The Country", "summary": "", "symbols": ["KSCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722137/knightscope-announces-over-1m-in-new-contracts-including-major-client-renewals-expanded-service-depl", "tags": []}
{"id": 45722197, "time": "2025-06-02 09:50:23", "headline": "CORRECTION: Announced May 31, 2025: 'Trump Administration Targets Tech Firms as It Cuts More Contracts'- WSJ", "summary": "", "symbols": ["ACN", "DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722197/correction-announced-may-31-2025-trump-administration-targets-tech-firms-as-it-cuts-more-contracts-w", "tags": []}
{"id": 45722224, "time": "2025-06-02 09:50:47", "headline": "JP Morgan Maintains Neutral on Melco Resorts and Enter, Raises Price Target to $7.2", "summary": "", "symbols": ["MLCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722224/jp-morgan-maintains-neutral-on-melco-resorts-and-enter-raises-price-target-to-7-2", "tags": ["analyst_other", "price_target_up"]}
{"id": 45722274, "time": "2025-06-02 09:52:07", "headline": "JP Morgan Maintains Neutral on United States Steel, Raises Price Target to $55", "summary": "", "symbols": ["X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722274/jp-morgan-maintains-neutral-on-united-states-steel-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 45722278, "time": "2025-06-02 09:52:19", "headline": "'EU Warns It Could Accelerate Retaliatory Tariffs Over US Duties'- Bloomberg", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722278/eu-warns-it-could-accelerate-retaliatory-tariffs-over-us-duties-bloomberg", "tags": []}
{"id": 45722415, "time": "2025-06-02 09:53:59", "headline": "Guggenheim Maintains Buy on Eos Energy Enterprises, Lowers Price Target to $6", "summary": "", "symbols": ["EOSE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722415/guggenheim-maintains-buy-on-eos-energy-enterprises-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 45722540, "time": "2025-06-02 09:55:08", "headline": "IM Cannabis Corp. Shares Halted On Circuit Breaker To The Upside, Stock Now Down -9.84%", "summary": "", "symbols": ["IMCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45722540/im-cannabis-corp-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down-9-84", "tags": ["halt"]}
{"id": 45722563, "time": "2025-06-02 09:55:41", "headline": "Mark Zuckerberg's Meta To Offer Fully Automated AI-Based Ad Creation By 2026: Report", "summary": "Meta Platforms Inc.\u00a0(NASDAQ: META) is set to revolutionize the advertising industry by introducing a fully automated ad creation system powered by artificial intelligence.", "symbols": ["META"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/tech/25/06/45722563/mark-zuckerbergs-meta-to-offer-fully-automated-ai-based-ad-creation-by-2026-report", "tags": []}
{"id": 45722616, "time": "2025-06-02 09:57:29", "headline": "Nebius Group Stock Is Sliding Monday: What's Going On?", "summary": "Nebius Group N.V. (NASDAQ:NBIS) shares are trading lower Monday after the company announced a $1 billion private convertible notes offering.", "symbols": ["NBIS"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/offerings/25/06/45722616/nebius-group-stock-is-sliding-monday-whats-going-on", "tags": ["why_moving", "offering"]}
{"id": 45722621, "time": "2025-06-02 09:57:41", "headline": "GDEV's Founder CEO Evaluates M&A Deals Using These 5 Metrics", "summary": "GDEV&#39;s Founder CEO Andrey Fadeev looks beyond creative assets and maturity of the team, to evaluate M&amp;A deals.", "symbols": [], "source": "benzinga", "author": "Andrey Fadeev", "url": "https://www.benzinga.com/m-a/25/06/45722621/gdevs-founder-ceo-evaluates-m-a-deals-using-these-5-metrics", "tags": ["management"]}
{"id": 45722629, "time": "2025-06-02 09:57:50", "headline": "Cantor Fitzgerald Initiates Coverage On United Therapeutics with Overweight Rating, Announces Price Target of $405", "summary": "", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722629/cantor-fitzgerald-initiates-coverage-on-united-therapeutics-with-overweight-rating-announces-price-t", "tags": ["analyst_init"]}
{"id": 45722678, "time": "2025-06-02 09:59:16", "headline": "Magnificent Seven Closed A Blockbuster May, Added Nearly $2 Trillion In Market Value", "summary": "Nvidia, Tesla and Meta drove the Magnificent Seven to a $1.75 trillion market cap surge in May 2025, led by booming AI demand and strong earnings.", "symbols": ["AAPL", "AMZN", "GOOGL", "MAGS", "META", "MSFT", "NVDA", "TSLA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/etfs/new-etfs/25/06/45722678/magnificent-seven-closed-a-blockbuster-may-added-nearly-2-trillion-in-market-value", "tags": ["earnings"]}
{"id": 45722725, "time": "2025-06-02 10:00:08", "headline": "USA ISM Manufacturing Prices For May 69.4 Vs 70.2 Est.; 69.8 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45722725/usa-ism-manufacturing-prices-for-may-69-4-vs-70-2-est-69-8-prior", "tags": []}
{"id": 45722749, "time": "2025-06-02 10:00:17", "headline": "USA ISM Manufacturing PMI For May 48.5 Vs 49.3 Est.; 48.7 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45722749/usa-ism-manufacturing-pmi-for-may-48-5-vs-49-3-est-48-7-prior", "tags": []}
{"id": 45722750, "time": "2025-06-02 10:00:18", "headline": "$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BSX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45722750/100-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45722762, "time": "2025-06-02 10:00:23", "headline": "Price Over Earnings Overview: Grupo Financiero Galicia", "summary": " ", "symbols": ["GGAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45722762/price-over-earnings-overview-grupo-financiero-galicia", "tags": ["earnings"]}
{"id": 45722764, "time": "2025-06-02 10:00:25", "headline": "Is ON Semiconductor Gaining or Losing Market Support?", "summary": " ", "symbols": ["ON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45722764/is-on-semiconductor-gaining-or-losing-market-support", "tags": []}
{"id": 45722765, "time": "2025-06-02 10:00:25", "headline": "Albany International Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["AIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722765/albany-international-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 45722772, "time": "2025-06-02 10:00:30", "headline": "How Is The Market Feeling About Fox?", "summary": " ", "symbols": ["FOXA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45722772/how-is-the-market-feeling-about-fox", "tags": []}
{"id": 45722775, "time": "2025-06-02 10:00:33", "headline": "USA Construction Spending (MoM) For April -0.4% Vs 0.4% Est.; -0.8% Prior (Revised From -0.5%)", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45722775/usa-construction-spending-mom-for-april-0-4-vs-0-4-est-0-8-prior-revised-from-0-5", "tags": []}
{"id": 45722778, "time": "2025-06-02 10:00:35", "headline": "How Do Investors Really Feel About Danaher?", "summary": " ", "symbols": ["DHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45722778/how-do-investors-really-feel-about-danaher", "tags": []}
{"id": 45722779, "time": "2025-06-02 10:00:36", "headline": "Forecasting The Future: 7 Analyst Projections For United Therapeutics", "summary": " ", "symbols": ["UTHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722779/forecasting-the-future-7-analyst-projections-for-united-therapeutics", "tags": []}
{"id": 45722786, "time": "2025-06-02 10:00:41", "headline": "A Preview Of Ferguson's Earnings", "summary": " ", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722786/a-preview-of-fergusons-earnings", "tags": ["earnings"]}
{"id": 45722795, "time": "2025-06-02 10:00:47", "headline": "Forecasting The Future: 23 Analyst Projections For Enphase Energy", "summary": " ", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722795/forecasting-the-future-23-analyst-projections-for-enphase-energy", "tags": []}
{"id": 45722802, "time": "2025-06-02 10:00:56", "headline": "Analyst Expectations For Shoals Technologies Gr's Future", "summary": " ", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722802/analyst-expectations-for-shoals-technologies-grs-future", "tags": []}
{"id": 45722810, "time": "2025-06-02 10:01:03", "headline": "Asana's Earnings: A Preview", "summary": " ", "symbols": ["ASAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722810/asanas-earnings-a-preview", "tags": ["earnings"]}
{"id": 45722816, "time": "2025-06-02 10:01:08", "headline": "A Glimpse Into The Expert Outlook On Fluence Energy Through 14 Analysts", "summary": " ", "symbols": ["FLNC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722816/a-glimpse-into-the-expert-outlook-on-fluence-energy-through-14-analysts", "tags": ["guidance"]}
{"id": 45722823, "time": "2025-06-02 10:01:16", "headline": "Donaldson Earnings Preview", "summary": " ", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722823/donaldson-earnings-preview", "tags": ["earnings"]}
{"id": 45722826, "time": "2025-06-02 10:01:18", "headline": "NorthWestern Energy Group Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["NWE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45722826/northwestern-energy-group-stock-a-deep-dive-into-analyst-perspectives-5-ratings", "tags": []}
{"id": 45722828, "time": "2025-06-02 10:01:27", "headline": "What's Next: HealthEquity's Earnings Preview", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722828/whats-next-healthequitys-earnings-preview", "tags": ["earnings"]}
{"id": 45722846, "time": "2025-06-02 10:01:41", "headline": "What to Expect from CrowdStrike Holdings's Earnings", "summary": " ", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722846/what-to-expect-from-crowdstrike-holdingss-earnings", "tags": ["earnings"]}
{"id": 45722848, "time": "2025-06-02 10:01:43", "headline": "Decoding Boeing's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45722848/decoding-boeings-options-activity-whats-the-big-picture", "tags": []}
{"id": 45722852, "time": "2025-06-02 10:01:45", "headline": "UroGen Pharma Announces Results From ENVISION And ATLAS Clinical Studies Exploring Investigational Therapy UGN-102 For Intravesical Solution For Treatment For Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer", "summary": "", "symbols": ["URGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722852/urogen-pharma-announces-results-from-envision-and-atlas-clinical-studies-exploring-investigational-t", "tags": ["fda"]}
{"id": 45722859, "time": "2025-06-02 10:01:53", "headline": "Looking At Netflix's Recent Unusual Options Activity", "summary": " ", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45722859/looking-at-netflixs-recent-unusual-options-activity", "tags": []}
{"id": 45722860, "time": "2025-06-02 10:01:55", "headline": "Examining the Future: Ollie's Bargain Outlet's Earnings Outlook", "summary": " ", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722860/examining-the-future-ollies-bargain-outlets-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45722877, "time": "2025-06-02 10:02:21", "headline": "Insights Ahead: Citi Trends's Quarterly Earnings", "summary": " ", "symbols": ["CTRN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722877/insights-ahead-citi-trendss-quarterly-earnings", "tags": ["earnings"]}
{"id": 45722879, "time": "2025-06-02 10:02:29", "headline": "Guidewire Software's Earnings: A Preview", "summary": " ", "symbols": ["GWRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722879/guidewire-softwares-earnings-a-preview", "tags": ["earnings"]}
{"id": 45722887, "time": "2025-06-02 10:02:39", "headline": "A Look at Yext's Upcoming Earnings Report", "summary": " ", "symbols": ["YEXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722887/a-look-at-yexts-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 45722890, "time": "2025-06-02 10:02:42", "headline": "BTIG Downgrades Shake Shack to Neutral", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722890/btig-downgrades-shake-shack-to-neutral", "tags": ["analyst_down"]}
{"id": 45722894, "time": "2025-06-02 10:02:50", "headline": "Earnings Outlook For Mama's Creations", "summary": " ", "symbols": ["MAMA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722894/earnings-outlook-for-mamas-creations", "tags": ["earnings", "guidance"]}
{"id": 45722904, "time": "2025-06-02 10:03:00", "headline": "Sportsman's Warehouse's Earnings Outlook", "summary": " ", "symbols": ["SPWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45722904/sportsmans-warehouses-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 45722925, "time": "2025-06-02 10:03:38", "headline": "Ming Shing Group Holdings Announces Chi Ming Lam Resigned As Chairman And CEO; Appointed Wenjin Li As Chairman And CEO", "summary": "", "symbols": ["MSW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722925/ming-shing-group-holdings-announces-chi-ming-lam-resigned-as-chairman-and-ceo-appointed-wenjin-li-as", "tags": ["management"]}
{"id": 45722928, "time": "2025-06-02 10:03:45", "headline": "CSP Inc. Added As Member Of Broad-Market Russell 3000 Index, Effective June 30, As Part Of 2025 Russell Indexes Reconstitution", "summary": "", "symbols": ["CSPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722928/csp-inc-added-as-member-of-broad-market-russell-3000-index-effective-june-30-as-part-of-2025-russell", "tags": []}
{"id": 45722937, "time": "2025-06-02 10:04:02", "headline": "JP Morgan Maintains Overweight on TJX Companies, Raises Price Target to $145", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722937/jp-morgan-maintains-overweight-on-tjx-companies-raises-price-target-to-145", "tags": ["analyst_other", "price_target_up"]}
{"id": 45716423, "time": "2025-06-02 05:35:33", "headline": "The Wall Street Journal Reported Meta Aims To Fully Automate Ad Creation Using AI By End 2026, Plans To Let Brands Create And Target Ads With AI Tools", "summary": "", "symbols": ["IPG", "META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45716423/the-wall-street-journal-reported-meta-aims-to-fully-automate-ad-creation-using-ai-by-end-2026-plans", "tags": []}
{"id": 45722997, "time": "2025-06-02 10:05:09", "headline": "Target ALS Partners With PacBio To Launch Largest Global Whole Genome Sequencing Initiative For ALS To Date", "summary": "", "symbols": ["PACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45722997/target-als-partners-with-pacbio-to-launch-largest-global-whole-genome-sequencing-initiative-for-als", "tags": ["contract"]}
{"id": 45723060, "time": "2025-06-02 10:06:58", "headline": "Barclays Maintains Equal-Weight on EOG Resources, Raises Price Target to $140", "summary": "", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723060/barclays-maintains-equal-weight-on-eog-resources-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723108, "time": "2025-06-02 10:07:42", "headline": "Innventure's AeroFlexx Awarded U.S. Patents 11,548,709 And 12,071,292 For Sustainable Packaging Innovation", "summary": "", "symbols": ["INV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723108/innventures-aeroflexx-awarded-u-s-patents-11-548-709-and-12-071-292-for-sustainable-packaging-innova", "tags": ["contract"]}
{"id": 45723113, "time": "2025-06-02 10:07:49", "headline": "Barclays Maintains Equal-Weight on Heico, Raises Price Target to $280", "summary": "", "symbols": ["HEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723113/barclays-maintains-equal-weight-on-heico-raises-price-target-to-280", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723123, "time": "2025-06-02 10:08:06", "headline": "BTIG Upgrades Doximity to Buy, Maintains Price Target to $80", "summary": "", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723123/btig-upgrades-doximity-to-buy-maintains-price-target-to-80", "tags": ["analyst_up", "analyst_other"]}
{"id": 45723208, "time": "2025-06-02 10:09:25", "headline": "Barclays Maintains Equal-Weight on Ulta Beauty, Raises Price Target to $485", "summary": "", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723208/barclays-maintains-equal-weight-on-ulta-beauty-raises-price-target-to-485", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723317, "time": "2025-06-02 10:12:13", "headline": "'Trump Wants to Sell US's 1 Million Barrel Reserve of Diesel Fuel'- Bloomberg", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723317/trump-wants-to-sell-uss-1-million-barrel-reserve-of-diesel-fuel-bloomberg", "tags": []}
{"id": 45723349, "time": "2025-06-02 10:13:20", "headline": "Barclays Maintains Overweight on Cigna Group, Raises Price Target to $385", "summary": "", "symbols": ["CI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723349/barclays-maintains-overweight-on-cigna-group-raises-price-target-to-385", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723369, "time": "2025-06-02 10:13:41", "headline": "U.S. SEC Declares Hotel101's Form F-4 Registration Effective As JVSPAC Sets June 24 Shareholder Meeting To Vote On Proposed Business Combination; Upon Listing, The Combined Co Will Operate As Hotel101 Global Holdings Corp. And Trade Under The Ticker Symbol \"HBNB\"", "summary": "", "symbols": ["JVSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723369/u-s-sec-declares-hotel101s-form-f-4-registration-effective-as-jvspac-sets-june-24-shareholder-meetin", "tags": []}
{"id": 45723371, "time": "2025-06-02 10:13:51", "headline": "5 Stock Picks Last Month From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["CVCO", "NVDA", "OKTA", "SOC", "ZS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/25/06/45723371/5-stock-picks-last-month-from-wall-streets-most-accurate-analysts-2", "tags": []}
{"id": 45723383, "time": "2025-06-02 10:14:16", "headline": "Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug", "summary": "BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones totaling up to $7.6 billion.", "symbols": ["BMY", "BNTX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45723383/bristol-myers-inks-11-billion-licensing-pact-with-biontech-for-bispecific-cancer-drug", "tags": ["contract"]}
{"id": 45723432, "time": "2025-06-02 10:15:16", "headline": "$100 Invested In Travelers Companies 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["TRV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45723432/100-invested-in-travelers-companies-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45723438, "time": "2025-06-02 10:15:24", "headline": "HCLTech and UiPath Announce Strategic Partnership To Drive Large-Scale Transformation For Enterprises Across Industries", "summary": "", "symbols": ["PATH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723438/hcltech-and-uipath-announce-strategic-partnership-to-drive-large-scale-transformation-for-enterprise", "tags": ["contract"]}
{"id": 45723452, "time": "2025-06-02 10:15:44", "headline": "Alliance Global Partners Initiates Coverage On Pluri with Buy Rating, Announces Price Target of $12", "summary": "", "symbols": ["PLUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723452/alliance-global-partners-initiates-coverage-on-pluri-with-buy-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 45723466, "time": "2025-06-02 10:16:13", "headline": "Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings", "summary": " ", "symbols": ["CPB", "INM", "LYRA", "MULN", "OGEN", "SBET", "XLO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/25/06/45723466/dow-dips-over-300-points-campbells-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 45723471, "time": "2025-06-02 10:16:26", "headline": "Barclays Maintains Overweight on CVS Health, Lowers Price Target to $79", "summary": "", "symbols": ["CVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723471/barclays-maintains-overweight-on-cvs-health-lowers-price-target-to-79", "tags": ["analyst_other", "price_target_down"]}
{"id": 45723490, "time": "2025-06-02 10:16:44", "headline": "'Supreme Court Won't Hear Challenge To Maryland Assault Weapons Ban' - NBC News", "summary": "", "symbols": ["RGR", "SPY", "SWBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723490/supreme-court-wont-hear-challenge-to-maryland-assault-weapons-ban-nbc-news", "tags": ["legal"]}
{"id": 45723511, "time": "2025-06-02 10:17:33", "headline": "Piper Sandler Maintains Overweight on Replimune Group, Raises Price Target to $22", "summary": "", "symbols": ["REPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723511/piper-sandler-maintains-overweight-on-replimune-group-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723517, "time": "2025-06-02 10:17:40", "headline": "Watching V.F. Corporation; Hearing Popular Newsletter Picks Stock", "summary": "", "symbols": ["VFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723517/watching-v-f-corporation-hearing-popular-newsletter-picks-stock", "tags": []}
{"id": 45723556, "time": "2025-06-02 10:19:39", "headline": "Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $480", "summary": "", "symbols": ["ELV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723556/barclays-maintains-overweight-on-elevance-health-lowers-price-target-to-480", "tags": ["analyst_other", "price_target_down"]}
{"id": 45723559, "time": "2025-06-02 10:19:53", "headline": "Uranium Energy Q3 EPS $(0.07) Down From $(0.05) YoY", "summary": "", "symbols": ["UEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45723559/uranium-energy-q3-eps-0-07-down-from-0-05-yoy", "tags": ["earnings"]}
{"id": 45723587, "time": "2025-06-02 10:20:38", "headline": "Fed's Logan Says Despite Uncertainty, Financial Market Volatility, Us Economy Is Resilient; Labor Market Is Stable; Inflation Still Somewhat Above Target; Risks Are Balanced On Both Sides Of Mandate; If Tariffs Change Inflation Expectations That Would Be Significant; Market Volatility, Uncertainty Could Cause Households, Businesses To Pull Back; Monetary Policy Well Positioned To Wait, Be Patient; Well-Positioned To Act If Risks Materialize", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45723587/feds-logan-says-despite-uncertainty-financial-market-volatility-us-economy-is-res", "tags": []}
{"id": 45723609, "time": "2025-06-02 10:21:12", "headline": "Barclays Maintains Overweight on HCA Healthcare, Raises Price Target to $416", "summary": "", "symbols": ["HCA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723609/barclays-maintains-overweight-on-hca-healthcare-raises-price-target-to-416", "tags": ["analyst_other", "price_target_up"]}
{"id": 45723688, "time": "2025-06-02 10:22:57", "headline": "VivoPower Forms Strategic Partnership With BitGo To Launch $100M XRP Acquisition And Digital Asset Treasury Strategy Using BitGo's Premier OTC Trading Desk and Custody Platform", "summary": "", "symbols": ["VVPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723688/vivopower-forms-strategic-partnership-with-bitgo-to-launch-100m-xrp-acquisition-and-digital-asset-tr", "tags": ["contract"]}
{"id": 45723698, "time": "2025-06-02 10:23:08", "headline": "Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273", "summary": "", "symbols": ["HUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723698/barclays-maintains-equal-weight-on-humana-lowers-price-target-to-273", "tags": ["analyst_other", "price_target_down"]}
{"id": 45723708, "time": "2025-06-02 10:23:20", "headline": "Rivian Stock Goes Red After Offering $1.25 Billion Green Bond To Refinance 2026 Debt", "summary": "Rivian stock traded lower Monday by about 2.86% after the EV company offered $1.25 billion in senior secured green notes.", "symbols": ["LCID", "RIVN"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/bonds/25/06/45723708/rivian-stock-goes-red-after-offering-1-25-billion-green-bond-to-refinance-2026-debt", "tags": ["offering"]}
{"id": 45723727, "time": "2025-06-02 10:23:41", "headline": "SAIC Stock Falls After Q1 Earnings Miss, Soft Guidance", "summary": "SAIC stock down after reporting Q1 2026 earnings. Sales up 2%, EPS misses estimates. CEO notes progress against growth strategy. Lower revenue and EPS outlook.", "symbols": ["SAIC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/earnings/25/06/45723727/saic-stock-falls-after-q1-earnings-miss-soft-guidance", "tags": ["earnings", "guidance", "management"]}
{"id": 45723879, "time": "2025-06-02 10:24:55", "headline": "Reported June 1, 2025: 'New Taxes On Sports Bets, Nicotine Products As Democrats Pass $55.2B Budget' - Capital News Illinois", "summary": "", "symbols": ["BYD", "CHDN", "CZR", "DKNG", "FLUT", "GAMB", "GAN", "IGT", "MGM", "PENN", "RSI", "WYNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45723879/reported-june-1-2025-new-taxes-on-sports-bets-nicotine-products-as-democrats-pass-55-2b-budget-capit", "tags": []}
{"id": 45718499, "time": "2025-06-02 07:52:28", "headline": "Amphenol Stock: What's Fueling the Rally and What's Next", "summary": "Amphenol Corporation (APH) is gaining strong momentum, and its current position in both the weekly and monthly phases of its Adhishthana Cycle", "symbols": ["APH"], "source": "benzinga", "author": "Shivank Goswami", "url": "https://www.benzinga.com/markets/equities/25/06/45718499/amphenol-stock-whats-fueling-the-rally-and-whats-next", "tags": []}
{"id": 45723960, "time": "2025-06-02 10:27:30", "headline": "Guardian Pharmacy Strengthens US Footprint With New Seattle-Area Acquisition", "summary": "\nGuardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest and meeting growing demand for LTC support.", "symbols": ["GRDN", "IYH", "XLV"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/m-a/25/06/45723960/guardian-pharmacy-strengthens-us-footprint-with-new-seattle-area-acquisition", "tags": ["merger"]}
{"id": 45724022, "time": "2025-06-02 10:29:00", "headline": "Barclays Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $351", "summary": "", "symbols": ["MOH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724022/barclays-maintains-equal-weight-on-molina-healthcare-lowers-price-target-to-351", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724029, "time": "2025-06-02 10:29:14", "headline": "Ryvyl Shares Resume Trade Following Circuit Breaker Halt", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45724029/ryvyl-shares-resume-trade-following-circuit-breaker-halt", "tags": ["halt"]}
{"id": 45724030, "time": "2025-06-02 10:29:24", "headline": "Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron's Blockbuster Dupixent In Early Biomarker Response", "summary": "Kymera&#39;s KT-621 achieved rapid, deep STAT6 degradation and showed a strong safety profile in Phase 1, with the next trials planned through early 2026.", "symbols": ["KYMR", "REGN", "SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45724030/kymera-therapeutics-says-atopic-dermatitis-potential-matches-sanofi-regenerons-blockbuster-dupixent-in-early-biomarker-response", "tags": ["fda"]}
{"id": 45724062, "time": "2025-06-02 10:29:56", "headline": "RBC Capital Maintains Underperform on Easterly Government Props, Lowers Price Target to $22", "summary": "", "symbols": ["DEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724062/rbc-capital-maintains-underperform-on-easterly-government-props-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724075, "time": "2025-06-02 10:30:20", "headline": "Here's How Much You Would Have Made Owning Applied Industrial Techs Stock In The Last 5 Years", "summary": " ", "symbols": ["AIT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724075/heres-how-much-you-would-have-made-owning-applied-industrial-techs-stock-in-the-last-5-years", "tags": []}
{"id": 45724097, "time": "2025-06-02 10:30:38", "headline": "Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $215", "summary": "", "symbols": ["THC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724097/barclays-maintains-overweight-on-tenet-healthcare-raises-price-target-to-215", "tags": ["analyst_other", "price_target_up"]}
{"id": 45724124, "time": "2025-06-02 10:31:56", "headline": "D-Wave Quantum Option Alert: Fri $18 Calls Sweep (43) near the Ask: 1904 @ $0.349 vs 5295 OI; Ref=$16.13", "summary": "", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724124/d-wave-quantum-option-alert-fri-18-calls-sweep-43-near-the-ask-1904-0-349-vs-5295-oi-ref-16-13", "tags": []}
{"id": 45724149, "time": "2025-06-02 10:33:05", "headline": "Fed's Logan Says Key Risk Is If Higher Short-term Inflation Expectations Become Entrenched; Our Job Is To Ensure Inflation Doesn't Become Persistent; Risks From Tariffs Is For Higher Unemployment And Higher Inflation, Putting Two Fed Goals In Conflict", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45724149/feds-logan-says-key-risk-is-if-higher-short-term-inflation-expectations-become-en", "tags": []}
{"id": 45724154, "time": "2025-06-02 10:33:51", "headline": "Truist Securities Maintains Buy on Mercury Sys, Raises Price Target to $60", "summary": "", "symbols": ["MRCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724154/truist-securities-maintains-buy-on-mercury-sys-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 45724181, "time": "2025-06-02 10:34:20", "headline": "Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $350", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724181/barclays-maintains-overweight-on-unitedhealth-group-lowers-price-target-to-350", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724223, "time": "2025-06-02 10:36:25", "headline": "Truist Securities Maintains Hold on Pebblebrook Hotel, Lowers Price Target to $9", "summary": "", "symbols": ["PEB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724223/truist-securities-maintains-hold-on-pebblebrook-hotel-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724287, "time": "2025-06-02 10:39:08", "headline": "Globalstar Announces FCC Space Bureau Acceptance And Public Notice Of C-3 System Petition", "summary": "", "symbols": ["GSAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724287/globalstar-announces-fcc-space-bureau-acceptance-and-public-notice-of-c-3-system-petition", "tags": []}
{"id": 45724296, "time": "2025-06-02 10:39:30", "headline": "Oppenheimer Initiates Coverage On American Integrity with Perform Rating", "summary": "", "symbols": ["AII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724296/oppenheimer-initiates-coverage-on-american-integrity-with-perform-rating", "tags": ["analyst_init"]}
{"id": 45724319, "time": "2025-06-02 10:40:43", "headline": "Needham Reiterates Buy on Applied Digital, Maintains $10 Price Target", "summary": "", "symbols": ["APLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724319/needham-reiterates-buy-on-applied-digital-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 45724414, "time": "2025-06-02 10:44:26", "headline": "Citigroup Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $650", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724414/citigroup-maintains-buy-on-regeneron-pharmaceuticals-lowers-price-target-to-650", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724429, "time": "2025-06-02 10:45:15", "headline": "$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724429/100-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45724441, "time": "2025-06-02 10:45:23", "headline": "HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target", "summary": "", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724441/hc-wainwright-co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target", "tags": ["analyst_other"]}
{"id": 45724489, "time": "2025-06-02 10:46:44", "headline": "Citigroup Maintains Neutral on NetApp, Raises Price Target to $110", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724489/citigroup-maintains-neutral-on-netapp-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 45724493, "time": "2025-06-02 10:46:49", "headline": "Fed's Logan Says With Oil Prices Down, There's A Risk Of Lower Production, Capital Investment By Energy Companies", "summary": "", "symbols": ["SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45724493/feds-logan-says-with-oil-prices-down-theres-a-risk-of-lower-production-capital-in", "tags": []}
{"id": 45724502, "time": "2025-06-02 10:47:31", "headline": "Broadcom Shares Rise On New AI Tools To Help Businesses Cut Cloud Costs", "summary": "Broadcom Inc. (AVGO) shares up 2.20% premarket after launch of new enhancements to VMware Tanzu CloudHealth platform, including AI-driven features.", "symbols": ["AVGO", "AVL", "SHOC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/large-cap/25/06/45724502/broadcom-shares-rise-on-new-ai-tools-to-help-businesses-cut-cloud-costs", "tags": []}
{"id": 45724536, "time": "2025-06-02 10:48:47", "headline": "Ryvyl Shares Halted On Circuit Breaker To The Upside, Stock Now Up 131.6%", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45724536/ryvyl-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-131-6", "tags": ["halt"]}
{"id": 45724588, "time": "2025-06-02 10:50:43", "headline": "Ryvyl Shares Resume Trade", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45724588/ryvyl-shares-resume-trade", "tags": []}
{"id": 45724572, "time": "2025-06-02 10:50:03", "headline": "Fed's Logan Says Repeats That All Banks Should Be Set Up To Use Discount Window; Healthy Banks Should Use The Discount Window", "summary": "", "symbols": ["KBE", "KRE", "SPY", "XLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45724572/feds-logan-says-repeats-that-all-banks-should-be-set-up-to-use-discount-window", "tags": []}
{"id": 45724684, "time": "2025-06-02 10:54:09", "headline": "Cleveland-Cliffs Stock Is Ripping Higher Monday: Here's Why", "summary": "Cleveland-Cliffs Inc (NYSE:CLF) shares are soaring Monday after U.S. President Donald Trump announced plans to double tariffs on steel.", "symbols": ["CLF", "SLX"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/commodities/25/06/45724684/cleveland-cliffs-stock-is-ripping-higher-monday-heres-why", "tags": []}
{"id": 45724783, "time": "2025-06-02 10:57:27", "headline": "'Trump and China's Xi will likely talk this week, White House official says' - CNBC", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45724783/trump-and-chinas-xi-will-likely-talk-this-week-white-house-official-says-cnbc", "tags": []}
{"id": 45724807, "time": "2025-06-02 10:58:44", "headline": "Gap Threads A Comeback: Turnaround Plan In Vogue, Says JPMorgan", "summary": "A JPMorgan analyst says a meeting with Gap management confirmed that a turnaround is on track for the retailer.", "symbols": ["GAP"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45724807/gap-threads-a-comeback-turnaround-plan-in-vogue-says-jpmorgan", "tags": []}
{"id": 45724821, "time": "2025-06-02 10:59:02", "headline": "Trump's Manufacturing Narrative Weakens As May Data Shows Sharper Contraction, Stubborn Inflation", "summary": "Trump&#39;s promised manufacturing renaissance has not materialized, as data shows continued contraction in factory activity. Cost pressures and tariffs are contributing factors.", "symbols": ["TLT", "UUP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/economic-data/25/06/45724821/trumps-manufacturing-narrative-weakens-as-may-data-shows-sharper-contraction-stubborn-inflation", "tags": []}
{"id": 45724879, "time": "2025-06-02 11:00:20", "headline": "Cactus Takes Majority Stake In Baker Hughes' SPC For Global Reach", "summary": "Cactus Inc. will acquire 65% of Baker Hughes&#39; Surface Pressure Control business, valued at $344.5M. The joint venture aims to expand global oilfield equipment footprint.", "symbols": ["BKR", "IEZ", "WHD", "XLE"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/m-a/25/06/45724879/cactus-takes-majority-stake-in-baker-hughes-spc-for-global-reach", "tags": ["merger"]}
{"id": 45724898, "time": "2025-06-02 11:00:56", "headline": "Exploring The Competitive Space: NVIDIA Versus Industry Peers In Semiconductors &amp; Semiconductor Equipment", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724898/exploring-the-competitive-space-nvidia-versus-industry-peers-in-semiconductors-amp-semiconductor-eq", "tags": []}
{"id": 45724900, "time": "2025-06-02 11:01:00", "headline": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724900/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45724902, "time": "2025-06-02 11:01:04", "headline": "Assessing Microsoft's Performance Against Competitors In Software Industry", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724902/assessing-microsofts-performance-against-competitors-in-software-industry", "tags": []}
{"id": 45724903, "time": "2025-06-02 11:01:05", "headline": "What's Driving the Market Sentiment Around Shift4 Payments?", "summary": " ", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45724903/whats-driving-the-market-sentiment-around-shift4-payments", "tags": []}
{"id": 45724904, "time": "2025-06-02 11:01:05", "headline": "A Look Ahead: Dollar Gen's Earnings Forecast", "summary": " ", "symbols": ["DG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45724904/a-look-ahead-dollar-gens-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 45724905, "time": "2025-06-02 11:01:06", "headline": "Price Over Earnings Overview: Energy Transfer", "summary": " ", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724905/price-over-earnings-overview-energy-transfer", "tags": ["earnings"]}
{"id": 45724909, "time": "2025-06-02 11:01:10", "headline": "What Does the Market Think About Hanesbrands?", "summary": " ", "symbols": ["HBI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45724909/what-does-the-market-think-about-hanesbrands", "tags": []}
{"id": 45724911, "time": "2025-06-02 11:01:14", "headline": "Comparing Meta Platforms With Industry Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724911/comparing-meta-platforms-with-industry-competitors-in-interactive-media-amp-services-industry", "tags": []}
{"id": 45724912, "time": "2025-06-02 11:01:15", "headline": "Is Wells Fargo Gaining or Losing Market Support?", "summary": " ", "symbols": ["WFC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45724912/is-wells-fargo-gaining-or-losing-market-support", "tags": []}
{"id": 45724913, "time": "2025-06-02 11:01:15", "headline": "A Look Ahead: Hewlett Packard's Earnings Forecast", "summary": " ", "symbols": ["HPE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45724913/a-look-ahead-hewlett-packards-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 45724915, "time": "2025-06-02 11:01:22", "headline": "Evaluating Apple Against Peers In Technology Hardware, Storage &amp; Peripherals Industry", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45724915/evaluating-apple-against-peers-in-technology-hardware-storage-amp-peripherals-industry", "tags": []}
{"id": 45724917, "time": "2025-06-02 11:01:31", "headline": "Earnings Outlook For Signet Jewelers", "summary": " ", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/06/45724917/earnings-outlook-for-signet-jewelers", "tags": ["earnings", "guidance"]}
{"id": 45724938, "time": "2025-06-02 11:01:51", "headline": "Space Stocks Weekly Countdown: RocketLab Gets Analyst Love While Virgin Galactic Slides Into June", "summary": "Here&#39;s a look at recent news, price action, IPOs and upcoming launches in the space sector:\u00a0", "symbols": ["BKSY", "PLTR", "RKLB", "SPCE"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/space/25/06/45724938/space-stocks-weekly-countdown-rocketlab-gets-analyst-love-while-virgin-galactic-slides-into-june", "tags": []}
{"id": 45724940, "time": "2025-06-02 11:01:52", "headline": "UroGen Pharma Highlights Presentation Of uTRACT Registry Study Design At 2025 ASCO Annual Meeting", "summary": "", "symbols": ["URGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724940/urogen-pharma-highlights-presentation-of-utract-registry-study-design-at-2025-asco-annual-meeting", "tags": []}
{"id": 45724950, "time": "2025-06-02 11:02:07", "headline": "Decoding Marvell Tech's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["MRVL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45724950/decoding-marvell-techs-options-activity-whats-the-big-picture", "tags": []}
{"id": 45724951, "time": "2025-06-02 11:02:07", "headline": "Harte Hanks Announces That It Has Obtained Exclusive Rights To License ADS Data Direct's Medical Ailment Database, With Limited Client Exceptions; No Financial Terms Disclosed", "summary": "", "symbols": ["HHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45724951/harte-hanks-announces-that-it-has-obtained-exclusive-rights-to-license-ads-data-directs-medical-ailm", "tags": []}
{"id": 45724954, "time": "2025-06-02 11:02:12", "headline": "Smart Money Is Betting Big In JPM Options", "summary": " ", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45724954/smart-money-is-betting-big-in-jpm-options", "tags": []}
{"id": 45724956, "time": "2025-06-02 11:02:17", "headline": "NVIDIA Unusual Options Activity", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45724956/nvidia-unusual-options-activity", "tags": []}
{"id": 45724974, "time": "2025-06-02 11:02:36", "headline": "UBS Maintains Neutral on Idacorp, Lowers Price Target to $120", "summary": "", "symbols": ["IDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45724974/ubs-maintains-neutral-on-idacorp-lowers-price-target-to-120", "tags": ["analyst_other", "price_target_down"]}
{"id": 45724982, "time": "2025-06-02 11:02:59", "headline": "Basel Medical Group Shares Halted On Circuit Breaker To The Downside, Stock Now Up 8.55%", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45724982/basel-medical-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-8-55", "tags": ["halt"]}
{"id": 45725021, "time": "2025-06-02 11:03:52", "headline": "UBS Maintains Neutral on Exelon, Raises Price Target to $48", "summary": "", "symbols": ["EXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725021/ubs-maintains-neutral-on-exelon-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725058, "time": "2025-06-02 11:04:42", "headline": "Loeb Rides Nvidia's AI Wave, Bets Big On AT&T's Telecom Comeback", "summary": "Dan Loeb diversified portfolio in Q1 2025, cutting Microsoft and Amazon stakes and acquiring AT&amp;T and Nvidia. Both had positive events recently.", "symbols": ["AMZN", "IYZ", "LUMN", "MSFT", "NVD", "NVDA", "T"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/markets/hedge-funds/25/06/45725058/loeb-rides-nvidias-ai-wave-bets-big-on-atts-telecom-comeback", "tags": ["merger"]}
{"id": 45725081, "time": "2025-06-02 11:05:16", "headline": "Star Bulk Carriers CEO: Strategic Discipline In Uncertain Markets", "summary": " ", "symbols": ["SBLK"], "source": "benzinga", "author": "Capital Link", "url": "https://www.benzinga.com/general/travel/25/06/45725081/star-bulk-carriers-ceo-strategic-discipline-in-uncertain-markets", "tags": ["management"]}
{"id": 45725085, "time": "2025-06-02 11:05:25", "headline": "Mullen Automotive Boosts Shareholder Equity By $3.5M Through Strategic Deal To Acquire 95% Of Bollinger Motors; Extinguishes Significant Debt, Gains Additional 21% Ownership And Regains Full Control Of Bollinger Motors; Financial Terms Of Transaction Not Disclosed", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45725085/mullen-automotive-boosts-shareholder-equity-by-3-5m-through-strategic-deal-to-acquire-95-of-bollinge", "tags": ["merger", "contract"]}
{"id": 45725091, "time": "2025-06-02 11:05:34", "headline": "UBS Maintains Neutral on Duke Energy, Raises Price Target to $127", "summary": "", "symbols": ["DUK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725091/ubs-maintains-neutral-on-duke-energy-raises-price-target-to-127", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725122, "time": "2025-06-02 11:06:32", "headline": "CrowdStrike Analyst Raises Price Target Ahead Of Q1 Results: Benefits From Stable Cybersecurity Budgets, Despite Macro Uncertainty", "summary": "CrowdStrike Holdings (CRWD) to report Q2 results on June 3, expected to show in-line growth. Analysts confident in company&#39;s strong execution and platform.", "symbols": ["CRWD"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45725122/crowdstrike-analyst-raises-price-target-ahead-of-q1-results-benefits-from-stable-cybersecurity-budgets-despite-macro-uncertainty", "tags": ["price_target_up", "earnings"]}
{"id": 45725169, "time": "2025-06-02 11:07:44", "headline": "Basel Medical Group Shares Resume Trade", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45725169/basel-medical-group-shares-resume-trade", "tags": []}
{"id": 45725180, "time": "2025-06-02 11:08:05", "headline": "Mullen Automotive Shares Halted On Circuit Breaker To The Downside, Stock Now Down -35.4%", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45725180/mullen-automotive-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-35-4", "tags": ["halt"]}
{"id": 45725210, "time": "2025-06-02 11:08:53", "headline": "UBS Maintains Neutral on Grupo Cibest, Raises Price Target to $38", "summary": "", "symbols": ["CIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725210/ubs-maintains-neutral-on-grupo-cibest-raises-price-target-to-38", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725215, "time": "2025-06-02 11:09:01", "headline": "Basel Medical Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -4.77%", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45725215/basel-medical-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-4-77", "tags": ["halt"]}
{"id": 45725253, "time": "2025-06-02 11:09:25", "headline": "Mullen Automotive Shares Resume Trade", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45725253/mullen-automotive-shares-resume-trade", "tags": []}
{"id": 45725426, "time": "2025-06-02 11:12:15", "headline": "UBS Maintains Neutral on Banco Santander Chile, Raises Price Target to $24", "summary": "", "symbols": ["BSAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725426/ubs-maintains-neutral-on-banco-santander-chile-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725454, "time": "2025-06-02 11:13:48", "headline": "UBS Maintains Buy on Credicorp, Raises Price Target to $257", "summary": "", "symbols": ["BAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725454/ubs-maintains-buy-on-credicorp-raises-price-target-to-257", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725464, "time": "2025-06-02 11:14:27", "headline": "Reported Earlier: BioAtla Reports 45% ORR And 100% DCR In Heavily Pretreated HPV+ OPSCC Patients In Phase 2 Trial Of Ozuriftamab Vedotin", "summary": "", "symbols": ["BCAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45725464/reported-earlier-bioatla-reports-45-orr-and-100-dcr-in-heavily-pretreated-hpv-opscc-patients-in-p", "tags": ["fda"]}
{"id": 45725480, "time": "2025-06-02 11:15:11", "headline": "UBS Maintains Buy on Ameren, Raises Price Target to $114", "summary": "", "symbols": ["AEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725480/ubs-maintains-buy-on-ameren-raises-price-target-to-114", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725483, "time": "2025-06-02 11:15:14", "headline": "$1000 Invested In Brown & Brown 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45725483/1000-invested-in-brown-brown-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45725499, "time": "2025-06-02 11:15:34", "headline": "Reported June 1, 2025: Seer And Korea University Launch Large-Scale Study Using Proteograph ONE Assay And Mass Spectrometry To Identify Early-Onset Cancer Biomarkers In Young Adults", "summary": "", "symbols": ["SEER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45725499/reported-june-1-2025-seer-and-korea-university-launch-large-scale-study-using-proteograph-one-ass", "tags": []}
{"id": 45725509, "time": "2025-06-02 11:16:18", "headline": "'Byron Allen Hires Moelis To Shop $1 Billion In Local TV Stations' - Bloomberg News", "summary": "", "symbols": ["MC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725509/byron-allen-hires-moelis-to-shop-1-billion-in-local-tv-stations-bloomberg-news", "tags": []}
{"id": 45725551, "time": "2025-06-02 11:16:59", "headline": "These Former Senior Tesla Employees Share What It Was Like Working With Elon Musk: \"It's Not A 9-To-5 Experience\u2026\"", "summary": "Former Tesla employees praise the company for fostering self-reliance and minimizing bureaucracy but acknowledge its challenges and pressures.", "symbols": ["TSLA"], "source": "benzinga", "author": "Badar Shaikh", "url": "https://www.benzinga.com/news/topics/25/06/45725551/these-former-senior-tesla-employees-share-what-it-was-like-working-with-elon-musk-its-not-a-9-to-5-experience", "tags": []}
{"id": 45725567, "time": "2025-06-02 11:17:46", "headline": "Reported Earlier: Sonim Technologies Signs LOI For Potential $20M Asset Sale To Social Mobile, Including $5M Earn-Out", "summary": "", "symbols": ["SONM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725567/reported-earlier-sonim-technologies-signs-loi-for-potential-20m-asset-sale-to-social-mobile-includin", "tags": []}
{"id": 45725576, "time": "2025-06-02 11:18:23", "headline": "Wells Fargo Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $550", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725576/wells-fargo-maintains-overweight-on-crowdstrike-holdings-raises-price-target-to-550", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725610, "time": "2025-06-02 11:19:34", "headline": "Wells Fargo Maintains Equal-Weight on Conagra Brands, Lowers Price Target to $23", "summary": "", "symbols": ["CAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725610/wells-fargo-maintains-equal-weight-on-conagra-brands-lowers-price-target-to-23", "tags": ["analyst_other", "price_target_down"]}
{"id": 45725615, "time": "2025-06-02 11:19:43", "headline": "Corcept Therapeutics Reports Phase 3 ROSELLA Trial Results As Relacorilant Plus Nab-Paclitaxel Improves Survival In Platinum-Resistant Ovarian Cancer Without Added Side Effects, Showing 30% Reduced Progression Risk And 31% Lower Death Risk In ASCO 2025 Late-Breaker And Simultaneous Lancet Publication", "summary": "", "symbols": ["CORT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45725615/corcept-therapeutics-reports-phase-3-rosella-trial-results-as-relacorilant-plus-nab-paclitaxel-im", "tags": ["fda"]}
{"id": 45725664, "time": "2025-06-02 11:21:48", "headline": "JMP Securities Reiterates Market Outperform on Broadstone Net Lease, Maintains $21 Price Target", "summary": "", "symbols": ["BNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725664/jmp-securities-reiterates-market-outperform-on-broadstone-net-lease-maintains-21-price-target", "tags": ["analyst_other"]}
{"id": 45725667, "time": "2025-06-02 11:22:06", "headline": "Wells Fargo Maintains Overweight on Dollar Tree, Raises Price Target to $105", "summary": "", "symbols": ["DLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725667/wells-fargo-maintains-overweight-on-dollar-tree-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725734, "time": "2025-06-02 11:24:02", "headline": "Wells Fargo Maintains Equal-Weight on Apellis Pharmaceuticals, Raises Price Target to $29", "summary": "", "symbols": ["APLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725734/wells-fargo-maintains-equal-weight-on-apellis-pharmaceuticals-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 45725823, "time": "2025-06-02 11:25:07", "headline": "JMP Securities Reiterates Market Outperform on Cidara Therapeutics, Maintains $47 Price Target", "summary": "", "symbols": ["CDTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725823/jmp-securities-reiterates-market-outperform-on-cidara-therapeutics-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 45725824, "time": "2025-06-02 11:25:07", "headline": "JMP Securities Reiterates Market Outperform on Cidara Therapeutics, Maintains $47 Price Target", "summary": "", "symbols": ["CDTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725824/jmp-securities-reiterates-market-outperform-on-cidara-therapeutics-maintains-47-price-target", "tags": ["analyst_other"]}
{"id": 45725896, "time": "2025-06-02 11:28:18", "headline": "JMP Securities Reiterates Market Outperform on Nuvation Bio, Maintains $6 Price Target", "summary": "", "symbols": ["NUVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725896/jmp-securities-reiterates-market-outperform-on-nuvation-bio-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 45725920, "time": "2025-06-02 11:28:47", "headline": "Ryvyl Shares Halted On Circuit Breaker To The Upside, Stock Now Up 164.5%", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45725920/ryvyl-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-164-5", "tags": ["halt"]}
{"id": 45725950, "time": "2025-06-02 11:29:45", "headline": "Equinor Re-Elects Erik Reinhardsen As Chair And Anne Drinkwater As Deputy Chair Of The Board", "summary": "", "symbols": ["EQNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45725950/equinor-re-elects-erik-reinhardsen-as-chair-and-anne-drinkwater-as-deputy-chair-of-the-board", "tags": []}
{"id": 45725990, "time": "2025-06-02 11:30:16", "headline": "Here's How Much $1000 Invested In Netflix 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45725990/heres-how-much-1000-invested-in-netflix-20-years-ago-would-be-worth-today", "tags": []}
{"id": 45726006, "time": "2025-06-02 11:30:36", "headline": "Webus International Shares Halted On Circuit Breaker To The Downside, Stock Now Down -21%", "summary": "", "symbols": ["WETO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45726006/webus-international-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-21", "tags": ["halt"]}
{"id": 45726138, "time": "2025-06-02 11:31:12", "headline": "Dell Stock Falls As Trump Administration Expands Spending Review To Tech Contracts", "summary": "Dell Technologies (NYSE: DELL) stock down as Trump administration expands spending review to include tech companies. Job cuts and savings expected.", "symbols": ["BAH", "CDW", "DELL"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/large-cap/25/06/45726138/dell-stock-falls-as-trump-administration-expands-spending-review-to-tech-contracts", "tags": []}
{"id": 45726204, "time": "2025-06-02 11:32:29", "headline": "Dollar General Q1 Earnings Preview: Could Tariffs Hit Discount Retail Hardest?", "summary": "Analysts expect Dollar General to report Q1 revenue of $10.31 billion, up from last year&#39;s $9.91 billion, according to data from Benzinga Pro.", "symbols": ["DG", "DLTR"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/previews/25/06/45726204/dollar-general-q1-earnings-preview-could-tariffs-hit-discount-retail-hardest", "tags": ["earnings"]}
{"id": 45726210, "time": "2025-06-02 11:32:35", "headline": "JMP Securities Reiterates Market Outperform on Summit Therapeutics, Maintains $40 Price Target", "summary": "", "symbols": ["SMMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726210/jmp-securities-reiterates-market-outperform-on-summit-therapeutics-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 45726297, "time": "2025-06-02 11:35:15", "headline": "Webus International Shares Resume Trade", "summary": "", "symbols": ["WETO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45726297/webus-international-shares-resume-trade", "tags": []}
{"id": 45726301, "time": "2025-06-02 11:35:22", "headline": "JMP Securities Reiterates Market Perform on Instil Bioto Market Perform", "summary": "", "symbols": ["TIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726301/jmp-securities-reiterates-market-perform-on-instil-bioto-market-perform", "tags": ["analyst_other"]}
{"id": 45726305, "time": "2025-06-02 11:35:42", "headline": "Ryvyl Shares Halted On Circuit Breaker To The Upside, Stock Now Up 212.9%", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45726305/ryvyl-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-212-9", "tags": ["halt"]}
{"id": 45726316, "time": "2025-06-02 11:36:32", "headline": "Basel Medical Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -44.7%", "summary": "", "symbols": ["BMGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/06/45726316/basel-medical-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-44-7", "tags": ["halt"]}
{"id": 45726349, "time": "2025-06-02 11:39:04", "headline": "Wells Fargo Maintains Overweight on CareTrust REIT, Raises Price Target to $32", "summary": "", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726349/wells-fargo-maintains-overweight-on-caretrust-reit-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 45726401, "time": "2025-06-02 11:40:43", "headline": "Wells Fargo Maintains Underweight on Healthcare Realty Trust, Lowers Price Target to $15", "summary": "", "symbols": ["HR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726401/wells-fargo-maintains-underweight-on-healthcare-realty-trust-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726405, "time": "2025-06-02 11:40:48", "headline": "RBC Capital Reiterates Outperform on Neurocrine Biosciences, Maintains $145 Price Target", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726405/rbc-capital-reiterates-outperform-on-neurocrine-biosciences-maintains-145-price-target", "tags": ["analyst_other"]}
{"id": 45726435, "time": "2025-06-02 11:42:50", "headline": "Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $20", "summary": "", "symbols": ["DOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726435/wells-fargo-maintains-equal-weight-on-healthpeak-properties-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726447, "time": "2025-06-02 11:43:33", "headline": "Wells Fargo Maintains Equal-Weight on Omega Healthcare Invts, Lowers Price Target to $38", "summary": "", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726447/wells-fargo-maintains-equal-weight-on-omega-healthcare-invts-lowers-price-target-to-38", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726456, "time": "2025-06-02 11:43:56", "headline": "Tempus AI Stock Is Surging Today: What Investors Are Watching", "summary": "Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer.", "symbols": ["TEM"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/movers-shakers/25/06/45726456/tempus-ai-stock-is-surging-today-what-investors-are-watching", "tags": []}
{"id": 45726471, "time": "2025-06-02 11:44:31", "headline": "Wells Fargo Maintains Overweight on Welltower, Raises Price Target to $175", "summary": "", "symbols": ["WELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726471/wells-fargo-maintains-overweight-on-welltower-raises-price-target-to-175", "tags": ["analyst_other", "price_target_up"]}
{"id": 45726483, "time": "2025-06-02 11:45:16", "headline": "If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["UHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45726483/if-you-invested-100-in-this-stock-20-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45726484, "time": "2025-06-02 11:45:21", "headline": "RBC Capital Reiterates Sector Perform on Upwork, Maintains $18 Price Target", "summary": "", "symbols": ["UPWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726484/rbc-capital-reiterates-sector-perform-on-upwork-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 45726495, "time": "2025-06-02 11:45:30", "headline": "Wells Fargo Maintains Underweight on EPR Props, Raises Price Target to $53", "summary": "", "symbols": ["EPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726495/wells-fargo-maintains-underweight-on-epr-props-raises-price-target-to-53", "tags": ["analyst_other", "price_target_up"]}
{"id": 45726507, "time": "2025-06-02 11:45:59", "headline": "Alphabet Set To Gain From Google AI Innovation, 'Underappreciated' YouTube: Goldman Sachs", "summary": "Goldman Sachs analyst believes Alphabet Inc is well-positioned for AI era, with potential growth in Search &amp; Other segment and YouTube revenues.", "symbols": ["GOOGL"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45726507/alphabet-set-to-gain-from-google-ai-innovation-underappreciated-youtube-goldman-sachs", "tags": []}
{"id": 45726524, "time": "2025-06-02 11:46:28", "headline": "Wells Fargo Maintains Overweight on Four Corners Property Tr, Lowers Price Target to $30", "summary": "", "symbols": ["FCPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726524/wells-fargo-maintains-overweight-on-four-corners-property-tr-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726539, "time": "2025-06-02 11:47:03", "headline": "Wathing UnitedHealth Group; During Shareholder Meeting, CEO Reportedly Says Co Has Incorporated Elevated Care Activity Experience Into The Medicare Advantage Bids Submitted To CMS This Week; Will Continue To Incorporated Elevated Care Activity Experience Into Pricing For Commercial Plans", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726539/wathing-unitedhealth-group-during-shareholder-meeting-ceo-reportedly-says-co-has-incorporated-elevat", "tags": ["management"]}
{"id": 45726572, "time": "2025-06-02 11:47:38", "headline": "Wells Fargo Maintains Equal-Weight on Gaming and Leisure Props, Lowers Price Target to $49", "summary": "", "symbols": ["GLPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726572/wells-fargo-maintains-equal-weight-on-gaming-and-leisure-props-lowers-price-target-to-49", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726576, "time": "2025-06-02 11:47:47", "headline": "RBC Capital Maintains Outperform on i-80 Gold, Lowers Price Target to $1.5", "summary": "", "symbols": ["IAUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726576/rbc-capital-maintains-outperform-on-i-80-gold-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726585, "time": "2025-06-02 11:48:26", "headline": "'Trump Wants To Delete State Medical Marijuana Protections From Budget While Continuing To Block Cannabis Sales Legalization In D.C.' - Marijuana Moment", "summary": "", "symbols": ["ACB", "AKAN", "CGC", "CRON", "GRWG", "IGC", "IMCC", "MAPS", "MJ", "MSOS", "SNDL", "SPY", "TLRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45726585/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-c", "tags": []}
{"id": 45726655, "time": "2025-06-02 11:51:42", "headline": "RBC Capital Maintains Outperform on i-80 Gold, Lowers Price Target to C$1.5", "summary": "", "symbols": ["TSX:IAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726655/rbc-capital-maintains-outperform-on-i-80-gold-lowers-price-target-to-c-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726656, "time": "2025-06-02 11:51:42", "headline": "RBC Capital Maintains Outperform on i-80 Gold, Lowers Price Target to C$1.5", "summary": "", "symbols": ["TSX:IAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726656/rbc-capital-maintains-outperform-on-i-80-gold-lowers-price-target-to-c-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45726838, "time": "2025-06-02 11:57:28", "headline": "SharpLink Gaming Stock Is Tumbling Monday: What's Going On?", "summary": "SharpLink Gaming Inc (NASDAQ:SBET) shares are trading lower, pulling back from a strong surge last week.", "symbols": ["ETHUSD", "SBET"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/penny-stocks/25/06/45726838/sharplink-gaming-stock-is-tumbling-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 45726871, "time": "2025-06-02 11:59:13", "headline": "RBC Capital Assumes Artemis Gold at Outperform, Announces Price Target of C$32", "summary": "", "symbols": [], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726871/rbc-capital-assumes-artemis-gold-at-outperform-announces-price-target-of-c-32", "tags": []}
{"id": 45726872, "time": "2025-06-02 11:59:16", "headline": "Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target", "summary": "Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies aim to reduce.", "symbols": ["NVO", "REGN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45726872/regeneron-experimental-weight-loss-drug-with-novo-nordisks-wegovy-helps-preserve-lean-mass-in-mid-stage-study", "tags": ["fda"]}
{"id": 45726928, "time": "2025-06-02 12:00:18", "headline": "Here's How Much You Would Have Made Owning Crocs Stock In The Last 15 Years", "summary": " ", "symbols": ["CROX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45726928/heres-how-much-you-would-have-made-owning-crocs-stock-in-the-last-15-years", "tags": []}
{"id": 45726931, "time": "2025-06-02 12:00:23", "headline": "Looking Into Adobe's Recent Short Interest", "summary": " ", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45726931/looking-into-adobes-recent-short-interest", "tags": []}
{"id": 45726932, "time": "2025-06-02 12:00:23", "headline": "Price Over Earnings Overview: CRH", "summary": " ", "symbols": ["CRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45726932/price-over-earnings-overview-crh", "tags": ["earnings"]}
{"id": 45726938, "time": "2025-06-02 12:00:28", "headline": "How Is The Market Feeling About TJX Companies?", "summary": " ", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45726938/how-is-the-market-feeling-about-tjx-companies", "tags": []}
{"id": 45726948, "time": "2025-06-02 12:00:34", "headline": "What's Driving the Market Sentiment Around Roper Technologies?", "summary": " ", "symbols": ["ROP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45726948/whats-driving-the-market-sentiment-around-roper-technologies", "tags": []}
{"id": 45726976, "time": "2025-06-02 12:01:18", "headline": "RBC Capital Assumes K92 Mining at Outperform, Announces Price Target of C$18", "summary": "", "symbols": ["TSX:KNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45726976/rbc-capital-assumes-k92-mining-at-outperform-announces-price-target-of-c-18", "tags": []}
{"id": 45727009, "time": "2025-06-02 12:01:45", "headline": "CrowdStrike And Microsoft Collaborate To Standardize Adversary Attribution Across Platforms", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727009/crowdstrike-and-microsoft-collaborate-to-standardize-adversary-attribution-across-platforms", "tags": []}
{"id": 45727051, "time": "2025-06-02 12:03:52", "headline": "RBC Capital Assumes OceanaGold at Outperform, Announces Price Target of C$8", "summary": "", "symbols": ["TSX:OGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727051/rbc-capital-assumes-oceanagold-at-outperform-announces-price-target-of-c-8", "tags": []}
{"id": 45727076, "time": "2025-06-02 12:05:01", "headline": "UPDATE: Radiopharm Theranostics Advances Toward IND Filing And 4Q25 Phase 1 Launch For RV01 Radiopharmaceutical Therapy After Preclinical Data Confirms RV01 Maintained High Tumour Uptake", "summary": "", "symbols": ["RADX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45727076/update-radiopharm-theranostics-advances-toward-ind-filing-and-4q25-phase-1-launch-for-rv01-radiop", "tags": ["fda"]}
{"id": 45727117, "time": "2025-06-02 12:07:34", "headline": "HC Wainwright & Co. Downgrades Adlai Nortye to Neutral", "summary": "", "symbols": ["ANL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727117/hc-wainwright-co-downgrades-adlai-nortye-to-neutral", "tags": ["analyst_down"]}
{"id": 45727167, "time": "2025-06-02 12:10:21", "headline": "IBM Launches watsonx AI Labs In New York City To Accelerate Enterprise AI Adoption", "summary": "", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727167/ibm-launches-watsonx-ai-labs-in-new-york-city-to-accelerate-enterprise-ai-adoption", "tags": []}
{"id": 45727221, "time": "2025-06-02 12:14:16", "headline": "Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday", "summary": " ", "symbols": ["AG", "APLD", "BPMC", "CENX", "CLF", "EGO", "HL", "IBRX", "KYMR", "LQDA", "NUE", "RGNX", "STLD", "TEM", "VERA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/25/06/45727221/vera-therapeutics-applied-digital-kymera-therapeutics-and-other-big-stocks-moving-higher-on-monday", "tags": ["why_moving"]}
{"id": 45727224, "time": "2025-06-02 12:14:31", "headline": "Triller Group Completes Strategic Review, Reorganizes InTo Three Core Business Units- Triller App, AGBA Group And BKFC", "summary": "", "symbols": ["ILLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727224/triller-group-completes-strategic-review-reorganizes-into-three-core-business-units-triller-app-agba", "tags": []}
{"id": 45727254, "time": "2025-06-02 12:15:16", "headline": "$100 Invested In Baker Hughes 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45727254/100-invested-in-baker-hughes-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45727360, "time": "2025-06-02 12:19:59", "headline": "Amazon Analyst Sees Robotics Unlocking Billions In Savings", "summary": "BofA Securities sees advanced robotics driving up to $16 billion in annual savings by 2032 and raised its price target on Amazon stock.\u00a0", "symbols": ["AMZN"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45727360/amazon-analyst-sees-robotics-unlocking-billions-in-savings", "tags": []}
{"id": 45727371, "time": "2025-06-02 12:20:26", "headline": "'Elon Musk's xAI Seeks $113B Valuation In $300M Share Sale' - Financial Times", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL", "MSFT", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727371/elon-musks-xai-seeks-113b-valuation-in-300m-share-sale-financial-times", "tags": []}
{"id": 45727379, "time": "2025-06-02 12:20:53", "headline": "BIG3 And iHeartMedia Join Forces To Bring 3-On-3 Basketball To New Audiences", "summary": "", "symbols": ["IHRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727379/big3-and-iheartmedia-join-forces-to-bring-3-on-3-basketball-to-new-audiences", "tags": []}
{"id": 45727395, "time": "2025-06-02 12:21:22", "headline": "Tom Lee Predicts Bitcoin To Hit $250,000 By End Of 2025, $3M Long Term", "summary": "Tom Lee, Managing Partner and Head of Research at Fundstrat Global Advisors, projected an aggressive long-term upside for Bitcoin (CRYPTO: BTC), estimating a terminal valuation of up ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45727395/tom-lee-predicts-bitcoin-to-hit-250000-by-end-of-2025-3m-long-term", "tags": []}
{"id": 45727400, "time": "2025-06-02 12:21:32", "headline": "Reuters Reports Trump Administration Asks U.S. Supreme Court To Intervene After Federal Judge Barred Mass Layoffs At Federal Agencies", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727400/reuters-reports-trump-administration-asks-u-s-supreme-court-to-intervene-after-federal-judge-barred", "tags": ["legal"]}
{"id": 45727606, "time": "2025-06-02 12:25:46", "headline": "Apple Stock Has 'Near Term Headwinds, Significant Long-Term Opportunity': Analyst Lays Out Bull, Bear Cases For Tech Giant", "summary": "Analyst presents a comprehensive summary of the bull/bear cases for Apple stock, highlighting headwinds such as tariffs and AI.", "symbols": ["AAPL", "GOOG", "GOOGL"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45727606/apple-stock-has-near-term-headwinds-significant-long-term-opportunity-analyst-lays-out-bull-bear-cases-for-tech-giant", "tags": []}
{"id": 45727654, "time": "2025-06-02 12:27:26", "headline": "Live On CNBC, Steve Weiss Announces Trimmed Netflix Position", "summary": "", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727654/live-on-cnbc-steve-weiss-announces-trimmed-netflix-position", "tags": []}
{"id": 45727741, "time": "2025-06-02 12:30:22", "headline": "Here's How Much You Would Have Made Owning Popular Stock In The Last 5 Years", "summary": " ", "symbols": ["BPOP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45727741/heres-how-much-you-would-have-made-owning-popular-stock-in-the-last-5-years", "tags": []}
{"id": 45727926, "time": "2025-06-02 12:37:25", "headline": "Jazz Pharmaceuticals Reports Long-Term Phase 2 Data For Ziihera Showing 36.5-Month Median Overall Survival And Durable Responses In HER2-Positive Gastroesophageal Cancer, With Manageable Safety Profile; Results Presented At ASCO 2025 And Published In The Lancet Oncology", "summary": "", "symbols": ["JAZZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45727926/jazz-pharmaceuticals-reports-long-term-phase-2-data-for-ziihera-showing-36-5-month-median-overall", "tags": ["fda"]}
{"id": 45727995, "time": "2025-06-02 12:39:36", "headline": "Reported Earlier: Regencell Bioscience Announces 38-For-1 Forward Stock Split, With Share Distribution On June 13, 2025 And Post-Split Trading Set For June 16, 2025", "summary": "", "symbols": ["RGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45727995/reported-earlier-regencell-bioscience-announces-38-for-1-forward-stock-split-with-share-distribution", "tags": []}
{"id": 45728052, "time": "2025-06-02 12:41:21", "headline": "What's Going On With Verastem Oncology Stock On Monday?", "summary": "Verastem&#39;s GFH375 trial data at ASCO 2025 shows a 52% response rate in pancreatic cancer and no dose-limiting toxicities across tested doses.", "symbols": ["VSTM"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45728052/whats-going-on-with-verastem-oncology-stock-on-monday", "tags": ["why_moving", "fda"]}
{"id": 45728076, "time": "2025-06-02 12:41:53", "headline": "Goldman Turns Bullish On Saia, Sees Room For Shipping Efficiency, Profit Growth", "summary": "Goldman Sachs upgraded Saia, Inc. and raised the price forecast to $410, citing potential growth opportunities and improved margins.", "symbols": ["SAIA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-stock-ratings/upgrades/25/06/45728076/goldman-turns-bullish-on-saia-sees-room-for-shipping-efficiency-profit-growth", "tags": ["analyst_up", "guidance"]}
{"id": 45728103, "time": "2025-06-02 12:43:19", "headline": "Watching Keysight Technologies; Reuters Cites Court Filing Saying U.S. Files Antitrust Lawsuit To Block Keysight Technologies Purchase Of Spirent Communications; Proposes Requiring Divesting Of Some Assets Before Allowing Merger To Be Completed", "summary": "", "symbols": ["KEYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45728103/watching-keysight-technologies-reuters-cites-court-filing-saying-u-s-files-antitrust-lawsuit-to-bloc", "tags": ["merger", "legal"]}
{"id": 45728135, "time": "2025-06-02 12:45:17", "headline": "$1000 Invested In Sea 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45728135/1000-invested-in-sea-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45728212, "time": "2025-06-02 12:48:04", "headline": "Boeing Just Got A Major Stock Upgrade: It's Trump's 'Favored Trade Tool,' Says Bank Of America", "summary": "Boeing is winning new deals, including one from Qatar after Trump visited the Arabian Peninsula and accepted a 747 as a gift.", "symbols": ["BA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45728212/boeing-just-got-a-major-stock-upgrade-its-trumps-favored-trade-tool-says-bank-of-america", "tags": ["analyst_up"]}
{"id": 45728254, "time": "2025-06-02 12:49:43", "headline": "Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May", "summary": " ", "symbols": ["APLD", "LYRA", "SBET", "VERA", "VSTM", "XLO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/equities/25/06/45728254/nasdaq-edges-higher-ism-manufacturing-pmi-falls-in-may", "tags": []}
{"id": 45728262, "time": "2025-06-02 12:50:06", "headline": "Ollie's Bargain Outlet Likely To Report Lower Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["OLLI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/cannabis/25/06/45728262/ollies-bargain-outlet-likely-to-report-lower-q1-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 45728555, "time": "2025-06-02 12:55:21", "headline": "'Disney Mass Layoffs Cut Across TV, Film, Corporate Finance' - Variety", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728555/disney-mass-layoffs-cut-across-tv-film-corporate-finance-variety", "tags": []}
{"id": 45728618, "time": "2025-06-02 12:58:03", "headline": "Stocks Stall, Commodities Rocket As Trade, Geopolitical Tensions Resume: What's Driving Market Monday?", "summary": "After delivering its strongest monthly performance since November 2023, Wall Street entered June on a cautious note, with mounting geopolitical tensions and new trade tariffs clouding investor appetite for risk assets.", "symbols": ["BA", "BTCUSD", "CPB", "DIA", "IWM", "NEM", "NUE", "QQQ", "SAIC", "SPY", "STLD", "TLT", "XLE", "XLI", "XLV", "XLY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/equities/25/06/45728618/stocks-stall-commodities-rocket-as-trade-geopolitical-tensions-resume-whats-driving-market-monday", "tags": []}
{"id": 45728643, "time": "2025-06-02 12:58:48", "headline": "Fed's Goolsbee Says So Far We've Had Excellent Inflation Reports, Surprisingly Little Direct Impact Of Tariffs; Don't Know If That Will Remain True In Next 1-2 Months", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45728643/feds-goolsbee-says-so-far-weve-had-excellent-inflation-reports-surprisingly-littl", "tags": []}
{"id": 45728723, "time": "2025-06-02 13:00:22", "headline": "Looking Into CareTrust REIT's Recent Short Interest", "summary": " ", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45728723/looking-into-caretrust-reits-recent-short-interest", "tags": []}
{"id": 45728724, "time": "2025-06-02 13:00:22", "headline": "A Look Into Southwest Airlines Inc's Price Over Earnings", "summary": " ", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45728724/a-look-into-southwest-airlines-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 45728725, "time": "2025-06-02 13:00:27", "headline": "What Does the Market Think About Tesla?", "summary": " ", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45728725/what-does-the-market-think-about-tesla", "tags": []}
{"id": 45728729, "time": "2025-06-02 13:00:32", "headline": "How Is The Market Feeling About Viper Energy?", "summary": " ", "symbols": ["VNOM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45728729/how-is-the-market-feeling-about-viper-energy", "tags": []}
{"id": 45728745, "time": "2025-06-02 13:00:51", "headline": "Identifying Winning Stocks Is Hard. Holding Winning Stocks Is A Nightmare", "summary": "The stocks offering the best returns for investors historically experienced incredibly painful max drawdowns.", "symbols": [], "source": "benzinga", "author": "Sam Ro", "url": "https://www.benzinga.com/markets/equities/25/06/45728745/identifying-winning-stocks-is-hard-holding-winning-stocks-is-a-nightmare", "tags": ["offering"]}
{"id": 45728761, "time": "2025-06-02 13:01:05", "headline": "Market Whales and Their Recent Bets on PLTR Options", "summary": " ", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45728761/market-whales-and-their-recent-bets-on-pltr-options", "tags": []}
{"id": 45728768, "time": "2025-06-02 13:01:17", "headline": "Check Out What Whales Are Doing With HIMS", "summary": " ", "symbols": ["HIMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45728768/check-out-what-whales-are-doing-with-hims", "tags": []}
{"id": 45728783, "time": "2025-06-02 13:01:46", "headline": "Oppenheimer Assumes Dyne Therapeutics at Outperform, Lowers Price Target of $34", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728783/oppenheimer-assumes-dyne-therapeutics-at-outperform-lowers-price-target-of-34", "tags": ["price_target_down"]}
{"id": 45728792, "time": "2025-06-02 13:01:58", "headline": "CNBC Halftime Report Final Trades: Freeport-McMoRan, Cheniere Energy, FTAI Aviation, Box, Inc", "summary": "", "symbols": ["BOX", "FCX", "FTAI", "LNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728792/cnbc-halftime-report-final-trades-freeport-mcmoran-cheniere-energy-ftai-aviation-box-inc", "tags": []}
{"id": 45728797, "time": "2025-06-02 13:02:13", "headline": "Foresight Diagnostics Partners With QIAGEN To Develop, Commercialize Kit-Based Version Of CLARITY Assay For Lymphoma", "summary": "", "symbols": ["QGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728797/foresight-diagnostics-partners-with-qiagen-to-develop-commercialize-kit-based-version-of-clarity-ass", "tags": ["contract"]}
{"id": 45728892, "time": "2025-06-02 13:04:52", "headline": "Paramount Global's CBS And Gray Media Renew Affiliation Agreements For 52 Of Gray's Existing 53 CBS Network Affiliations", "summary": "", "symbols": ["GTN", "PARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728892/paramount-globals-cbs-and-gray-media-renew-affiliation-agreements-for-52-of-grays-existing-53-cbs-ne", "tags": []}
{"id": 45728917, "time": "2025-06-02 13:05:50", "headline": "12 Information Technology Stocks Moving In Monday's Intraday Session", "summary": " ", "symbols": ["APLD", "ATGL", "BNAI", "CISO", "GRYP", "LEDS", "MLGO", "MOVE", "PONY", "UPLD", "WYY", "YXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45728917/12-information-technology-stocks-moving-in-mondays-intraday-session", "tags": ["why_moving"]}
{"id": 45728919, "time": "2025-06-02 13:05:55", "headline": "12 Industrials Stocks Moving In Monday's Intraday Session", "summary": " ", "symbols": ["FGI", "GWH", "HCAI", "HKPD", "LNZA", "LVRO", "SAIC", "SCWO", "UAVS", "VATE", "ZEO", "ZONE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45728919/12-industrials-stocks-moving-in-mondays-intraday-session", "tags": ["why_moving"]}
{"id": 45728921, "time": "2025-06-02 13:06:00", "headline": "12 Health Care Stocks Moving In Monday's Intraday Session", "summary": " ", "symbols": ["BLRX", "BMGL", "HYPR", "LYRA", "MODV", "OLMA", "PCSA", "PSTV", "TXMD", "VERA", "VSTM", "XLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45728921/12-health-care-stocks-moving-in-mondays-intraday-session", "tags": ["why_moving"]}
{"id": 45728925, "time": "2025-06-02 13:06:05", "headline": "12 Consumer Discretionary Stocks Moving In Monday's Intraday Session", "summary": " ", "symbols": ["AGAE", "CHGG", "KIDZ", "LOGC", "LVWR", "NWTN", "PMNT", "QVCGP", "ROLR", "RRGB", "SBET", "UHG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45728925/12-consumer-discretionary-stocks-moving-in-mondays-intraday-session", "tags": ["why_moving"]}
{"id": 45728990, "time": "2025-06-02 13:07:21", "headline": "Gray Media's Local Television Station WANF To End 31-Year Affiliation With CBS Network On August 15, 2025 To Begin As Independent Television Station", "summary": "", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45728990/gray-medias-local-television-station-wanf-to-end-31-year-affiliation-with-cbs-network-on-august-15-2", "tags": []}
{"id": 45729009, "time": "2025-06-02 13:08:41", "headline": "Atlantic International Appoints Matt Evelt As COO, Effective Immediately", "summary": "", "symbols": ["ATLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45729009/atlantic-international-appoints-matt-evelt-as-coo-effective-immediately", "tags": ["management"]}
{"id": 45729020, "time": "2025-06-02 13:09:07", "headline": "Oppenheimer Assumes Abeona Therapeutics at Outperform, Announces Price Target of $19", "summary": "", "symbols": ["ABEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729020/oppenheimer-assumes-abeona-therapeutics-at-outperform-announces-price-target-of-19", "tags": []}
{"id": 45729089, "time": "2025-06-02 13:11:57", "headline": "China Stocks Get Boost As UBS, HSBC Cite Stimulus Hopes, Tariff Truce, Cheap Valuations", "summary": "UBS optimistic about Chinese stocks due to tariff pause, potential stimulus, and low valuations.", "symbols": ["BABA", "BIDU", "JD", "PDD", "TCEHY"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/large-cap/25/06/45729089/china-stocks-get-boost-as-ubs-hsbc-cite-stimulus-hopes-tariff-truce-cheap-valuations", "tags": []}
{"id": 45728009, "time": "2025-06-02 12:40:03", "headline": "Tomorrow's Energy Crisis? MIT's Alarming Analysis of AI Power Consumption", "summary": "As the energy demands of AI mount, MIT finds urgent steps must be taken to align innovation with sustainability.", "symbols": [], "source": "benzinga", "author": "Andre F. Bourque", "url": "https://www.benzinga.com/markets/commodities/25/06/45728009/tomorrows-energy-crisis-mits-alarming-analysis-of-ai-power-consumption", "tags": []}
{"id": 45729158, "time": "2025-06-02 13:13:03", "headline": "Fed's Goolsbee Says Still Think Underneath All The Tariff 'Dirt In The Air,' Rates Can Come Down Over 12-18 Months; Still Think If We Can Get Past This Bumpy Period, Dual Mandate Looks Pretty Good; A Little Gun-Shy About Arguing That Tariffs Will Have A Transitory Effect On Inflation", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45729158/feds-goolsbee-says-still-think-underneath-all-the-tariff-dirt-in-the-air-rates-ca", "tags": []}
{"id": 45729188, "time": "2025-06-02 13:14:07", "headline": "Tesla Stock Is Trading Lower Today: What's Going On?", "summary": "Shares of Tesla Inc. (NASDAQ: TSLA) are trading lower Monday as the company faces growing pressure from Chinese electric vehicle competitors, which posted strong delivery numbers for May.", "symbols": ["TSLA"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45729188/tesla-stock-is-trading-lower-today-whats-going-on", "tags": ["why_moving"]}
{"id": 45729192, "time": "2025-06-02 13:14:18", "headline": "Oppenheimer Assumes Aquestive Therapeutics at Outperform, Lowers Price Target of $7", "summary": "", "symbols": ["AQST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729192/oppenheimer-assumes-aquestive-therapeutics-at-outperform-lowers-price-target-of-7", "tags": ["price_target_down"]}
{"id": 45729296, "time": "2025-06-02 13:16:59", "headline": "Oppenheimer Assumes Harmony Biosciences Hldgs at Outperform, Announces Price Target of $61", "summary": "", "symbols": ["HRMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729296/oppenheimer-assumes-harmony-biosciences-hldgs-at-outperform-announces-price-target-of-61", "tags": []}
{"id": 45729309, "time": "2025-06-02 13:18:04", "headline": "Fed's Goolsbee Says Recent PCE Inflation Print May Have Been 'Last Vestige' Of Pre-Tariff Impact", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/06/45729309/feds-goolsbee-says-recent-pce-inflation-print-may-have-been-last-vestige-of-pre-t", "tags": []}
{"id": 45729338, "time": "2025-06-02 13:19:25", "headline": "Aspen Insurance Emerges From Turnaround With Momentum: Analyst Sees More Upside Ahead", "summary": "Piper Sandler analyst initiates coverage on Aspen Insurance Holdings (AHL) with Overweight rating and $40 price forecast. Company&#39;s IPO on NYSE in May 2019 with improved profitability and growth expected.", "symbols": ["AHL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/45729338/aspen-insurance-emerges-from-turnaround-with-momentum-analyst-sees-more-upside-ahead", "tags": ["analyst_init", "guidance"]}
{"id": 45729344, "time": "2025-06-02 13:19:36", "headline": "Why Decentralized Swaps Are The Next Frontier For Secure Crypto Trading", "summary": " Image by Gerd Altmann from Pixabay", "symbols": [], "source": "benzinga", "author": "Michael Collins", "url": "https://www.benzinga.com/markets/cryptocurrency/25/06/45729344/why-decentralized-swaps-are-the-next-frontier-for-secure-crypto-trading", "tags": []}
{"id": 45729389, "time": "2025-06-02 13:20:19", "headline": "US Is Poised To Become Global Crypto Hub After Regulatory Breakthrough, Binance CEO Says", "summary": "Binance CEO Teng says US is back in the driver&#39;s seat for crypto industry after regulatory win. Compliance and user protection a top priority.", "symbols": [], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45729389/us-is-poised-to-become-global-crypto-hub-after-regulatory-breakthrough-binance-ceo-says", "tags": ["management"]}
{"id": 45729390, "time": "2025-06-02 13:20:19", "headline": "Moderna Stock Is Trading Higher Monday: What's Going On?", "summary": "Moderna, Inc. (NASDAQ:MRNA) shares are trading higher Monday after the company announced its new COVID-19 vaccine secured clearance from the U.S. Food and Drug Administration (FDA) for seniors and at-risk individuals.", "symbols": ["MRNA"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45729390/moderna-stock-is-trading-higher-monday-whats-going-on-2", "tags": ["why_moving", "fda"]}
{"id": 45729456, "time": "2025-06-02 13:23:30", "headline": "JP Morgan Downgrades Blueprint Medicines to Neutral, Lowers Price Target to $129", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729456/jp-morgan-downgrades-blueprint-medicines-to-neutral-lowers-price-target-to-129", "tags": ["analyst_down", "price_target_down"]}
{"id": 45729645, "time": "2025-06-02 13:28:01", "headline": "Scotiabank Downgrades Blueprint Medicines to Sector Perform, Announces $135 Price Target", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729645/scotiabank-downgrades-blueprint-medicines-to-sector-perform-announces-135-price-target", "tags": ["analyst_down"]}
{"id": 45729811, "time": "2025-06-02 13:31:23", "headline": "Zscaler Shares Hit New 52-Week High: What's Driving The Momentum?", "summary": "Zscaler Inc. (NASDAQ: ZS) shares are trading higher Monday on what appears to be continued momentum after the company posted better-than-expected fiscal third-quarter earnings and raised its full-year guidance last week.", "symbols": ["ZS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45729811/zscaler-shares-hit-new-52-week-high-whats-driving-the-momentum", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 45729853, "time": "2025-06-02 13:33:11", "headline": "'Musk's xAI Launches $5 Billion Debt Sale Through Morgan Stanley' - Bloomberg News", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL", "MS", "MSFT", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729853/musks-xai-launches-5-billion-debt-sale-through-morgan-stanley-bloomberg-news", "tags": []}
{"id": 45729863, "time": "2025-06-02 13:33:48", "headline": "Scotiabank Maintains Sector Outperform on i-80 Gold, Lowers Price Target to $1.5", "summary": "", "symbols": ["IAUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729863/scotiabank-maintains-sector-outperform-on-i-80-gold-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 45729885, "time": "2025-06-02 13:35:12", "headline": "10 Information Technology Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AAPL", "AMD", "ARM", "AVGO", "INTC", "KOPN", "MSFT", "NVDA", "PLTR", "RGTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45729885/10-information-technology-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 45729886, "time": "2025-06-02 13:35:17", "headline": "10 Consumer Discretionary Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AMZN", "BABA", "CMG", "DASH", "DKNG", "EAT", "GME", "HD", "SIG", "TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45729886/10-consumer-discretionary-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 45729887, "time": "2025-06-02 13:35:23", "headline": "10 Industrials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AAL", "BA", "CAR", "GE", "GEV", "GWW", "RKLB", "SMR", "UAL", "ZIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45729887/10-industrials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 45729929, "time": "2025-06-02 13:37:14", "headline": "Needham Reiterates Buy on Taysha Gene Therapies, Raises Price Target to $8", "summary": "", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729929/needham-reiterates-buy-on-taysha-gene-therapies-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 45729973, "time": "2025-06-02 13:39:20", "headline": "'Google to spend $500M on compliance to settle shareholder antitrust suit'- Financial Times", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45729973/google-to-spend-500mn-on-compliance-to-settle-shareholder-antitrust-suit-financial-times", "tags": []}
{"id": 45730050, "time": "2025-06-02 13:41:51", "headline": "Scotiabank Maintains Sector Outperform on Vera Therapeutics, Raises Price Target to $65", "summary": "", "symbols": ["VERA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730050/scotiabank-maintains-sector-outperform-on-vera-therapeutics-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 45730063, "time": "2025-06-02 13:42:31", "headline": "New ETFs Let Investors Mirror Buffett, Ackman, Burry's Top Stock Trades", "summary": " ", "symbols": ["CMG", "GOOGL", "HHH", "HTZ", "NKE", "OMAH", "QSR", "UBER"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/06/45730063/new-etfs-let-investors-mirror-buffett-ackman-burrys-top-stock-trades", "tags": []}
{"id": 45730088, "time": "2025-06-02 13:43:09", "headline": "DraftKings Stock Is Facing Selling Pressure Monday: What's Going On?", "summary": "Shares of DraftKings Inc. (NASDAQ: DKNG) are trading lower Monday after Illinois passed a new budget proposal that includes increased taxes on sports betting.", "symbols": ["DKNG"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/sports-betting/25/06/45730088/draftkings-stock-is-facing-selling-pressure-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 45730127, "time": "2025-06-02 13:44:31", "headline": "Oppenheimer Assumes Praxis Precision Medicine at Outperform, Announces Price Target of $97", "summary": "", "symbols": ["PRAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730127/oppenheimer-assumes-praxis-precision-medicine-at-outperform-announces-price-target-of-97", "tags": []}
{"id": 45730248, "time": "2025-06-02 13:50:27", "headline": "'Honda Joins 2028 Los Angeles Olympic Games as Major Partner'- Bloomberg", "summary": "", "symbols": ["HMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730248/honda-joins-2028-los-angeles-olympic-games-as-major-partner-bloomberg", "tags": []}
{"id": 45729253, "time": "2025-06-02 13:15:59", "headline": "AstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCO", "summary": "AstraZeneca reports major survival benefits in breast and gastric cancer trials with Enhertu, Imfinzi, and camizestrant at ASCO 2025.", "symbols": ["AZN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45729253/astrazeneca-highlights-significant-gains-across-three-major-cancer-trials-at-asco", "tags": []}
{"id": 45730328, "time": "2025-06-02 13:53:51", "headline": "Amid A Reversal In Investor Sentiment, The S&P 500 Rose Over 6% Last Month, Resulting In The Strongest May Performance For The Index In 35 years", "summary": "", "symbols": ["ACWI", "DIA", "IWM", "QQQ", "SPY", "VTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/equities/25/06/45730328/amid-a-reversal-in-investor-sentiment-the-s-p-500-rose-over-6-last-month-resulting-in-the-strong", "tags": []}
{"id": 45730426, "time": "2025-06-02 13:57:03", "headline": "Mizuho Upgrades Red Rock Resorts to Outperform, Raises Price Target to $59", "summary": "", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730426/mizuho-upgrades-red-rock-resorts-to-outperform-raises-price-target-to-59", "tags": ["analyst_up", "price_target_up"]}
{"id": 45730480, "time": "2025-06-02 13:59:51", "headline": "FactSet Research Says The German Equity Market Has Delivered Above 30% Returns Year-To-Date, As Investors Flock To Global Alternatives Amid U.S. Economic And Policy Uncertainty.", "summary": "", "symbols": ["ACWI", "DIA", "IWM", "QQQ", "SPY", "VTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/equities/25/06/45730480/factset-research-says-the-german-equity-market-has-delivered-above-30-returns-year-to-date-as-in", "tags": []}
{"id": 45730507, "time": "2025-06-02 14:00:19", "headline": "Demystifying Upwork: Insights From 8 Analyst Reviews", "summary": " ", "symbols": ["UPWK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730507/demystifying-upwork-insights-from-8-analyst-reviews", "tags": []}
{"id": 45730509, "time": "2025-06-02 14:00:21", "headline": "P/E Ratio Insights for Chimera Investment", "summary": " ", "symbols": ["CIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45730509/pe-ratio-insights-for-chimera-investment", "tags": []}
{"id": 45730510, "time": "2025-06-02 14:00:22", "headline": "What's Driving the Market Sentiment Around Cognizant Tech Solns?", "summary": " ", "symbols": ["CTSH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45730510/whats-driving-the-market-sentiment-around-cognizant-tech-solns", "tags": []}
{"id": 45730512, "time": "2025-06-02 14:00:27", "headline": "What's Driving the Market Sentiment Around SAP?", "summary": " ", "symbols": ["SAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45730512/whats-driving-the-market-sentiment-around-sap", "tags": []}
{"id": 45730514, "time": "2025-06-02 14:00:32", "headline": "How Is The Market Feeling About Murphy USA?", "summary": " ", "symbols": ["MUSA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45730514/how-is-the-market-feeling-about-murphy-usa", "tags": []}
{"id": 45730515, "time": "2025-06-02 14:00:33", "headline": "Morgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $15", "summary": "", "symbols": ["PATH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730515/morgan-stanley-maintains-equal-weight-on-uipath-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 45730516, "time": "2025-06-02 14:00:35", "headline": "13 Analysts Assess Church & Dwight Co: What You Need To Know", "summary": " ", "symbols": ["CHD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730516/13-analysts-assess-church-dwight-co-what-you-need-to-know", "tags": []}
{"id": 45730517, "time": "2025-06-02 14:00:38", "headline": "Market Whales and Their Recent Bets on OKTA Options", "summary": " ", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45730517/market-whales-and-their-recent-bets-on-okta-options", "tags": []}
{"id": 45730519, "time": "2025-06-02 14:00:43", "headline": "Forecasting The Future: 7 Analyst Projections For Welltower", "summary": " ", "symbols": ["WELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730519/forecasting-the-future-7-analyst-projections-for-welltower", "tags": []}
{"id": 45730521, "time": "2025-06-02 14:00:49", "headline": "Spotlight on PayPal Holdings: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45730521/spotlight-on-paypal-holdings-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 45730522, "time": "2025-06-02 14:00:53", "headline": "What 10 Analyst Ratings Have To Say About CVS Health", "summary": " ", "symbols": ["CVS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730522/what-10-analyst-ratings-have-to-say-about-cvs-health", "tags": []}
{"id": 45730563, "time": "2025-06-02 14:01:00", "headline": "Forecasting The Future: 9 Analyst Projections For Humana", "summary": " ", "symbols": ["HUM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730563/forecasting-the-future-9-analyst-projections-for-humana", "tags": []}
{"id": 45730570, "time": "2025-06-02 14:01:09", "headline": "Where Harmony Biosciences Hldgs Stands With Analysts", "summary": " ", "symbols": ["HRMY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45730570/where-harmony-biosciences-hldgs-stands-with-analysts", "tags": []}
{"id": 45730607, "time": "2025-06-02 14:01:48", "headline": "Morgan Stanley Maintains Equal-Weight on American Eagle Outfitters, Lowers Price Target to $10", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730607/morgan-stanley-maintains-equal-weight-on-american-eagle-outfitters-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 45730076, "time": "2025-06-02 13:42:49", "headline": "Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients", "summary": "Trevi&#39;s Haduvio met its primary endpoint in a Phase 2b trial for IPF-related chronic cough, with statistically significant results at multiple doses.", "symbols": ["TRVI"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/health-care/25/06/45730076/trevi-therapeutics-showcases-drug-that-cuts-cough-frequency-in-lung-disease-patients", "tags": ["fda"]}
{"id": 45730723, "time": "2025-06-02 14:05:39", "headline": "USDC Issuer Circle Aims For $7.2B Initial Public Offering Valuation", "summary": "Circle Internet Financial is pushing forward with its public listing plans, now targeting a valuation of $7.2 billion as it gears up for an initial public offering.", "symbols": ["BLK", "USDCUSD", "USDTUSD", "XRPUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45730723/usdc-issuer-circle-aims-for-7-2b-initial-public-offering-valuation", "tags": ["offering"]}
{"id": 45730717, "time": "2025-06-02 14:05:17", "headline": "NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial", "summary": "TTField therapy with chemotherapy improved median overall and pain-free survival in pancreatic cancer, according to new data from the PANOVA-3 trial.", "symbols": ["NVCR", "ZLAB"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/markets/biotech/25/06/45730717/novocures-tumor-treating-fields-boosts-one-year-and-pain-free-survival-in-pancreatic-cancer-trial", "tags": ["fda"]}
{"id": 45730747, "time": "2025-06-02 14:06:26", "headline": "Mullen Automotive Stock Is Falling Monday: What's Going On?", "summary": "Mullen Automotive, Inc. (NASDAQ:MULN) shares are trading lower Monday after the company announced it acquired an additional 21% of Bollinger Motors.", "symbols": ["MULN"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45730747/mullen-automotive-stock-is-falling-monday-whats-going-on", "tags": ["why_moving", "merger"]}
{"id": 45730758, "time": "2025-06-02 14:06:45", "headline": "Interactive Brokers Group Reports 3.384M Daily Average Revenue Trades In May, Up 43% From Last Year And 11% Lower Than Prior Month", "summary": "", "symbols": ["IBKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730758/interactive-brokers-group-reports-3-384m-daily-average-revenue-trades-in-may-up-43-from-last-year-an", "tags": ["earnings"]}
{"id": 45730789, "time": "2025-06-02 14:07:32", "headline": "QIAGEN Expands Oncology Diagnostics Portfolio With Two Strategic Partnerships To Advance Use Of MRD Testing In Clinical Trials To Support Pharma Co-Development Projects For Companion Diagnostics", "summary": "", "symbols": ["QGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730789/qiagen-expands-oncology-diagnostics-portfolio-with-two-strategic-partnerships-to-advance-use-of-mrd", "tags": ["fda"]}
{"id": 45730836, "time": "2025-06-02 14:09:22", "headline": "'U.S. nuclear deal offer allows Iran to enrich uranium'- Axios", "summary": "", "symbols": ["SPY", "URA", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730836/u-s-nuclear-deal-offer-allows-iran-to-enrich-uranium-axios", "tags": ["contract"]}
{"id": 45730982, "time": "2025-06-02 14:17:05", "headline": "Reuters Citing Draft Of Request Reports Trump Administration Wants Other Countries' 'Best Offer' By Wednesday In Tariff Talks", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45730982/reuters-citing-draft-of-request-reports-trump-administration-wants-other-countries-best-offer-by-wed", "tags": []}
{"id": 45731031, "time": "2025-06-02 14:19:47", "headline": "'Supreme Court Seeks DOJ View on Hertz Bondholder Case'- Bloomberg", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731031/supreme-court-seeks-doj-view-on-hertz-bondholder-case-bloomberg", "tags": ["legal"]}
{"id": 45731042, "time": "2025-06-02 14:20:06", "headline": "3 Gold Alternatives Set To Soar Next", "summary": " ", "symbols": ["B", "FCX", "RIO", "SCCO", "SLV", "TECK"], "source": "benzinga", "author": "Nic Chahine", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45731042/3-gold-alternatives-set-to-soar-next", "tags": []}
{"id": 45731052, "time": "2025-06-02 14:20:36", "headline": "Warner Bros' Debt Downgrade Is An 'Ironically Positive' Event: Analyst", "summary": " BofA Securities maintains Buy rating on Warner Bros. Discovery (WBD) with price forecast of $14, citing strategic flexibility and upcoming catalysts. BofA Securities maintains Buy rating on WBD with $14 price forecast, citing flexibility and upcoming catalysts. Analyst believes in valuable assets and potential for unlocking shareholder value.", "symbols": ["WBD"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45731052/warner-bros-debt-downgrade-is-an-ironically-positive-event-analyst", "tags": ["analyst_down", "analyst_other", "guidance"]}
{"id": 45731082, "time": "2025-06-02 14:21:11", "headline": "Telsey Advisory Group Maintains Market Perform on Victoria's Secret, Maintains $24 Price Target", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731082/telsey-advisory-group-maintains-market-perform-on-victorias-secret-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 45731127, "time": "2025-06-02 14:22:49", "headline": "Telsey Advisory Group Maintains Market Perform on G-III Apparel Group, Maintains $30 Price Target", "summary": "", "symbols": ["GIII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731127/telsey-advisory-group-maintains-market-perform-on-g-iii-apparel-group-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 45731210, "time": "2025-06-02 14:24:55", "headline": "Telsey Advisory Group Maintains Market Perform on Torrid Holdings, Maintains $6 Price Target", "summary": "", "symbols": ["CURV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731210/telsey-advisory-group-maintains-market-perform-on-torrid-holdings-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 45731315, "time": "2025-06-02 14:26:55", "headline": "Expert Applauds SEC's Protocol Staking Clarity, Boosting Crypto Innovation", "summary": "Experts commend the SEC&#39;s statement clarifying that protocol staking on proof-of-stake networks does not constitute securities, fostering crypto innovation.", "symbols": ["ETHUSD"], "source": "benzinga", "author": "Murtuza J Merchant", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45731315/expert-applauds-secs-protocol-staking-clarity-boosting-crypto-innovation", "tags": []}
{"id": 45731408, "time": "2025-06-02 14:27:52", "headline": "Telsey Advisory Group Maintains Market Perform on Guess, Maintains $13 Price Target", "summary": "", "symbols": ["GES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731408/telsey-advisory-group-maintains-market-perform-on-guess-maintains-13-price-target", "tags": ["analyst_other"]}
{"id": 45731431, "time": "2025-06-02 14:29:15", "headline": "Telsey Advisory Group Maintains Outperform on Lululemon Athletica, Maintains $385 Price Target", "summary": "", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731431/telsey-advisory-group-maintains-outperform-on-lululemon-athletica-maintains-385-price-target", "tags": ["analyst_other"]}
{"id": 45731490, "time": "2025-06-02 14:30:47", "headline": "Hyperfine Stock Is Soaring Higher Monday: What's Going On?", "summary": "Hyperfine announced it secured clearance from the FDA for its new Swoop system.", "symbols": ["HYPR"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45731490/hyperfine-stock-is-soaring-higher-monday-whats-going-on", "tags": ["why_moving", "fda"]}
{"id": 45731500, "time": "2025-06-02 14:31:01", "headline": "Investors Are Buying Gold Stocks: What's Going On With Barrick Mining, US Gold And Newmont Shares Today?", "summary": "Shares of gold-related equities, including Barrick Mining Corp (NYSE:B), U.S. Gold Corp (NASDAQ:USAU) and Newmont Corp (NYSE:NEM) are rallying on Monday as mounting trade tensions and geopolitical instability drive investors toward safe-haven assets.", "symbols": ["B", "GLD", "NEM", "USAU"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45731500/investors-are-buying-gold-stocks-whats-going-on-with-barrick-mining-us-gold-and-newmont-shares-today", "tags": ["why_moving"]}
{"id": 45731556, "time": "2025-06-02 14:32:54", "headline": "Genmab Announces New Data From Cohort B2 Of Phase 1/2 RAINFOL-01 Trial Evaluating Rina-S, TOPO1-Inhibitor Antibody-Drug Conjugate", "summary": "", "symbols": ["GMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731556/genmab-announces-new-data-from-cohort-b2-of-phase-12-rainfol-01-trial-evaluating-rina-s-topo1-inhibi", "tags": ["fda"]}
{"id": 45731558, "time": "2025-06-02 14:33:09", "headline": "'Newark Airport Flights Set for Increase After Reopening Runway'- Bloomberg", "summary": "", "symbols": ["AAL", "DAL", "SPY", "UAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731558/newark-airport-flights-set-for-increase-after-reopening-runway-bloomberg", "tags": []}
{"id": 45731591, "time": "2025-06-02 14:34:49", "headline": "Fifth Third's Southeast Expansion, Fee Income Drives Optimism", "summary": "Ebrahim H. Poonawala of B of A Securities revised estimates for FITB after an investor meeting, highlighting management&#39;s commitment to shareholder returns.", "symbols": ["FITB"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45731591/fifth-thirds-southeast-expansion-fee-income-drives-optimism", "tags": []}
{"id": 45731615, "time": "2025-06-02 14:35:18", "headline": "'Russian Proposals to Ukraine Seek Gas Transit Return, Tass Says'- Bloomberg", "summary": "", "symbols": ["SPY", "UNG", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731615/russian-proposals-to-ukraine-seek-gas-transit-return-tass-says-bloomberg", "tags": []}
{"id": 45731628, "time": "2025-06-02 14:36:09", "headline": "Colombier Acquisition Corp. II Shares Surge As GrabAGun SPAC Deal Advances With New Filing", "summary": "Shares of Colombier Acquisition Corp. II (NYSE: CLBR) are trading higher Monday following the announcement of an amended regulatory filing tied to its proposed business combination with online firearms retailer GrabAGun. ", "symbols": ["CLBR"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45731628/colombier-acquisition-corp-ii-shares-surge-as-grabagun-spac-deal-advances-with-new-filing", "tags": ["contract"]}
{"id": 45731982, "time": "2025-06-02 14:50:40", "headline": "Rapport Therapeutics Says Phase 2a Trial Of RAP-219 In Refractory Focal Epilepsy Is Now Fully Enrolled; Remains On Track To Report Topline Results In September 2025", "summary": "", "symbols": ["RAPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45731982/rapport-therapeutics-says-phase-2a-trial-of-rap-219-in-refractory-focal-epilepsy-is-now-fully-enroll", "tags": ["fda"]}
{"id": 45732142, "time": "2025-06-02 14:55:09", "headline": "Prudent Investors Pay Attention; World's Most Respected Banker Pours Gas Over Bond Fire; Oil Surges", "summary": " ", "symbols": ["JPM", "TLT"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/equities/25/06/45732142/prudent-investors-pay-attention-worlds-most-respected-banker-pours-gas-over-bond-fire-oil-surges", "tags": []}
{"id": 45732185, "time": "2025-06-02 14:56:47", "headline": "What's Going On With Ford Stock Monday?", "summary": "Ford Motor Company (NYSE: F) shares are trading lower Monday. Investors appear to be reacting to comments from executive chair Bill Ford warning that a Republican-led tax proposal could jeopardize the company&#39;s $3 billion EV battery project in Michigan.", "symbols": ["F"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45732185/whats-going-on-with-ford-stock-monday-2", "tags": ["why_moving"]}
{"id": 45732271, "time": "2025-06-02 15:00:21", "headline": "Is the Market Bullish or Bearish on Broadcom?", "summary": " ", "symbols": ["AVGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45732271/is-the-market-bullish-or-bearish-on-broadcom", "tags": []}
{"id": 45732272, "time": "2025-06-02 15:00:24", "headline": "Breaking Down Healthpeak Properties: 7 Analysts Share Their Views", "summary": " ", "symbols": ["DOC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732272/breaking-down-healthpeak-properties-7-analysts-share-their-views", "tags": []}
{"id": 45732276, "time": "2025-06-02 15:00:26", "headline": "How Is The Market Feeling About CNO Finl Group?", "summary": " ", "symbols": ["CNO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45732276/how-is-the-market-feeling-about-cno-finl-group", "tags": []}
{"id": 45732277, "time": "2025-06-02 15:00:31", "headline": "What's Driving the Market Sentiment Around MicroAlgo?", "summary": " ", "symbols": ["MLGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45732277/whats-driving-the-market-sentiment-around-microalgo", "tags": []}
{"id": 45732280, "time": "2025-06-02 15:00:34", "headline": "Price Over Earnings Overview: Pure Storage", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45732280/price-over-earnings-overview-pure-storage", "tags": ["earnings"]}
{"id": 45732281, "time": "2025-06-02 15:00:36", "headline": "Forecasting The Future: 29 Analyst Projections For UnitedHealth Group", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732281/forecasting-the-future-29-analyst-projections-for-unitedhealth-group", "tags": []}
{"id": 45732290, "time": "2025-06-02 15:00:45", "headline": "Where Broadstone Net Lease Stands With Analysts", "summary": " ", "symbols": ["BNL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732290/where-broadstone-net-lease-stands-with-analysts", "tags": []}
{"id": 45732297, "time": "2025-06-02 15:00:53", "headline": "Where Taysha Gene Therapies Stands With Analysts", "summary": " ", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732297/where-taysha-gene-therapies-stands-with-analysts", "tags": []}
{"id": 45732299, "time": "2025-06-02 15:01:03", "headline": "Forecasting The Future: 11 Analyst Projections For Samsara", "summary": " ", "symbols": ["IOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732299/forecasting-the-future-11-analyst-projections-for-samsara", "tags": []}
{"id": 45732303, "time": "2025-06-02 15:01:10", "headline": "Beyond The Numbers: 9 Analysts Discuss Elevance Health Stock", "summary": " ", "symbols": ["ELV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45732303/beyond-the-numbers-9-analysts-discuss-elevance-health-stock", "tags": []}
{"id": 45732313, "time": "2025-06-02 15:01:24", "headline": "Home Depot Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45732313/home-depot-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 45732316, "time": "2025-06-02 15:01:29", "headline": "Looking At Capital One Finl's Recent Unusual Options Activity", "summary": " ", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/06/45732316/looking-at-capital-one-finls-recent-unusual-options-activity", "tags": []}
{"id": 45732425, "time": "2025-06-02 15:04:40", "headline": "27% Holders Of Lifeway Foods, Edward And Ludmila Smolyansky, Criticize Q1 2025 Results And Board Governance, Citing Weak Operating Performance Masked by One-Time Gain, Declining Margins, Rising Costs, Insider Stock Sales, And Mismanagement Of Danone Offer; Calls For Board Overhaul And Independent Review Of Strategic Alternatives", "summary": "", "symbols": ["LWAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45732425/27-holders-of-lifeway-foods-edward-and-ludmila-smolyansky-criticize-q1-2025-results-and-board-govern", "tags": ["earnings", "insider"]}
{"id": 45732455, "time": "2025-06-02 15:05:49", "headline": "MultiSensor AI Holdings Appoints New CEO And President, Mr. Akram, To Lead Strategic Growth Starting June 23, 2025", "summary": "", "symbols": ["MSAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45732455/multisensor-ai-holdings-appoints-new-ceo-and-president-mr-akram-to-lead-strategic-growth-starting-ju", "tags": ["management"]}
{"id": 45732479, "time": "2025-06-02 15:06:32", "headline": "What's Going On With Meta Shares Today?", "summary": "Meta Platforms Inc. (NASDAQ: META) shares are trading higher Monday following reports that the company is preparing to launch a fully automated ad creation system powered by artificial intelligence by the end of 2026. ", "symbols": ["META"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45732479/whats-going-on-with-meta-shares-today-2", "tags": ["why_moving"]}
{"id": 45732488, "time": "2025-06-02 15:06:50", "headline": "The Fed Will Not Save Us This Year", "summary": "There are no emergency Fed interest rate cuts coming, because the economy is way too strong, says financial influencer Gav Blaxberg.", "symbols": [], "source": "benzinga", "author": "Gav Blaxberg", "url": "https://www.benzinga.com/markets/equities/25/06/45732488/the-fed-will-not-save-us-this-year", "tags": []}
{"id": 45732514, "time": "2025-06-02 15:07:19", "headline": "MultiSensor AI Appoints Asim Akram As CEO And President To Lead Strategic Growth Objectives, June 23, 2025", "summary": "", "symbols": ["MSAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45732514/multisensor-ai-appoints-asim-akram-as-ceo-and-president-to-lead-strategic-growth-objectives-june-23", "tags": ["management"]}
{"id": 45732613, "time": "2025-06-02 15:11:23", "headline": "Broadcom Stock Is Trading Higher Monday: What's Going On?", "summary": "Broadcom announced the launch of the latest enhancements to VMware Tanzu Cloudhealth.", "symbols": ["AVGO"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45732613/broadcom-stock-is-trading-higher-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 45721848, "time": "2025-06-02 09:40:57", "headline": "How Investor Presentations Are Evolving In The AI Era", "summary": " ", "symbols": [], "source": "benzinga", "author": "Jacob Fuller", "url": "https://www.benzinga.com/opinion/25/06/45721848/how-investor-presentations-are-evolving-in-the-ai-era", "tags": []}
{"id": 45732695, "time": "2025-06-02 15:15:46", "headline": "NIO Q1 Earnings Preview: Chinese EV Shows Delivery Growth, Will Tariff Concerns Minimize?", "summary": "NIO is set to release Q1 results on Tuesday, June 3; Deliveries, new brands, tariffs and losses are expected to shape EV outlook.", "symbols": ["NIO"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/previews/25/06/45732695/nio-q1-earnings-preview-chinese-ev-shows-delivery-growth-tariff-concerns-minimize", "tags": ["earnings", "guidance"]}
{"id": 45732701, "time": "2025-06-02 15:15:58", "headline": "What's Going On With Disney Stock Monday?", "summary": "Shares of Walt Disney Company (NYSE: DIS) are treading water on Monday. New reports indicate the company is initiating another round of layoffs impacting several hundred employees globally.", "symbols": ["DIS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45732701/whats-going-on-with-disney-stock-monday", "tags": ["why_moving"]}
{"id": 45733130, "time": "2025-06-02 15:36:00", "headline": "Watching Cantaloupe; Shares Spike Higher, Traders Circulate Unconfirmed Report That The Company Has Seen Multiple Takeover Bids As Final Deal Nears", "summary": "", "symbols": ["CTLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45733130/watching-cantaloupe-shares-spike-higher-traders-circulate-unconfirmed-report-that-the-company-has-se", "tags": ["merger", "contract"]}
{"id": 45733245, "time": "2025-06-02 15:44:41", "headline": "Looking For Summer Seasonal Gains? Here Are 10 S&P 500 Stocks That Historically Rallied In June", "summary": "Seasonal trends highlight 10 S&amp;P 500 stocks with strong June performance. Tesla leads the list, joined by consistent gainers like Eli Lilly.", "symbols": ["AAPL", "ADBE", "AMZN", "DLR", "DPZ", "FICO", "GNRC", "LLY", "ORCL", "TSLA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/large-cap/25/06/45733245/looking-for-summer-seasonal-gains-here-are-10-sp-500-stocks-that-historically-rallied-in-june", "tags": []}
{"id": 45733424, "time": "2025-06-02 15:53:30", "headline": "'FDA Launches Agency-Wide AI Tool To Optimize Performance For The American People' - FDA", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45733424/fda-launches-agency-wide-ai-tool-to-optimize-performance-for-the-american-people-fda", "tags": ["fda"]}
{"id": 45733543, "time": "2025-06-02 15:58:21", "headline": "Classover Stock Trades Higher Monday: What's Going On?", "summary": "Classover Holdings, Inc. (NASDAQ:KIDZ) stock is trading higher on Monday after the company announced it entered into a securities purchase agreement with Solana Growth Ventures for the issuance of up to $500 million in senior secured convert", "symbols": ["KIDZ", "SOLUSD"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/06/45733543/classover-stock-trades-higher-monday-whats-going-on", "tags": ["why_moving", "contract"]}
{"id": 45733632, "time": "2025-06-02 16:00:19", "headline": "12 Analysts Assess Tenet Healthcare: What You Need To Know", "summary": " ", "symbols": ["THC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733632/12-analysts-assess-tenet-healthcare-what-you-need-to-know", "tags": []}
{"id": 45733634, "time": "2025-06-02 16:00:23", "headline": "Price Over Earnings Overview: Carpenter Tech", "summary": " ", "symbols": ["CRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45733634/price-over-earnings-overview-carpenter-tech", "tags": ["earnings"]}
{"id": 45733635, "time": "2025-06-02 16:00:24", "headline": "How Do Investors Really Feel About Advanced Micro Devices?", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45733635/how-do-investors-really-feel-about-advanced-micro-devices", "tags": []}
{"id": 45733636, "time": "2025-06-02 16:00:25", "headline": "Here's How Much You Would Have Made Owning Watts Water Technologies Stock In The Last 15 Years", "summary": " ", "symbols": ["WTS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45733636/heres-how-much-you-would-have-made-owning-watts-water-technologies-stock-in-the-last-15-years", "tags": []}
{"id": 45733637, "time": "2025-06-02 16:00:28", "headline": "Expert Outlook: Global Payments Through The Eyes Of 10 Analysts", "summary": " ", "symbols": ["GPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733637/expert-outlook-global-payments-through-the-eyes-of-10-analysts", "tags": ["guidance"]}
{"id": 45733638, "time": "2025-06-02 16:00:29", "headline": "How Do Investors Really Feel About Carlyle Secured Lending?", "summary": " ", "symbols": ["CGBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45733638/how-do-investors-really-feel-about-carlyle-secured-lending", "tags": []}
{"id": 45733642, "time": "2025-06-02 16:00:34", "headline": "Looking Into Essex Property Trust's Recent Short Interest", "summary": " ", "symbols": ["ESS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/06/45733642/looking-into-essex-property-trusts-recent-short-interest", "tags": []}
{"id": 45733643, "time": "2025-06-02 16:00:39", "headline": "Beyond The Numbers: 47 Analysts Discuss Amazon.com Stock", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733643/beyond-the-numbers-47-analysts-discuss-amazon-com-stock", "tags": []}
{"id": 45733650, "time": "2025-06-02 16:00:50", "headline": "Forecasting The Future: 4 Analyst Projections For Omega Healthcare Invts", "summary": " ", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733650/forecasting-the-future-4-analyst-projections-for-omega-healthcare-invts", "tags": []}
{"id": 45733676, "time": "2025-06-02 16:01:22", "headline": "Analyst Expectations For Neurocrine Biosciences's Future", "summary": " ", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733676/analyst-expectations-for-neurocrine-biosciencess-future", "tags": []}
{"id": 45733685, "time": "2025-06-02 16:01:30", "headline": "Rollins Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["ROL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45733685/rollins-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 45733741, "time": "2025-06-02 16:02:10", "headline": "Personalis Presents New Clinical Results From PREDICT DNA And SCANDARE Studies Highlighting Capabilities Of Ultrasensitive NeXT Personal ctDNA Blood Test For Monitoring And Predicting NAT Response In TNBC", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45733741/personalis-presents-new-clinical-results-from-predict-dna-and-scandare-studies-highlighting-capabili", "tags": ["fda"]}
{"id": 45733771, "time": "2025-06-02 16:02:36", "headline": "Trevi Therapeutics Launches $100M Public Offering Of Common Stock To Support Development Of Haduvio For Chronic Cough In IPF And RCC", "summary": "", "symbols": ["TRVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45733771/trevi-therapeutics-launches-100m-public-offering-of-common-stock-to-support-development-of-haduvio-f", "tags": ["offering"]}
{"id": 45733961, "time": "2025-06-02 16:05:46", "headline": "Credo Technology Group Q4 Adj. EPS $0.35 Beats $0.28 Estimate, Sales $170.03M Beat $162.96M Estimate", "summary": "", "symbols": ["CRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45733961/credo-technology-group-q4-adj-eps-0-35-beats-0-28-estimate-sales-170-03m-beat-162-96m-estimate", "tags": ["earnings"]}
{"id": 45734004, "time": "2025-06-02 16:06:24", "headline": "Credo Technology Group Sees Q1 Sales $185.000M-$195.000M vs $167.83M Est", "summary": "", "symbols": ["CRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734004/credo-technology-group-sees-q1-sales-185-000m-195-000m-vs-167-83m-est", "tags": []}
{"id": 45734019, "time": "2025-06-02 16:06:55", "headline": "VeriSign Executive Vice President And Chief Financial Officer George E. Kilguss III Retired From The Company Effective May 31, 2025", "summary": "", "symbols": ["VRSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734019/verisign-executive-vice-president-and-chief-financial-officer-george-e-kilguss-iii-retired-from-the", "tags": []}
{"id": 45734021, "time": "2025-06-02 16:06:58", "headline": "Snowflake To Acquire Crunchy Data; Terms Undisclosed", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734021/snowflake-to-acquire-crunchy-data-terms-undisclosed", "tags": ["merger"]}
{"id": 45734085, "time": "2025-06-02 16:09:10", "headline": "Natera Presents Results From Large-Scale Pan-Cancer Study Of Signatera Genome Assay At 2025 ASCO Annual Meeting", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734085/natera-presents-results-from-large-scale-pan-cancer-study-of-signatera-genome-assay-at-2025-asco-ann", "tags": []}
{"id": 45734090, "time": "2025-06-02 16:09:14", "headline": "Jazz Pharmaceuticals Announces Phase 3 IMforte Trial Results Showing Zepzelca Plus Atezolizumab First-Line Maintenance Therapy Reduces Disease Progression Risk By 46% And Extends Median Overall Survival To 13.2 Months In ES-SCLC; Data Presented At ASCO 2025 And Published In The Lancet, Supporting New Standard Of Care And FDA sNDA Submission", "summary": "", "symbols": ["JAZZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45734090/jazz-pharmaceuticals-announces-phase-3-imforte-trial-results-showing-zepzelca-plus-atezolizumab-f", "tags": ["fda"]}
{"id": 45734091, "time": "2025-06-02 16:09:21", "headline": "Essential Properties Realty Trust Increases Quarterly Dividend From $0.295 To $0.30/Share", "summary": "", "symbols": ["EPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734091/essential-properties-realty-trust-increases-quarterly-dividend-from-0-295-to-0-30share", "tags": ["dividend"]}
{"id": 45734148, "time": "2025-06-02 16:10:45", "headline": "The Ensign Group Acquires Nursing Facility In California; Financial Terms Not Disclosed", "summary": "", "symbols": ["ENSG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45734148/the-ensign-group-acquires-nursing-facility-in-california-financial-terms-not-disclosed", "tags": ["merger"]}
{"id": 45734155, "time": "2025-06-02 16:11:00", "headline": "Cardiff Oncology Presents Data From Investigator-Initiated Phase 1b Clinical Trial Evaluating Onvansertib In Combination With Paclitaxel In Patients With mTNBC At 2025 ASCO Annual Meeting", "summary": "", "symbols": ["CRDF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734155/cardiff-oncology-presents-data-from-investigator-initiated-phase-1b-clinical-trial-evaluating-onvans", "tags": ["fda"]}
{"id": 45734172, "time": "2025-06-02 16:11:27", "headline": "Broadway Financial Announces Nasdaq Noncompliance Notification", "summary": "", "symbols": ["BYFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734172/broadway-financial-announces-nasdaq-noncompliance-notification", "tags": []}
{"id": 45734191, "time": "2025-06-02 16:12:24", "headline": "Both ISS And Glass Lewis Urge Forward Air Shareholders To Vote Against Chairman George Mayes Jr., Directors Javier Polit And Laurie Tucker, Citing Poor Oversight Of Omni Deal And Lack Of Value-Enhancing Contributions", "summary": "", "symbols": ["FWRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734191/both-iss-and-glass-lewis-urge-forward-air-shareholders-to-vote-against-chairman-george-mayes-jr-dire", "tags": ["contract"]}
{"id": 45734290, "time": "2025-06-02 16:15:19", "headline": "$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45734290/100-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45734304, "time": "2025-06-02 16:15:44", "headline": "Donaldson Appoints Richard Lewis Chief Operating Officer, Effective August 1, 2025", "summary": "", "symbols": ["DCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734304/donaldson-appoints-richard-lewis-chief-operating-officer-effective-august-1-2025", "tags": ["management"]}
{"id": 45734412, "time": "2025-06-02 16:20:54", "headline": "Avis Budget Rental Car Funding (AESOP) Issues $736.5M In Asset-Backed Securities Across Two Series With Maturities Of 3 And 5 Years", "summary": "", "symbols": ["CAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734412/avis-budget-rental-car-funding-aesop-issues-736-5m-in-asset-backed-securities-across-two-series-with", "tags": []}
{"id": 45734372, "time": "2025-06-02 16:18:56", "headline": "NuCana Q1 EPADS $(0.75)", "summary": "", "symbols": ["NCNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45734372/nucana-q1-epads-0-75", "tags": []}
{"id": 45734457, "time": "2025-06-02 16:22:27", "headline": "Amaze Holdings To Implement 1-For-23 Reverse Stock Split, Aiming To Regain NYSE American Compliance; Stock To Begin Trading On Split-Adjusted Basis June 13, 2025", "summary": "", "symbols": ["AMZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734457/amaze-holdings-to-implement-1-for-23-reverse-stock-split-aiming-to-regain-nyse-american-compliance-s", "tags": []}
{"id": 45734601, "time": "2025-06-02 16:25:42", "headline": "CERo Therapeutics Appoints Chris Ehrlich As CEO", "summary": "", "symbols": ["CERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734601/cero-therapeutics-appoints-chris-ehrlich-as-ceo", "tags": ["management"]}
{"id": 45734615, "time": "2025-06-02 16:26:32", "headline": "Strategy Announces Plans For IPO Of 2.5M Shares Of 10% Series A Perpetual Stride Preferred Stock (STRD) To Fund Bitcoin Acquisitions And Corporate Operations", "summary": "", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734615/strategy-announces-plans-for-ipo-of-2-5m-shares-of-10-series-a-perpetual-stride-preferred-stock-strd", "tags": []}
{"id": 45734620, "time": "2025-06-02 16:26:36", "headline": "Credo Technology Group Q4 Earnings: Revenue Beat, EPS Beat, Strong Guidance, Company Says Results Fueled By 'Surging Demand'", "summary": "Credo Technology Group reports fourth-quarter revenue of $170.03 million, beating analyst estimates of $162.96 million.", "symbols": ["CRDO"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/markets/earnings/25/06/45734620/credo-technology-group-q4-earnings-revenue-beat-eps-beat-strong-guidance-company-says-results-fueled-by-surging-demand", "tags": ["earnings", "guidance"]}
{"id": 45734673, "time": "2025-06-02 16:28:37", "headline": "Uber Technologies Appoints Andrew \"Mac\" Macdonald As President & Chief Operating Officer, Effective Immediately", "summary": "", "symbols": ["UBER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734673/uber-technologies-appoints-andrew-mac-macdonald-as-president-chief-operating-officer-effective-immed", "tags": ["management"]}
{"id": 45734677, "time": "2025-06-02 16:28:46", "headline": "Shineco To Raise $13.5M Through Sale Of 18M Common Shares At $0.75 Each To Non-U.S. Investors", "summary": "", "symbols": ["SISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734677/shineco-to-raise-13-5m-through-sale-of-18m-common-shares-at-0-75-each-to-non-u-s-investors", "tags": []}
{"id": 45734735, "time": "2025-06-02 16:30:07", "headline": "Cannabis Stock Gainers And Losers From June 2, 2025", "summary": " ", "symbols": ["AUSAF", "BMMJ", "CBDY", "CGC", "CNGGF", "CNTMF", "CVSI", "CWBHF", "CXXIF", "ELLXF", "FFNTF", "FUAPF", "GNLN", "GTBIF", "LBUY", "LVRLF", "MRMD", "OILFF", "RMHB", "RSSFF", "SMG", "SOL", "SOLCF", "TGIFF", "TLRY", "VFF", "YCBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cannabis/25/06/45734735/cannabis-stock-gainers-and-losers-from-june-2-2025", "tags": []}
{"id": 45734747, "time": "2025-06-02 16:30:14", "headline": "Here's How Much You Would Have Made Owning Shopify Stock In The Last 10 Years", "summary": " ", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45734747/heres-how-much-you-would-have-made-owning-shopify-stock-in-the-last-10-years", "tags": []}
{"id": 45734836, "time": "2025-06-02 16:31:18", "headline": "Neuronetics Set To Join Russell 3000 Index And Russell 2000 Index, Effective June 30, 2025", "summary": "", "symbols": ["STIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734836/neuronetics-set-to-join-russell-3000-index-and-russell-2000-index-effective-june-30-2025", "tags": []}
{"id": 45734924, "time": "2025-06-02 16:33:57", "headline": "BILL Holdings Names Rohini Jain As CFO, Effective July 7th; John Rettig Will Take On An Expanded Role As Both President And Chief Operating Officer", "summary": "", "symbols": ["BILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734924/bill-holdings-names-rohini-jain-as-cfo-effective-july-7th-john-rettig-will-take-on-an-expanded-role", "tags": ["management"]}
{"id": 45734934, "time": "2025-06-02 16:34:29", "headline": "Venus Concept And Subsidiaries Reached Consent Agreement With Madryn Health Partners, Waiving Certain Liquidity Requirements To Apply June 8 Cash Interest Payment To Principal Balance Through June 30, 2025.", "summary": "", "symbols": ["VERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734934/venus-concept-and-subsidiaries-reached-consent-agreement-with-madryn-health-partners-waiving-certain", "tags": ["contract"]}
{"id": 45734939, "time": "2025-06-02 16:34:37", "headline": "Centerspace To Acquire Community In Fort Collins, CO, With Closing Expected In Mid-June; Anticipated Purchase Price Is About $132M And Will Include Assumption Of About $76M Of Long-Term, Below-Market Rate Mortgage Debt", "summary": "", "symbols": ["CSR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734939/centerspace-to-acquire-community-in-fort-collins-co-with-closing-expected-in-mid-june-anticipated-pu", "tags": ["merger"]}
{"id": 45734941, "time": "2025-06-02 16:34:55", "headline": "UPDATE: ClearOne Authorizes 1-For-15 Reverse Stock Split, Will Begin Trading On A Reverse Stock Split Adjusted Basis On The Nasdaq Capital Market At Market Open On June 10, 2025", "summary": "", "symbols": ["CLRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45734941/update-clearone-authorizes-1-for-15-reverse-stock-split-will-begin-trading-on-a-reverse-stock-split", "tags": []}
{"id": 45734958, "time": "2025-06-02 16:35:45", "headline": "Netflix Creates Christmas Day Dilemma: How NFL Games, 'Stranger Things' Season 5 Could Complicate Holidays", "summary": " ", "symbols": ["AMZN", "NFLX"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/entertainment/25/06/45734958/netflix-creates-christmas-day-dilemma-how-nfl-games-stranger-things-season-5-could-complicate-holidays", "tags": []}
{"id": 45734999, "time": "2025-06-02 16:37:36", "headline": "Invitation Homes Invests Over $100M To Acquire 300+ New Homes In Key Growth Markets Located In Dallas, Denver, and Nashville", "summary": "", "symbols": ["INVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45734999/invitation-homes-invests-over-100m-to-acquire-300-new-homes-in-key-growth-markets-located-in-dallas", "tags": ["merger"]}
{"id": 45735029, "time": "2025-06-02 16:39:54", "headline": "OR Royalties Updates Long-Term Growth Outlook With Multiple Advancing Projects And Acquires 100% Silver Stream On Orla Mining's South Railroad Project In Nevada; No Financial Terms Disclosed", "summary": "", "symbols": ["OR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45735029/or-royalties-updates-long-term-growth-outlook-with-multiple-advancing-projects-and-acquires-100-silv", "tags": ["guidance", "merger"]}
{"id": 45734752, "time": "2025-06-02 16:30:25", "headline": "'Trump Administration To Open Alaska Wilderness To Drilling And Mining' - New York Times", "summary": "", "symbols": ["SPY", "UAMY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/25/06/45734752/trump-administration-to-open-alaska-wilderness-to-drilling-and-mining-new-york-times", "tags": []}
{"id": 45735089, "time": "2025-06-02 16:42:35", "headline": "Royalty Management Holding Files For Mixed Shelf Of Up to $50M", "summary": "", "symbols": ["RMCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45735089/royalty-management-holding-files-for-mixed-shelf-of-up-to-50m", "tags": []}
{"id": 45735088, "time": "2025-06-02 16:42:23", "headline": "UPDATE: 'Snowflake To Buy Crunchy Data For $250M' - WSJ", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45735088/update-snowflake-to-acquire-crunchy-data-for-250m-wsj", "tags": []}
{"id": 45735141, "time": "2025-06-02 16:45:18", "headline": "Here's How Much You Would Have Made Owning Apple Stock In The Last 10 Years", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45735141/heres-how-much-you-would-have-made-owning-apple-stock-in-the-last-10-years", "tags": []}
{"id": 45735226, "time": "2025-06-02 16:51:17", "headline": "'Merck Held Talks To Buy Swiss Biotech MoonLake Immunotherapeutics For More Than $3B' - Financial Times", "summary": "", "symbols": ["MLTX", "MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45735226/merck-held-talks-to-buy-swiss-biotech-moonlake-immunotherapeutics-for-more-than-3b-financial-times", "tags": []}
{"id": 45735271, "time": "2025-06-02 16:53:20", "headline": "Jamie Dimon's 5 Most Recent Dire Warnings Include Recession, 'Panic' And Zero Growth", "summary": "JPMorgan Chase &amp; Co. (NYSE:JPM) CEO Jamie Dimon has sounded the alarm on a series of mounting threats facing the U.S.", "symbols": ["BTCUSD", "JPM"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/guidance/25/06/45735271/jamie-dimons-5-most-recent-dire-warnings-include-recession-panic-and-zero-growth", "tags": ["management"]}
{"id": 45735548, "time": "2025-06-02 17:00:17", "headline": "Here's How Much You Would Have Made Owning Equitable Holdings Stock In The Last 5 Years", "summary": " ", "symbols": ["EQH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45735548/heres-how-much-you-would-have-made-owning-equitable-holdings-stock-in-the-last-5-years", "tags": []}
{"id": 45735551, "time": "2025-06-02 17:00:20", "headline": "Price Over Earnings Overview: Synovus Financial", "summary": " ", "symbols": ["SNV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45735551/price-over-earnings-overview-synovus-financial", "tags": ["earnings"]}
{"id": 45735553, "time": "2025-06-02 17:00:22", "headline": "What Analysts Are Saying About Arvinas Stock", "summary": " ", "symbols": ["ARVN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735553/what-analysts-are-saying-about-arvinas-stock", "tags": []}
{"id": 45735566, "time": "2025-06-02 17:00:36", "headline": "Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews", "summary": " ", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735566/demystifying-immunocore-holdings-insights-from-9-analyst-reviews", "tags": []}
{"id": 45735576, "time": "2025-06-02 17:00:44", "headline": "Deep Dive Into NetApp Stock: Analyst Perspectives (11 Ratings)", "summary": " ", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735576/deep-dive-into-netapp-stock-analyst-perspectives-11-ratings", "tags": []}
{"id": 45735617, "time": "2025-06-02 17:01:24", "headline": "Doximity Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)", "summary": " ", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735617/doximity-stock-a-deep-dive-into-analyst-perspectives-12-ratings", "tags": []}
{"id": 45735619, "time": "2025-06-02 17:01:34", "headline": "Breaking Down Gaming and Leisure Props: 8 Analysts Share Their Views", "summary": " ", "symbols": ["GLPI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735619/breaking-down-gaming-and-leisure-props-8-analysts-share-their-views", "tags": []}
{"id": 45735628, "time": "2025-06-02 17:01:42", "headline": "Expert Outlook: RPM Intl Through The Eyes Of 8 Analysts", "summary": " ", "symbols": ["RPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45735628/expert-outlook-rpm-intl-through-the-eyes-of-8-analysts", "tags": ["guidance"]}
{"id": 45735732, "time": "2025-06-02 17:05:46", "headline": "12 Information Technology Stocks Moving In Monday's After-Market Session", "summary": " ", "symbols": ["AIP", "BNAI", "CRDO", "CXDO", "DGNX", "DUOT", "MFH", "MOVE", "MSAI", "OBLG", "SMTK", "SOBR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45735732/12-information-technology-stocks-moving-in-mondays-after-market-session", "tags": ["why_moving"]}
{"id": 45735734, "time": "2025-06-02 17:05:51", "headline": "12 Industrials Stocks Moving In Monday's After-Market Session", "summary": " ", "symbols": ["AQMS", "FIP", "GLXG", "HKPD", "ILAG", "RAIN", "SCWO", "SPWR", "TOMZ", "WETO", "WXM", "ZONE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45735734/12-industrials-stocks-moving-in-mondays-after-market-session", "tags": ["why_moving"]}
{"id": 45735737, "time": "2025-06-02 17:05:57", "headline": "12 Health Care Stocks Moving In Monday's After-Market Session", "summary": " ", "symbols": ["ANL", "BDMD", "CLNN", "FGEN", "MLTX", "MODV", "OWLT", "RAPP", "TIL", "TLPH", "TOVX", "UNCY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45735737/12-health-care-stocks-moving-in-mondays-after-market-session", "tags": ["why_moving"]}
{"id": 45735739, "time": "2025-06-02 17:06:02", "headline": "12 Consumer Discretionary Stocks Moving In Monday's After-Market Session", "summary": " ", "symbols": ["AGAE", "AMST", "CLEU", "ECDA", "FLYE", "GORV", "LVWR", "MMA", "NAAS", "NRDY", "QVCGA", "UHG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/06/45735739/12-consumer-discretionary-stocks-moving-in-mondays-after-market-session", "tags": ["why_moving"]}
{"id": 45735786, "time": "2025-06-02 17:07:21", "headline": "Pembina Pipeline To Issue $200M Aggregate Principal Amount Of 5.95% Fixed-To-Fixed Rate Subordinated Notes, Series 2  Due June 6, 2055", "summary": "", "symbols": ["PBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45735786/pembina-pipeline-to-issue-200m-aggregate-principal-amount-of-5-95-fixed-to-fixed-rate-subordinated-n", "tags": []}
{"id": 45735841, "time": "2025-06-02 17:11:24", "headline": "Tucows Announces The Appointment Of Laurenz Nienaber As Chair Of The Board Of Directors", "summary": "", "symbols": ["TCX", "TSX:TC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45735841/tucows-announces-the-appointment-of-laurenz-nienaber-as-chair-of-the-board-of-directors", "tags": []}
{"id": 45735892, "time": "2025-06-02 17:15:22", "headline": "Here's How Much $100 Invested In Canadian Pacific Kansas 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["CP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45735892/heres-how-much-100-invested-in-canadian-pacific-kansas-20-years-ago-would-be-worth-today", "tags": []}
{"id": 45736015, "time": "2025-06-02 17:24:13", "headline": "Northern Dynasty Minerals Received Payment Of $12M Representing The Third Tranche Investment Under The Co's Royalty Agreement Dated July 26, 2022", "summary": "", "symbols": ["NAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736015/northern-dynasty-minerals-received-payment-of-12m-representing-the-third-tranche-investment-under-th", "tags": ["contract"]}
{"id": 45736292, "time": "2025-06-02 17:29:50", "headline": "Customers Bancorp Executive Vice President, Chief Financial Officer Philip Watkins To Transition To EVP, Head Of Corporate Development; Mark McCollom Appointed EVP, CFO Effective On Or Around August 15,2025", "summary": "", "symbols": ["CUBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736292/customers-bancorp-executive-vice-president-chief-financial-officer-philip-watkins-to-transition-to-e", "tags": ["management"]}
{"id": 45736309, "time": "2025-06-02 17:30:05", "headline": "Bridgford Foods Q2 EPS $(0.43) Down From $(0.24) YoY, Sales $50.64M Up From $47.31M YoY", "summary": "", "symbols": ["BRID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/06/45736309/bridgford-foods-q2-eps-0-43-down-from-0-24-yoy-sales-50-64m-up-from-47-31m-yoy", "tags": ["earnings"]}
{"id": 45736312, "time": "2025-06-02 17:30:29", "headline": "$100 Invested In Axis Capital Holdings 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["AXS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736312/100-invested-in-axis-capital-holdings-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45736355, "time": "2025-06-02 17:34:37", "headline": "Parsons Corp Removes Confidential Contract From 2025 Guidance; Lowers FY25 Total Revenue Guidance To $6.45B-$6.65B; FY25 Revenue Excluding Confidential Contract Guidance $6.165B-$6.365B; Lowers FY25 Adj EBITDA Guidance To $590M-$630M", "summary": "", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736355/parsons-corp-removes-confidential-contract-from-2025-guidance-lowers-fy25-total-revenue-guidance-to", "tags": ["earnings", "guidance", "contract"]}
{"id": 45736466, "time": "2025-06-02 17:45:22", "headline": "Here's How Much $1000 Invested In Uber Technologies 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["UBER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736466/heres-how-much-1000-invested-in-uber-technologies-5-years-ago-would-be-worth-today", "tags": []}
{"id": 45736491, "time": "2025-06-02 17:51:17", "headline": "Uber Reveals Vice President Of Delivery Is Leaving After 'The Ride Of A Lifetime'", "summary": "Uber reveals that Pierre-Dimitri Gore-Coty, senior vice president of delivery, is leaving the company.", "symbols": ["TSLA", "UBER"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/markets/tech/25/06/45736491/uber-reveals-vice-president-of-delivery-is-leaving-after-the-ride-of-a-lifetime", "tags": []}
{"id": 45736634, "time": "2025-06-02 17:58:34", "headline": "'Microsoft Cuts Hundreds More Jobs After Firing 6,000 Last Month'- Bloomberg", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736634/microsoft-cuts-hundreds-more-jobs-after-firing-6-000-last-month-bloomberg", "tags": []}
{"id": 45736647, "time": "2025-06-02 18:00:18", "headline": "Here's How Much $1000 Invested In Ecolab 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["ECL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736647/heres-how-much-1000-invested-in-ecolab-20-years-ago-would-be-worth-today", "tags": []}
{"id": 45736648, "time": "2025-06-02 18:00:20", "headline": "Price Over Earnings Overview: Steel Dynamics", "summary": " ", "symbols": ["STLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736648/price-over-earnings-overview-steel-dynamics", "tags": ["earnings"]}
{"id": 45736649, "time": "2025-06-02 18:00:21", "headline": "Beyond The Numbers: 7 Analysts Discuss Molina Healthcare Stock", "summary": " ", "symbols": ["MOH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45736649/beyond-the-numbers-7-analysts-discuss-molina-healthcare-stock", "tags": []}
{"id": 45736675, "time": "2025-06-02 18:00:57", "headline": "48 Analysts Have This To Say About Zscaler", "summary": " ", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45736675/48-analysts-have-this-to-say-about-zscaler", "tags": []}
{"id": 45736681, "time": "2025-06-02 18:01:19", "headline": "Where Couchbase Stands With Analysts", "summary": " ", "symbols": ["BASE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/06/45736681/where-couchbase-stands-with-analysts", "tags": []}
{"id": 45736772, "time": "2025-06-02 18:12:51", "headline": "Kura Oncology And Kyowa Kirin Announce Phase 2 KOMET-001 Trial Results For Once-Daily Oral Menin Inhibitor Ziftomenib In Relapsed/Refractory NPM1-Mutated AML Showing 23% CR/CRh Rate, Durable MRD-Negative Responses Across Key Subgroups, Favorable Safety With Limited Myelosuppression At ASCO 2025", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/06/45736772/kura-oncology-and-kyowa-kirin-announce-phase-2-komet-001-trial-results-for-once-daily-oral-menin-", "tags": ["fda"]}
{"id": 45736777, "time": "2025-06-02 18:15:17", "headline": "Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["MASI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736777/heres-how-much-100-invested-in-masimo-15-years-ago-would-be-worth-today", "tags": []}
{"id": 45736797, "time": "2025-06-02 18:20:04", "headline": "President Trump Posts On Truth Social \"The AUTOPEN should have stopped Iran a long time ago from \"enriching.\" Under our potential Agreement \u2014 WE WILL NOT ALLOW ANY ENRICHMENT OF URANIUM!\"", "summary": "", "symbols": ["SPY", "URA", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736797/president-trump-posts-on-truth-social-the-autopen-should-have-stopped-iran-a-long-time-ago-from-enri", "tags": ["contract"]}
{"id": 45736798, "time": "2025-06-02 18:20:43", "headline": "Tesla Sales Hit 3-Year Low In This European Nation Despite Musk's Claims Of 'No Demand Problem'", "summary": "Tesla is facing declining deliveries in many regions, with Europe being hit the hardest due to competition and CEO Elon Musk&#39;s political involvement.", "symbols": ["TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/eurozone/25/06/45736798/tesla-sales-hit-3-year-low-in-this-european-nation-despite-musks-claims-of-no-demand-problem", "tags": ["management"]}
{"id": 45736862, "time": "2025-06-02 18:27:03", "headline": "Afya Limited's Board Approves Engagement Of KPMG As New Independent Auditor", "summary": "", "symbols": ["AFYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45736862/afya-limiteds-board-approves-engagement-of-kpmg-as-new-independent-auditor", "tags": []}
{"id": 45736873, "time": "2025-06-02 18:30:15", "headline": "Here's How Much $1000 Invested In Guidewire Software 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["GWRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736873/heres-how-much-1000-invested-in-guidewire-software-10-years-ago-would-be-worth-today", "tags": []}
{"id": 45736948, "time": "2025-06-02 18:45:19", "headline": "$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45736948/1000-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45736983, "time": "2025-06-02 18:51:50", "headline": "Warren Buffett Makes Over $2.2 Million A Day From This Stock", "summary": "Warren Buffett&#39;s Berkshire Hathaway is set to earn $816 million in Coca-Cola dividends in 2025.", "symbols": ["BRK", "KO"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/movers-shakers/25/06/45736983/warren-buffett-makes-over-2-2-million-a-day-from-this-stock", "tags": []}
{"id": 45737091, "time": "2025-06-02 19:00:18", "headline": "Here's How Much You Would Have Made Owning Morgan Stanley Stock In The Last 10 Years", "summary": " ", "symbols": ["MS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45737091/heres-how-much-you-would-have-made-owning-morgan-stanley-stock-in-the-last-10-years", "tags": []}
{"id": 45737152, "time": "2025-06-02 19:15:18", "headline": "$100 Invested In Booking Holdings 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45737152/100-invested-in-booking-holdings-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 45737250, "time": "2025-06-02 19:30:15", "headline": "If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["ON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45737250/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 45737318, "time": "2025-06-02 19:45:23", "headline": "Here's How Much $100 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/06/45737318/heres-how-much-100-invested-in-palo-alto-networks-10-years-ago-would-be-worth-today", "tags": []}
{"id": 45737342, "time": "2025-06-02 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SPYQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45737342/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45737343, "time": "2025-06-02 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["QQQP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45737343/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45737344, "time": "2025-06-02 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["MQQQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45737344/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45737345, "time": "2025-06-02 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["AGMH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/06/45737345/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 45737860, "time": "2025-06-02 21:07:49", "headline": "Kevin O'Leary Blasts Four-Day Workweek As The 'Stupidest Idea Ever' \u2014 Here's Why Mr Wonderful Thinks The Concept Doesn't Work In The Era Of Remote Work", "summary": "Kevin O&#39;Leary slammed France&#39;s four-day workweek proposal as &#34;the stu**dest idea ever,&#34; but leaders like Bernie Sanders, Bill Gates and tech CEOs argue AI-driven productivity could soon make shorter workweeks not only feasible, but inevitable.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/25/06/45737860/kevin-oleary-blasts-four-day-workweek-as-the-stupidest-idea-ever-heres-why-mr-wonderful-thinks-the-concept-doesnt-work-in-the-era-of-remote-work", "tags": []}
{"id": 45737979, "time": "2025-06-02 21:38:51", "headline": "Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground \u2014 Ark Dumps Palantir Amid Privacy Concerns", "summary": "On Monday, Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, amidst competition and data misuse concerns. Ark also made significant trades in other companies, such as eToro and Illumina. ", "symbols": ["ARKK", "PLTR", "TSLA"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/markets/equities/25/06/45737979/cathie-wood-sells-tesla-stock-as-chinese-rivals-gain-ground-ark-dumps-palantir-amid-privacy-concerns", "tags": []}
{"id": 45738110, "time": "2025-06-02 22:15:01", "headline": "Bitcoin, Ethereum, Dogecoin Rise As China Counters Trump's Trade Deal Breach Claim: Analyst Says BTC Success Riding On Health Of US Economy", "summary": "Leading cryptocurrencies climbed on Monday, despite rising trade tensions between the U.S. and China.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45738110/bitcoin-ethereum-dogecoin-rise-as-china-counters-trumps-trade-deal-breach-claim-analyst-says-btc-success-riding-on-health-of-us-economy", "tags": ["contract"]}
{"id": 45738323, "time": "2025-06-02 22:27:54", "headline": "Steve Jobs' Widow Is Backing Jony Ive's Mystery AI Device Even Though She's Still 'Very Close' To Apple Leadership: 'If It Wasn't For Laurene\u2026'", "summary": " ", "symbols": ["AAPL", "GOOG", "GOOGL", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/25/06/45738323/steve-jobs-widow-is-backing-jony-ives-mystery-ai-device-even-though-shes-still-very-close-to-apple-leadership-if-it-wasnt-for-laurene", "tags": []}
{"id": 45738351, "time": "2025-06-02 22:41:35", "headline": "Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today", "summary": "U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average inching up 0.08% to 42,305.48, the S&amp;P 500 advancing 0.4% to 5,935.94.", "symbols": ["APLD", "GOOG", "GOOGL", "LYRA", "META", "TSLA"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/markets/equities/25/06/45738351/applied-digital-corp-meta-platforms-alphabet-lyra-therapeutics-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 45738364, "time": "2025-06-02 22:50:43", "headline": "Meta Platforms Shareholders Say No To Mark Zuckerberg-Led Social Media Titan Putting Bitcoin On The Balance Sheet", "summary": "Shareholders of\u00a0Meta Platforms Inc.\u00a0(NASDAQ:META) rejected a proposal to consider adding Bitcoin (CRYPTO: BTC) to the company\u2019s balance sheet.", "symbols": ["AMZN", "BTCUSD", "META", "MSFT"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45738364/meta-platforms-shareholders-say-no-to-mark-zuckerberg-led-social-media-titan-putting-bitcoin-on-the-balance-sheet", "tags": []}
{"id": 45738435, "time": "2025-06-02 23:21:31", "headline": "Elizabeth Warren Says Trump 'Approved' The Largest Meat Company In World To Be Listed On NYSE Ignoring Corruption And Bribery History, Demands Answers", "summary": "Sen.\u00a0Elizabeth Warren\u00a0(D-Mass.) is once again calling out corruption in the Trump Administration, following a questionable decision made by the U.S. Securities and Exchange Commission.", "symbols": ["AAPL", "AMZN", "GOOG", "JBSAY", "META"], "source": "benzinga", "author": "Vishaal Sanjay", "url": "https://www.benzinga.com/markets/equities/25/06/45738435/elizabeth-warren-says-trump-approved-the-largest-meat-company-in-world-to-be-listed-on-nyse-ignoring-corruption-and-bribery-history-demands-answers", "tags": []}
{"id": 45738444, "time": "2025-06-02 23:22:48", "headline": "Mark Cuban Says Doing This One Thing Paid Him 'Dividends' For The Rest Of His Life, Shark Suggests Doing It When Money Is Scarce", "summary": " ", "symbols": [], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/news/education/25/06/45738444/mark-cuban-says-doing-this-one-thing-paid-him-dividends-for-the-rest-of-his-life-shark-suggests-doing-it-when-money-is-scarce", "tags": []}
{"id": 45738505, "time": "2025-06-02 23:36:26", "headline": "Peter Schiff Says It Was His Economic Teachings That Made People Want To Buy Bitcoin: 'An Unintended Consequence'", "summary": "Peter Schiff\u00a0said Monday that his teachings on economics inadvertently led many to invest in Bitcoin (CRYPTO: BTC), despite his advice against it.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/crypto/cryptocurrency/25/06/45738505/peter-schiff-says-it-was-his-economic-teachings-that-made-people-want-to-buy-bitcoin-an-unintended-consequence", "tags": []}
{"id": 45738506, "time": "2025-06-02 23:36:31", "headline": "Microsoft Fires Hundreds More Workers Amid AI-Fueled Growth, Calls It Positioning The Company For 'Success'", "summary": " ", "symbols": ["META", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/tech/25/06/45738506/microsoft-fires-hundreds-more-workers-amid-ai-fueled-growth-calls-it-positioning-the-company-for-success", "tags": []}
{"id": 45737741, "time": "2025-06-02 20:51:50", "headline": "Chuck Schumer Says If 'TACO Trump' Is Already Folding On Iran, The American People Need To Know: 'One Day, He Sounds Tough, The Next Day He's Backing Off'", "summary": "\n\nSchumer criticizes Trump&#39;s possible secret deal with Iran and demands transparency. US offers a proposal allowing limited uranium enrichment.", "symbols": [], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/news/politics/25/06/45737741/chuck-schumer-says-if-taco-trump-is-already-folding-on-iran-the-american-people-need-to-know-one-day-he-sounds-tough-the-next-day-hes-backing-off", "tags": ["contract"]}
{"id": 45734329, "time": "2025-06-02 16:16:35", "headline": "Black Spade Acquisition II To Voluntarily Delist From Nasdaq Upon Consummation Of Pending Business Combination With The Generation Essentials Group", "summary": "", "symbols": ["BSII", "TGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/06/45734329/black-spade-acquisition-ii-to-voluntarily-delist-from-nasdaq-upon-consummation-of-pending-business-c", "tags": []}
{"id": 45732180, "time": "2025-06-02 14:56:13", "headline": "UPDATED: GameStop Option Alert: Fri $32.5 Calls Sweep (4) near the Ask: 1000 @ $0.49 vs 2881 OI; Earnings 6/10 After Close [est] Ref=$30.59", "summary": "", "symbols": ["GME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/06/45732180/gamestop-option-alert-fri-32-5-calls-sweep-4-near-the-ask-1000-0-49-vs-2881-oi-earnings-613-before-o", "tags": ["earnings"]}
